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xvii Summary 
The  overall  aims  of  the  studies  were  to  obtain  objective  measures 
of  oral  precancerous  lesions  based  upon  studies  of  the  cell  cycle  and  to 
investigate  these  parameters  as  possible  prognostic  indicators  with 
regard  to  malignant  transformation  of  these  lesions.  The  majority  of  the 
precancerous  lesions  in  the  present  study  were  clysplastic.  These  are  the 
lesions  which  cause  the  greatest  concern  clinically  with  regard  to 
malignant  transformation. 
The  first  part  of  the  study  investigated  the  S-phase,  growth  fraction 
and  the  relationship  of  these  to  each  other  and  with  the  degree  of 
dysplasia  with  the  aim  of  achieving  objective  measurements  of  the 
dysplasia  and  prognostic  information.  This  was  achieved  by  the  use  of 
BrdU  for  labelling  of  cells  in  the  S-phase  and  anti-Ki67  antibody  as  a 
marker  of  cells  in  the  growth  fraction.  The  BrdU  labelling  index  was 
demonstrated  to  provide  an  objective  assessment  of  the  dysplastic 
lesions  when  compared  to  the  semi-objective  method  of  Smith  and 
Pindborg  (1969).  The  ratio  of  the  S-phase  to  the  growth  fraction  was 
higher  in  those  lesions  which  progressed  to  malignancy  and  was  cited  as 
a  possible  prognostic  indicator. 
A  number  of  methodological  problems  were  identified  from  this  first 
part  of  the  study  and  these  were  investigated  further  by  the  development 
of  techniques  in  Chapter  3.  Firstly,  a  method  was  developed  to  enable 
the  BrdU  labelled  tissues  to  be  formalin  fixed  and  then  allow  other  cell 
xviii cycle  associated  markers  to  be  studied  on  sequential  sections  of  the 
same  tissue  block.  Secondly,  numerous  antigen  retrieval  techniques 
were  carried  out  in  order  to  optimise  the  immunohistochernical  staining  of 
Ki67  and  subsequently  other  antibodies  utilised  in  later  parts  of  the  study. 
Normal  oral  epithelium,  derived  post-mortem,  was  studied  in 
Chapter  4  to  investigate  the  apparent  underestimation  of  proliferating 
cells  identified  by  anti-Ki67  antibody  in  Chapter  2.  It  was  apparent  that, 
as  in  dysplastic  epithelia,  Ki67  significantly  underestimated  progenitor 
cells  of  the  morphologically  identified  progenitor  compartment.  Ki67  did 
not  identify  all  of  those  cells  which  would  have  been  expected  to  be  in  the 
cell  cycle  as  it  was  originally  claimed  to  do.  Also,  this  work  demonstrated 
that  post-mortern  tissue  was  a  useful  source  of  control  tissue  in 
proliferation  studies. 
With  the  use  of  antibodies  against  the  G,  cyclins,  cyclins  Dl,  D3 
and  E,  the  studies  of  Chapter  5  investigated  the  possible  lack  of 
expression  of  Ki67  in  the  G,  phase  of  the  cell  cycle.  The  results 
demonstrated  that  the  expression  of  the  D  cyclins  was  high  in  oral 
epithelial  dysplasia  and  was  correlated  with  Ki67.  The  reasons  for  this 
were  less  clear.  It  may  represent  a  true  overexpression  of  the  protein  in 
these  lesions  or  more  likely  a  continued  expression  of  the  protein 
throughout  other  phases  of  the  cell  cycle  in  addition  to  G, 
- 
The 
distribution  of  cyclin  E  was  unexpected  and  largely  appeared  in  cells  that 
would  be  classified  as  belonging  to  the  maturation  compartment.  There 
xix was  some  association  of  the  cyclin  labelling  indices  to  the  degree  of 
dysplasia  but  this  was  not  as  marked  as  the  association  of  BrdU 
previously  demonstrated. 
Finally  a  further  study  of  the  relationship  of  the  S-phase  with  the 
growth  fraction  was  performed  in  Chapter  6.  In  addition  to  utilising  the 
techniques  developed  in  the  methods  chapter  of  formalin  fixation  of  the 
BrdU  labelled  tissue,  the  S-phase  associated  cyclin  A  was  investigated 
as  a  possible  alternative  to  BrdU.  A  correlation  of  cyclin  A  with  BrdU  was 
demonstrated.  However,  the  cyclin  A  labelling  indices  were  much  higher 
in  some  more  severely  dysplastic  lesions  suggesting  this  protein  may  be 
overexpressed  as  part  of  the  carcinogenic  process.  The  use  of  this 
marker  for  cells  in  the  S-phase  is  probably  only  appropriate  in  normal  or 
minimally  dysplastic  tissues. 
Overall,  although  BrdU  requires  prospective  collection  of  tissues,  it 
consistently  provided  unequivocal  positivity  when  detected 
immunohistochemically  compared  with  some  of  the  other  antibodies 
studied.  The  relationship  of  the  S-phase  to  the  growth  fraction  appears  to 
be  a  promising  parameter  to  assess  the  prognosis  of  oral  epithelial 
dysplasia.  However,  due  to  the  often  protracted  natural  history  of  such 
lesions,  much  longer  term  studies  would  be  required  to  assess  the 
validity  of  this.  Post-mortem  tissue  appears  useful  as  a  source  of  truly 
normal  epithelium.  The  G,  cyclins  have  not  contributed  greatly  to  the 
present  studies  of  oral  epithelial  dysplasia  and  until  their  precise 
xx functions  within  the  cell  have  been  established  their  usefulness  in 
proliferation  studies  of  this  kind  is  severely  limited.  Cyclin  A,  with  its 
recognised  limitations,  appears  to  be  a  viable  alternative  to  BrdU  in  the 
study  of  the  S-phase. 
xxi Chapter  I 
Introduction  and  Review  of  the  Literature 1.1  Oral  Cancer 
1.1.1  Incidence  and  epidemiology  of  oral  cancer 
Oral  cancer  is  estimated  to  be  the  sixth  most  prevalent  cancer  on  a 
world-wide  scale  (Parkin  et  aL,  1988).  There  are,  however,  significant 
geographical  and  regional  variations  in  incidence  with  oral  cancer  being 
prevalent  in  parts  of  Asia,  but  only  accounting  for  about  2%  of 
malignancies  in  Europe  including  the  UK  (Johnson,  1991).  In  the  literature 
and  in  this  thesis  oral  cancer  is  taken  to  refer  to  squamous  cell  carcinoma 
arising  from  the  oral  mucosa  as  this  is  by  far  the  most  common  oral 
malignancy  accounting  for  the  majority  of  cases;  carcinomas  and 
sarcomas  arising  from  salivary  glands,  bone  and  other  soft  tissues 
account  for  a  relatively  small  number  and  have  a  different  aetiology  to  oral 
squamous  cell  carcinoma. 
In  the  UK,  the  majority  of  cases  of  oral  cancer  occur  in  older  adults 
and  more  males  than  females  are  affected  (Johnson,  1991).  The 
incidence  of  oral  cancer  in  England  and  Wales  was  decreasing  in  the  first 
half  of  this  century  but  there  is  evidence  that  the  incidence  is  beginning  to 
rise  again  (Hindle  et  aL,  1996;  La  Vecchia  et  aL,  1997;  Macfarlane  et  aL, 
1992).  While  there  has  been  a  decline  in  incidence  and  mortality  in  older 
age  groups,  there  is  an  increasing  incidence  and  mortality  in  younger 
males  with  evidence  for  clear  birth  cohort  differences  (particularly  those 
born  after  about  1920)  and  implications  for  expected  frequency  in  the 
future  (Hindle  et  aL,  1996).  This  trend  is  also  observed  in  Scotland 
2 (Macfarlane  et  aL,  1992).  The  age-standardised  rates  for  oral  cancer 
showed  the  UK  incidence  in  males  to  be  5.7  per  100  000  and  2.5  per  100 
000  in  females  with  mortality  rates  of  2.9  and  1.1  per  100  000  for  males 
and  females  respectively  in  1990  (Black  et  aL,  1997).  A  recent  study 
based  in  the  North-East  of  England  suggested  a  possible  link  between 
oral  cancer  incidence  and  social  deprivation  (O'Hanlon  et  aL,  1997). 
Intraoral  cancer  most  commonly  affects  the  lateral  border  of  the 
tongue  and  the  floor  of  the  mouth  with  much  lower  incidences  reported  for 
the  buccal  mucosa,  mandibular  alveolus  and  soft-palate  complex 
(Johnson,  1991).  Cancer  of  the  lip  traditionally  had  a  higher  incidence  in 
those  manual  workers  who  had  worked  for  long  periods  outside  but  with 
fewer  people  employed  in  such  tasks  the  incidence  is  declining. 
1.1.2  Aetiology 
There  is  overwhelming  and  consistent  evidence  linking  tobacco  to 
the  aetiology  of  oral  cancer.  In  developed  countries  tobacco  is  smoked 
predominantly  in  the  form  of  cigarettes  whilst  in  Asia  (and,  indeed,  among 
Asian  populations  now  residing  in  the  West)  a  wide  variety  of  methods  are 
practised  many  involving  combining  tobacco  with  other  substances  which 
are  often  chewed  or  held  for  long  periods  in  the  mouth.  An  example  of  this 
is  the  betel  quid  or  pan  comprising  tobacco  mixed  with  areca  nut  and 
slaked  lime  and  wrapped  in  betel  leaf.  This  widespread  practice  accounts 
for  the  increased  incidence  and  different  sites  involved  (the  buccal 
mucosa  and  retromolar  areas)  among  these  people  (Johnson,  1991). 
3 Alcohol  is  also  strongly  linked  to  the  aetiology  of  oral  cancer  and 
appears  to  act  synergistically  with  tobacco  (Brugere  et  aL,  1986).  Alcohol 
therefore  probably  contributes  to  many  of  the  cases  in  the  developed 
world  where  it  is  widely  available. 
The  role  of  viruses  in  the  aetiology  of  oral  cancer  is  less  clear. 
Despite  being  strongly  implicated  in  some  human  carcinomas  including 
the  uterine  cervix  and  nasopharynx  there  is  little  evidence  for  the  role  of 
viruses  in  oral  carcinoma.  Applications  of  recently  developed  molecular 
techniques  such  as  in  situ  hybridisation  and  the  polymerase  chain  reaction 
(PCR)  have  demonstrated  the  presence  of  human  papilloma  virus  (HPV) 
DNA  in  oral  cancer  cells.  This  may  be  an  incidental  finding  of  a  relatively 
ubiquitous  virus  or  an  effect  rather  than  a  cause  as  it  is  also  found  in  a 
significant  proportion  of  normal  oral  mucosae  and  in  benign  conditions 
(Miller  and  White,  1996). 
The  atrophic  epithelium  associated  with  nutritional  deficiencies, 
particularly  iron,  has  been  shown  to  have  an  association  with  the 
development  of  carcinoma. 
1.1.3  Treatment 
The  treatment  of  oral  cancer  is  based  on  surgical  resection  and 
radiotherapy  either  alone  or  in  combination  for  both  the  primary  tumour 
and  regional  lymph  node  metastases  (Brown  and  Langdon,  1995). 
Chemotherapy,  although  still  practised  by  some,  has  not  been  proven  as 
4 effective  as  the  other  treatment  modalities  with  no  significant  influence  on 
survival  (Stell  and  Rawson,  1990).  The  overall  five  year  survival  for  oral 
cancer  is  in  the  region  of  40%  and  despite  advances  in  treatment  this 
figure  has  not  improved  significantly  over  the  last  20  years  (Johnson, 
1991).  Failure  of  treatment  often  results  in  recurrence  of  the  tumour  at  the 
primary  site  or  development  of  metastases  in  the  cervical  lymph  nodes, 
although,  as  treatment  of  the  primary  and  regional  sites  improves  there 
are  increasing  problems  with  distant  metastases  (Brown  and  Langdon, 
1995).  Similarly,  the  incidence  of  second  primary  tumours  is  increasing  in 
the  oral  cavity,  pharynx  or  larynx  (Ogden,  1991).  Such  occurrences  are 
often  attributed  to  so  called  field  cancerisation  (Ogden,  1996;  Slaughter  et 
aL,  1953)  or  field  change  (Ogden,  1998)  based  on  the  theory  that 
widespread  exposure  of  the  mucosa  of  the  upper  aero-digestive,  tract  to 
carcinogenic  substances  may  induce  similar  changes  to  cells  in  more  than 
one  site  and,  therefore,  account  for  the  occurrence  of  turnours  at  different 
sites.  , 
1.1.4  Early  oral  cancer 
The  term  "early  oral  cancer  has  been  applied  to  those  lesions 
which  are  small  and  asymptomatic,  located  in  the  soft  palate  complex  or 
floor  of  mouth  and  manifest  most  commonly  as  predominantly  red  lesions 
(Mashberg  and  Samit,  1995).  These  lesions  are  said  to  differ  from  more 
advanced  cases  in  that  they  are  not  ulcerated  or  indurated  and  often 
resemble  precancerous  lesions  (see  below)  although  histological 
5 examination  reveals  early  invasion. 
Early  diagnosis  of  oral  cancer  should  offer  the  best  prognosis  for 
the  patient  in  terms  of  ease  of  removal  with  less  ablative  surgery, 
therefore  less  post-operative  morbidity,  and  long-term  survival.  However, 
data  to  support  this  assumption  are  scarce  and  as  Johnson  et  al  (1995) 
point  out,  a  small  lesion  may  be  such  because  it  is  slow  growing  with  an 
inherently  good  prognosis.  "Early"  detection  of  a  small  lesion  which  is 
aggressive  in  terms  of  its  histology  and  speed  of  growth  may  not  confer 
any  significant  prognostic  advantage. 
Screening  for  oral  cancer  has  received  much  attention  recently  but, 
as  yet,  there  is  no  consensus  of  opinion  to  support  such  a  measure  in  the 
UK  despite  the  oral  cavity  being  one  of  the  most  accessible  sites  to  screen 
(Franceschi  et  aL,  1997;  Speight  et  aL,  1992).  There  may  be  merit  in 
some  form  of  screening  for  those  deemed  to  be  in  high  risk  groups  on  the 
basis  of  tobacco  and  alcohol  habits  but  individuals  of  such  groups  are 
often  those  with  low  compliance  with  screening  schemes  (Jullien  et  aL, 
1995). 
1.2  Precancerous  Lesions 
1.2.1  Definitions 
A  precancerous  (premalignant)  lesion  as  defined  recently  by  an 
international  working  group  (Ax6Il  et  aL,  1996)  is  "a  morphologically 
altered  tissue  in  which  cancer  is  more  likely  to  occur  than  in  its  apparently 
6 normal  counterpart".  This  was  updated  from  a  previous  definition  from  the 
same  group  (Kramer  et  aL,  1978)  to  attempt  to  overcome  some  of  the 
problems  identified  with  the  previous  definitions.  Examples  of  such  lesions 
are  oral  leukoplakia  and  erythroplakia.  To  clarify  the  terminology,  a 
precancerous  (premalignant)  condition  is  a  generalised  state  associated 
with  a  significantly  increased  risk  of  cancer,  an  example  being  oral 
submucous  fibrosis  (Ax6ll  et  aL,  1996).  Morphological  alterations  referred 
to  in  this  context  are  changes  in  clinical  appearance  and  not 
histopathologically  (MacDonald  and  Saka,  1991). 
1.2.2  Leukoplakia 
Oral  leukoplakia  is  a  predominantly  white  lesion  of  the  oral  mucosa 
that  cannot  be  characterised  as  any  other  definable  lesion  (Ax6ll  et  aL, 
1996).  It  is  a  purely  clinical  diagnosis  and  is  based  upon  identifying  and 
eliminating  any  possible  aetiologic  factors  such  as  trauma  or  chemical 
agents  (other  than  tobacco)  and  bears  no  relation  to  the  histopathological 
features.  once  the  diagnosis  of  leukoplakia  is  established, 
histopathological  examination  is  usually  performed  which  serves  two 
important  purposes,  namely  to  exclude  other  mucosal  disease  and 
determine  the  presence  and  degree  of  dysplasia  (van  der  Waal  et  aL, 
1997).  A  proportion  of  these  lesions  will  transform  into  carcinoma.  In  the 
literature  of  the  past  there  has  often  been  erroneous  use  of  leukoplakia  in 
a  histopathological  sense  which  can  lead  to  some  confusion  in  interpreting 
results. 
7 Three  clinical  variants  of  white  and  red  lesions  are  proposed  (Ax6ll 
et  aL,  1996):  homogenous  leukoplakia  which  is  a  predominantly  white 
lesion  of  uniform  flat,  thin  appearance  that  may  exhibit  shallow  cracks  and 
has  a  smooth,  wrinkled  or  corrugated  surface  with  a  consistent  texture 
throughout.  Non-homogeneous  leukoplakia  is  a  predominantly white  or 
white  and  red  lesion  that  may  be  irregularly  flat,  nodular  or  exophytic.  A 
lesion  showing  white  and  red  areas  is  referred  to  as  erythroleukoplakia. 
Erythroplakia  is  analogous  to  leukoplakia  in  that  it  is  a  red  patch  that 
cannot  be  diagnosed  as  any  other  definable  lesion. 
1.2.3  Aetiology 
As  with  oral  cancer,  tobacco  and  alcohol  are  strongly  associated 
with  leukoplakia.  The  relative  importance  of  the  two  agents  is  difficult  to 
assess  since  most  patients  with  leukoplakia  tend  to  indulge  in  both  habits. 
If  trauma  or  other  agents  are  found  to  be  responsible  for  oral  white  lesions 
(usually  by  exclusion)  then  the  diagnosis  of  leukoplakia  must  not  be 
applied.  For  example,  frictional  keratosis  should  be  applied  if  friction  is 
causative  agent.  Idiopathic  leukoplakia  has  been  proposed  for  those 
lesions  which  are  not  associated  with  tobacco  use  or  other  aetiology. 
However  under  the  definition  proposed  these  lesions  should  be  included 
as  leukoplakia  along  with  the  tobacco  associated  lesions. 
1.2.4  Other  white  lesions 
The  term  proliferative  verrucous  leukoplakia  was  coined  by  Hansen 
et  al  (1985)  to  denote  a  characteristic  form  of  leukoplakia  which  is  a 
8 progressively  expanding  exophytic  lesion  which  has  a  high  risk  of 
malignant  transformation.  The  same  group  recently  reported  a  follow-up 
study  of  54  patients  with  this  lesion  (Silverman  and  Gorsky,  1997).  They 
reported  the  lesion  to  be  more  common  in  women  than  men  with  no  clear 
association  to  tobacco  use  and  over  70%  transformation  to  carcinoma 
over  a  period  of  nearly  eight  years. 
Hairy  leukoplakia  is  a  bilateral  white  lesion  usually  found  on  the 
tongue,  sometimes  the  buccal  mucosa,  in  immunocompromised  patients 
and  is  known  to  be  caused  by  Epstein-Barr  virus.  It  is  not,  however,  a 
precancerous  lesion  despite  the  use  of  the  term  leukoplakia  and  the 
alternative  term  "Greenspan  lesion"  has  been  proposed  (van  der  Waal, 
1996). 
Lichen  planus  and  related  lesions  (lichenoid  reactions,  drug 
eruptions)  often  present  as  white  patches,  typically  of  the  buccal  mucosa 
and  lateral  borders  of  tongue.  Controversy  exists  regarding  the 
premalignant  potential  of  these  lesions  which  may  in  part  be  due  to 
problems  of  interpreting  the  significance  of  dysplasia  in  some  of  these 
lesions.  The  term  lichenoid  dysplasia  has  been  applied  to  those  lesions 
exhibiting  dysplasia  which  have  some  of  the  histological  features  of  lichen 
planus  (Eisenberg  and  Krutchkoff,  1992).  Recently,  Zhang  et  al  (1997) 
using  loss  of  heterozygosity  (LOH)  studies  of  chromosomes  frequently 
involved  in  oral  cancer,  reported  that  LOH  was  not  prevalent  in  lichen 
planus  compared  to  epithelial  dysplasia.  They  concluded  that  if  malignant 
9 change  occurred  in  lichen  planus  it  was  due  to  different  genetic  changes 
than  in  dysplastic  lesions. 
1.2.5  Transformation  to  oral  cancer 
As  stated  in  the  definition  of  leukoplakia,  a  proportion  of  these 
lesions  will  transform  into  carcinoma.  However  the  number  of  such  lesions 
and  in  particular,  which  lesions  will  become  malignant  is  the  basis  of  much 
research  and  discussion  and  indeed  one  of  the  aims  of  this  thesis.  Also, 
opinions  vary  as  to  how  many  oral  cancers  are  preceded  by  premalignant 
lesions,  but  it  is  thought  that  the  majority  of  oral  carcinomas  arise  from 
apparently  clinically  normal  mucosa.  Bouquot  et  al  (1988)  reported  that 
only  36%  of  intraoral  cancers  were  associated  with  leukoplakia  while 
nearly  twice  as  many  lip  cancers  were.  There  is  however,  thought  to  be  a 
marked  geographic  variation  with  the  majority  of  lesions  in  the  high  risk 
counties  of  the  Eastern  subcontinent  being  preceded  by  precancerous 
lesions  (MacDonald  and  Saka,  1991). 
A  proportion  of  the  clinical  lesions  of  leukoplakia  demonstrate 
histopathological  signs  of  epithelial  dysplasia,  however,  the  number  of 
lesions  doing  so  appears  to  be  relatively  few  (Silverman  et  aL,  1984).  The 
study  of  Silverman  et  a/  (1984)  is,  to  date,  one  of  the  largest  and  most 
comprehensive  studies  of  the  behaviour  of  oral  leukoplakia  in  developed 
counties  and  showed  that  only  22  out  of  257  cases  (8.5%)  demonstrated 
epithelial  dysplasia.  Of  this  large  group  17.5%  developed  carcinoma,  but 
36%  of  those  exhibiting  dysplasia  transformed  into  squamous  carcinoma. 
10 Lummerman  et  al  (1996)  recently  produced  a  retrospective  study  and 
found  that  16%,  7  of  44  cases  of  epithelial  dysplasia,  developed  invasive 
carcinoma  and  reviewing  the  literature  of  similar  studies  found  an  average 
transformation  rate  of  13.8%.  This  and  other  studies  are  summarised  in 
Table  1.1.  It  should  be  noted  that  the  aetiology,  treatment  and  follow-up 
regimes  for  these  lesions  varied  considerably  and  must  influence  the 
figures  of  such  studies  somewhat.  The  time  scale  over  which  this 
transformation  occurs  appears  to  vary  considerably  with  periods  of  up  to 
20  years  being  recorded  (136n6czy,  1977).  A  further  complication  in 
interpreting  these  figures  is  introduced  when  consideration  is  given  to  the 
fact  that  the  assessment  of  epithelial  dysplasia  is  subjective,  varies 
considerably  between  pathologists  (Abbey  et  aL,  1995;  Pindborg  et  aL, 
1985)  and  is  particularly  difficult  in  atrophic  epithelia  (Pindborg  et  aL, 
1985). 
1.2.6  Treatment 
Biopsy  is  often  the  first  line  of  action  in  the  management  of 
leukoplakia.  This  should  be  regarded  as  mandatory  for  all  lesions  which 
clinically  fit  into  the  category  of  leukoplakia  (i.  e.  cannot  be  categorised  as 
any  other  definable  lesion  (Ax6il  et  aL,  1996)).  The  histology  report  should 
always  include  an  observation  of  the  presence  or  absence  of  dysplasia 
and  its  severity  (Ax6II  et  aL,  1996).  It  is  well  known,  however,  that  a  biopsy 
may  not  be  representative  of  the  entire  lesion  and  this  raises  the  question 
of  appropriate  sampling  of  such  lesions.  Lummerman  et  al  (1996) 
11 observed  skip  areas  where  normal  epithelium  intervened  between 
dysplastic  epithelium  and  that  a  range  of  severity  of  dysplasia  could  be 
seen  within  various  portions  of  the  same  specimen.  Clinical  experience 
and  the  knowledge  of  the  natural  history  of  such  lesions  indicates  that 
lesions  appearing  as  erythroplakia  or  eryth  role  u  kop  lakia  (speckled 
leukoplakia)  have  a  higher  incidence  of  dysplasia  and  malignant 
transformation  (Speight  and  Morgan,  1993)  and  would,  therefore,  be  the 
areas  of  choice  for  biopsy. 
An  old  idea  regaining  popularity  among  some  surgeons  is  the  use 
of  toluidine  blue  dye  to  aid  in  the  selection  of  more  dysplastic  areas 
(Tradati  et  aL,  1997).  A  recent  study  concluded  it  was  highly  sensitive  for 
detecting  carcinomas  but  there  was  an  alarming  rate  of  false  positives  for 
detection  of  dysplasia  (Martin  et  aL,  1998).  This  method  may  have  some 
place  in  aiding  the  diagnosis  in  high-risk  groups  (Warnakulasuriya  and 
Johnson,  1996)  but  it  is  not  widely  advocated  for  general  use. 
The  definitive  management  of  oral  leukoplakia  still  has  no  standard 
protocol  and  variation  has  been  demonstrated  regarding  the  treatment  of 
these  lesions  at  different  centres  in  the  UK  (Marley  et  aL,  1996).  There  is 
usually  little  doubt  that  those  lesions  showing  more  severe  degrees  of 
dysplasia  histologically  require  active  treatment.  However,  it  is  those 
lesions  where  clysplasia  is  minimal  or  absent  where  there  are  more 
varying  practices. 
Surgical  excision  or  laser  excision  are  the  more  popular  modalities 
12 of  treatment  and  probably  still  the  most  widely  used  modalities  (van  der 
Waal  et  aL,  1997).  A  problem  with  the  use  of  the  latter  is  the  inability  to 
assess  the  margins  histologically. 
Vitamin  A  and  its  derivatives  (retinoids)  appear  to  have  at  least 
some  protective  effect  regarding  the  development  of  cancer  and  are  used 
in  the  treatment  of  premalignant  lesions  in  their  capacity  as  antioxidants 
(Kaugars  et  al.,  1996).  McGregor  et  al  (11997)  have  recently  demonstrated 
loss  of  retinoic  acid  receptors  in  oral  dysplastic  lesions  was  accompanied 
by  the  development  of  an  immortal  phenotype  associated  with 
malignancy. 
A  relatively  new  approach  to  the  treatment  of  leukoplakia  is  that  of 
photodynamic  therapy  in  which  photosensitising  drugs  (porphyrin 
derivatives)  are  administered  systemically  and  are  then  activated  by  the 
use  of  light  and  the  presence  of  oxygen  (Nauta  et  aL,  1996).  There  are  as 
yet  no  long-term  studies  to  prove  the  effectiveness  of  this  treatment. 
1.2.7  Histopathology 
Histopathologically,  epithelial  dysplasia  is  characterised  by  the 
presence  of  features  such  as  drop-shaped  rete-ridges,  disturbed  epithelial 
stratification  and  changes  in  the  size,  shape  and  staining  characteristics  of 
the  nuclei.  There  are  at  least  13  histological  features  described,  a 
complete  list  of  which  can  be  found  in  Appendix  1.  The  above  features 
relate  just  to  the  epithelium.  Wright  and  Shear  (1985)  also  included 
Russell  bodies,  eosinophils  and  inflammation  to  their  assessments  of 
13 epithelial  dysplasia;  these  being  features  of  the  reaction  of  the  host  to  the 
abnormal  epithelium.  This  aspect  of  dysplasia  would  seem  to  be 
important,  particularly  with  regard  to  the  prevention  of  invasion,  but  it 
appears  to  have  received  less  attention  in  oral  precancer  than  it  has  in 
oral  cancer  where  it  is  one  of  the  features  assessed  in  the  histological 
scoring  system  proposed  by  Anneroth  et  a/  (1987).  Interestingly,  the  latest 
World  Health  Organisation  publication  on  the  histological  typing  of  oral 
epithelial  dysplasia  includes  prominent  nucleoli  as  one  of  the  features  of 
dysplasia  (Pindborg  et  aL,  1997).  This  is  presumably  as  a  reflection  of  the 
proliferative  state  of  the  tissue  (see  below). 
The  identification  of  the  features  of  dysplasia  is  not  difficult  but  the 
relative  importance  of  the  individual  features  and  hence  assessment  of  the 
severity  of  dysplasia  is  considerably  more  of  a  problem.  Compared  with 
the  number  of  publications  investigating  other  markers  of  potentially  high 
risk  lesions  there  are  few  investigating  the  histopathological  features  of 
oral  epithelial  dysplasia.  This  is  surprising  since  this  is  the  sole  method 
employed  by  the  majority  of  pathologists  in  routinely  reporting  these 
specimens.  Kramer  et  al  (1970)  using  a  discriminant  analysis  investigated 
the  histological  features  of  oral  leukoplakia  that  segregated  those  lesions 
that  will  undergo  transformation  to  carcinomas.  They  identified  nuclear 
hyperchromatism  and  loss  of  basal  cell  polarity  as  possible  markers  of 
such  lesions. 
Banoczy  and  Csiba  (1976)  found  disturbed  epithelial  maturation  in 
14 75%  of  cases  of  epithelial  dysplasia  but  this  was  not  a  predictor  of 
malignant  transformation.  They  found  a  lower  incidence  of  basal  cell 
hyperplasia,  loss  of  basal  cell  polarity,  loss  of  adherence  and  nuclear 
hyperchromatism  in  their  series.  The  criteria  for  inclusion  in  their  study, 
however,  were  cases  which  histologically  showed  as  few  as  two  features 
of  dysplasia.  Many  pathologists  would  not  classify  such  cases  as 
dysplastic  on  this  basis  and  this  highlights  the  subjective  nature  of 
assessments. 
Dysplasia  is  often  found  adjacent  to  established  squarnous  cell 
carcinoma  and  on  the  assumption  that  dysplastic  features  in  such  a  site 
may  be  better  indicators  of  carcinoma  development,  Wright  and  Shear 
(1985)  reported  a  high  incidence  of  basal  cell  hyperplasia  and  disturbed 
epithelial  maturation  in  these  cases  but  a  relatively  low  incidence  of  mitotic 
abnormalities. 
An  increased  nuclear  cytoplasmic  ratio  of  basal  and  spinous  cells  is 
a  histological  feature  of  dysplastic  epithelium  but  has  been  reported  as 
being  present  in  less  than  50%  of  dysplasias  adjacent  to  carcinomas 
(Wright  and  Shear,  1985).  In  recent  studies  the  nuclear  cytoplasmic  ratios 
were  less  than  those  of  non-clysplastic  and  benign  lesions  of  buccal 
mucosa  (White  et  aL,  1997)  and  palate  (Jin  et  A,  1995).  The  authors 
believed  this  was  therefore  of  little  predictive  value  for  the  assessment  of 
potentially  malignant  lesions. 
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While  it  is  appreciated  that  those  clinically  precancerous  lesions 
which  show  the  histopathological  features  of  epithelial  dysplasia  are  of 
more  concern  and  more  likely  than  those  not  showing  dysplasia  to 
undergo  transformation  into  carcinoma,  it  is  still  a  minority  of  these  lesions 
which  do  undergo  this  transformation  (Lummerman  et  al.,  1996;  Silverman 
et  aL,  1984).  Ideally  there  would  be  a  "tumour  marker"  which  would  be 
present  in  those  lesions  which  will  become  malignant  but  absent  in  those 
lesions  which  will  not.  Unfortunately  matters  are  not  that  simple. 
Carcinogenesis  is  a  multistage  process  requiring  an  accumulation  of  gene 
defects  before  a  malignant  clone  is  established  with  the  ability  to  become 
autonomous  with  regard  to  its  growth  control,  evade  the  host  defence 
mechanisms  and  behave  in  a  malignant  fashion.  The  investigation  of 
potential  markers  is  based  on  the  assumption  that  a  key  step  in  this 
process  could  be  identified  that  will  distinguish  a  lesion  which  will  behave 
in  a  malignant  fashion  from  one  which  will  behave  in  a  benign  manner.  By 
the  multifactorial  nature  of  the  process  it  seems  unlikely  that  such  a 
perfect  marker  actually  exists.  To  further  compound  studies  of  oral 
premalignant  lesions,  the  sometimes  protracted  natural  history  of  such 
lesions  means  meaningful  data  regarding  malignant  transformation  would 
ideally  require  long-term  follow  up  periods  which  are  often  neither  practical 
or  possible. 
16 There  now  follows  a  review  of  the  various  parameters  that  have 
been  investigated  in  relation  to  their  differences  in  normal,  dysplastic  and 
malignant  epithelia.  It  should  be  appreciated  from  the  outset  that  there  are 
various  levels  on  which  such  an  investigation  can  be  performed.  Until 
recent  years  many  of  the  investigations  involved  either  specialised 
histological  techniques  or  immunohistochernistry  which  gave  the 
investigator  some  indication  of  the  expression  of  particular  proteins. 
However,  since  it  is  defects  at  the  level  of  the  genes  encoding  such 
proteins  which  are  important  there  followed  the  development  of  methods 
to  enable  this  level  of  investigation.  The  latter  methods  necessitated  the 
use  of  fresh  tissue  but  developments  have  meant,  that  now,  many 
molecular  techniques  can  be  applied  to  archival  formalin-fixed,  paraffin- 
embedded  tissues.  These  developments  may  make  it  possible  to  study 
more  lesions  where  the  natural  history  is  known  and  well  documented. 
Firstly  there  will  be  a  brief  overview  of  a  vast  literature  concerning 
markers  other  than  those  directly  associated  with  cell  proliferation.  This 
will  be  followed  by  a  more  detailed  analysis  of  the  investigations  relating  to 
the  cell  cycle  which  forms  the  basis  of  the  work  of  this  thesis. 
1.3.1  Cell  surface  features 
The  loss  of  cell  to  cell  and  cell  to  tissue  matrix  adherence  due  to 
changes  in  the  cell  surface  components  is  one  characteristic  of  the 
malignant  phenotype.  The  majority  of  work  in  this  area  has  been  achieved 
by  the  use  of  immunohistochernistry  and  has  been  comprehensively 
17 reviewed  with  respect  to  oral  precancer  by  Scully  and  Burkhardt  (1993) 
and  more  generally  with  regard  to  human  carcinomas  by  Dabelsteen 
(11996).  A  brief  overview  of  the  salient  points  now  follows. 
Cell  surface  carbohydrates  have  received  much  attention  and  it  has 
been  shown  that  the  development  of  malignancy  can  be  associated  with 
the  synthesis  of  new  carbohydrates,  the  accumulation  of  precursors  or  the 
loss  of  complex  carbohydrates  from  the  cell  surface  (Hakomori,  1989). 
The  ABH  blood  group  antigens  are  found  on  oral  mucosal  cells  as  well as 
blood  cells  and  are  readily  detected  by  the  use  of  lectin  histochemistry. 
Dabelstein  et  al  (1983)  have  shown  that  in  clysplastic  oral  epithelium  there 
was  an  accumulation  of  the  precursor,  H-antigen,  with  the  consequent 
loss  of  expression  of  the  A  and  B  antigens.  This  pattern  of  distribution  was 
also  seen  in  less  aggressive  squamous  cell  carcinomas  (Dabelsteen  et  aL, 
1983).  Loss  of  the  H-antigen  has  been  reported  in  histologically  benign 
epithelium  which  subsequently  underwent  malignant  transformation  but 
the  predictive  value  in  dysplastic  lesions  was  not  significant  (Auclair, 
1984).  The  Ley  antigen,  a  modified  H-antigen,  is  present  on  all  spinous 
cells  in  normal  oral  epithelium  but  is found  only  on  the  superficial  cells  in 
clysplastic  lesions  (Dabelsteen  et  aL,  1991).  The  expression  of  these 
antigens  is,  of  course,  related  to  the  genetic  background  of  the  individual 
and  varies  between  individuals  of  the  same  ABO  blood  group. 
The  Thornsen-Friedenreich  antigen  (T)  is  found  in  the  sialosyl-T 
form  on  normal  basal  and  parabasal  oral  epithelial  cells  and  the 
18 precursors  Tn  and  sialosyl-Tn  are  seen  in  the  cytoplasm  of  some  spinous 
cells  but  not  basal  cells  in  normal  oral  epithelium  (Mandel  et  aL,  1991). 
Sialosyl-T  disappeared  in  basal  cells  in  oral  epithelial  dysplasia  while 
sialosyl-Tn  expression  appeared  in  the  basal  cells  and  these  changes 
increased  as  the  severity  of  dysplasia  increased  (Bryne  et  aL,  1991). 
These  changes  were  not  specific  to  precancerous  lesions  and,  therefore, 
were  of  little  value  in  predicting  malignant  transformation  (Bryne  et  aL, 
1991). 
An  epithelial-specific  cell  surface  glycoprotein,  MI-199,  has  been 
reported  to  be  expressed  in  clysplastic  oral  epithelium  but  not  in  normal  or 
hyperkeratotic  tissues  and  in  relatively  low  amounts  in  squamous  cell 
carcinoma  and  has  been  proposed  as  a  potential  marker  of  malignant 
transformation  (High  et  aL,  1996). 
Growth  factors  and  receptors  are  known  to  be  important  in 
carcinomas.  The  most  studied  of  these  is  epidermal  growth  factor  receptor 
(EGFR)  which  is  responsive  to  the  polypeptide,  epidermal  growth  factor 
(EGF)  (Scully  and  Burkhardt,  1993).  In  dysplastic  and  malignant  oral 
epithelia  increased  amounts  of  EGF  were  observed  in  the  upper  lamina 
propria  in  fibroblasts,  the  presumed  source  of  EGF  (Shirasuna  et  aL, 
1991).  The  EGFR  may  be  increased  in  oral  epithelial  dysplasia  and 
carcinoma  (Shirasuna  et  aL,  1991).  The  EGFR  is  related  to  the  cellular 
oncogene,  c-erbB-2.  Overexpression  of  c-erbB-2  is  reported  to  be 
significantly  correlated  with  poor  survival  in  oral  squamous  cell  carcinoma 
19 (Xia  et  aL,  1997)  as  it  has  been  for  breast  cancer  (Ostrowski  et  aL,  1991). 
Integrins  are  a  family  of  adhesion  molecules  expressed  by  a  variety 
of  cells  and  are  involved  in  cell  to  cell  and  cell  to  extracellular  matrix 
interactions  (Thomas  et  aL,  1997).  In  oral  squamous  cell  carcinoma  a 
considerable  variation  in  integrin  expression  has  been  reported  and  no 
consistent  relationship  to  tumour  prognosis  has  been  established 
(Thomas  et  aL,  1997).  There  have  been  no  reported  investigations  of 
integrins  in  oral  precancerous  lesions  to  the  authors  knowledge. 
1.3.2  Cytosolic  features 
The  intermediate  filaments  of  the  cytoskeleton,  the  cytokeratins  are 
found  in  epithelial  cells.  In  a  similar  manner  to  cell  surface  antigen 
expression,  there  is  a  topographical  distribution  of  many  of  the 
cytokeratins  in  normal  oral  epithelia.  An  altered  distribution  of  cytokeratins 
was  observed  in  oral  epithelial  clysplastic  lesions  (Heyden  et  aL,  1992; 
Morgan  et  aL,  1991).  Morgan  et  al  (1991)  also  reported  a  tendency  for  the 
expression  of  those  keratins  normally  associated  with  simple  epithelia 
particularly  in  lesions  with  histologically  more  severe  dysplasia.  These 
studies,  however,  lacked  follow-up  data  and  it  was  not  possible  to  relate 
these  observations  to  the  subsequent  behaviour  of  the  lesions. 
The  proteins  filaggrin  and  involucrin  are  normally  found  respectively 
in  the  keratinised  layer  and  stratum  spinosum  of  oral  epithelia  and  can, 
therefore,  be  considered  as  markers  of  differentiation.  However,  their 
expression  appears  to  be  independent  of  the  degree  of  dysplasia  and 
20 aggressiveness  (Scully  and  Burkhardt,  1993). 
Heat  shock  proteins  (HSP)  are  ubiquitous,  highly  conserved 
proteins  produced  in  cells  under  stress  of  many  kinds,  including  tumour 
cells.  HSP  70  expression  in  oral  carcinoma  was  reported  to  be  increased 
as  it  was  in  dysplastic  lesions  and  benign  oral  mucosal  lesions  suggesting 
it  is  not  a  marker  of  malignant  potential  (Sugerman  et  aL,  1995).  Kaur  et  al 
(1996)  demonstrated  the  formation  of  a  complex  between  HSP  70  and 
p53  in  oral  epithelial  dysplasia  and  squamous  cell  carcinoma  but  not  in 
normal  oral  mucosa  and  suggested  this  may  be  one  mechanism  of 
inactivation  of  p53  in  the  carcinogenic  process. 
1.3.3  Extracellular  components 
The  basal  lamina  is  composed  primarily  of  laminin,  type  IV  collagen 
and  heparan  sulphate.  In  carcinomas  the  basement  membrane 
components  may  be  absent  but  it  has  been  suggested  that  larninin  may 
promote  invasion  and  metastasis  through  its  role  in  adhesion  to  integrins 
on  the  surface  of  tumour  cells  (Pattaramalai  and  Skubitz,  1994;  Scully  and 
Burkhardt,  1993).  Kumagai  et  a/  (1994)  reported  that  carcinomas  with  a 
widespread  loss  of  basement  membrane  components  showed  a  high 
frequency  of  lymph  node  metastasis  and  suggested  this  may  be  due  to 
the  production  of  meta  Hop  rotein  ases,  type  IV  collagenase  in  particular,  by 
the  tumour  cells.  In  precancerous  lesions,  breaks  in  the  continuity  of  the 
basement  membrane  were  reported,  assessed  by  immunohistochernical 
localisation  of  laminin  and  type  IV  collagen  (Firth  and  Reade,  1996). 
21 These  breaks  were  more  extensive  in  more  severely  clysplastic  lesions  but 
the  study  lacked  follow-up  data  to  support  the  notion  that  these  findings 
may  signify  a  progression  to  malignancy.  Increased  expression  of  laminin- 
5  mRNA  was  reported  in  oral  epithelial  clysplastic  lesions  and  in  the 
invasive  front  of  carcinomas  supporting  a  possible  role  in  invasion 
(Kainulainen  etaL,  1997). 
Tenascin  is  an  extracellular  matrix  protein  involved  in  epithelial- 
mesenchymal  interactions  during  embryogenesis  and  in  adult  tissues  is 
expressed  in  inflammation,  repair  and  tumourigenesis.  Tenascin 
imm  u  no  reactivity  was  increased  in  the  underlying  stroma  of  oral  epithelial 
dysplastic  lesions  particularly  those  with  more  severe  dysplasia  (Tiifta  et 
aL,  1994).  However,  this  was  seen  most  prominently  in  those  lesions 
containing  Candida  infection  and  hence  associated  with  a  prominent 
inflammatory  reaction. 
1.3.4  Nuclear  features 
The  majority  of  nuclear  parameters  have  an  association  with  the 
cell  cycle  or  cell  proliferation  and  will  therefore  be  discussed  under  those 
headings. 
Genetic  analyses  of  oral  squamous  cell  carcinomas  have  revealed 
some  consistent  genetic  alterations  in  these  turnours.  Loss  of 
heterozygosity  is  suggestive  of  the  existence  of  turnour  suppressor  genes 
and  has  been  observed  commonly  in  chromosomes  3p,  5q,  9p,  17p  and 
18q  of  oral  carcinomas,  some  of  which  are  also  found  in  tumours  with  a 
22 common  aetiology  to  oral  cancer  such  as  the  lung  (Califano  et  aL,  1996; 
Papadimitrakopoulou  et  aL,  1998;  Ransom  et  aL,  1996;  Sakata,  1996;  Wu 
et  aL,  1994).  A  putative  turnour  suppressor  gene,  deleted  in  oral  cancer-1 
(doc-1),  has  been  identified  which  altered  the  behaviour  of  malignant 
hamster  keratinocytes  reversing  some  of  the  malignant  phenotypes  (Todd 
et  aL,  1995). 
Sidransky's  team  in  the  USA  have  proposed  a  genetic  progression 
model  for  head  and  neck  cancer  using  PCR-based  microsatellite  analysis 
(Califano  et  aL,  1996).  These  workers  have  endorsed  the  field 
cancerisation  theory,  based  on  the  finding  that  mucosal  cells  adjacent  to 
turnours  shared  common  genetic  changes  and  that  more  histologically 
advanced  areas  showed  additional  changes  (Califano  et  aL,  1996).  These 
workers  have  proposed  a  further  theory  of  a  common  clonal  origin  for  the 
existence  of  multiple  primary  tumours.  This  is  based  upon  the  observation 
of  identical  genetic  alterations  in  multiple  turnours  and  it  was  suggested 
that  this  is  due  to  the  migration  of  a  transformed  clone  through  the 
mucosa  to  other  sites  (Bedi  et  aL,  1996).  Clinically  normal  tissues  some 
distance  from  the  primary  tumour  site  harboured  identical  genetic 
alterations  and  this  was  accounted  for  by  so-called  clonal  expansion  and 
migration  of  cells  to  these  sites.  This  could  account  for  the  development  of 
second  primary  turnours  in  these  patients  and  could  have  far-reaching 
implications  for  the  assessment  of  surgical  clearance  of  tumours.  Other 
workers  have  demonstrated  differing  genetic  alterations  in  dysplastic 
23 lesions  compared  with  subsequent  carcinomas  at  the  same  site  (Partridge 
et  aL,  1997) 
With  regard  to  oral  epithelial  clysplastic  lesions,  it  has  been 
suggested  that  loss  of  heterozygosity  at  chromosomes  3p  and  9p  is 
related  to  early  carcinogenesis  (Mao  et  aL,  1996).  Certainly,  chromosome 
3p  appears  to  be  consistently  affected  in  oral  dysplastic  lesions  (Califano 
et  aL,  1996;  Mao  et  aL,  1996;  Partridge  et  aL,  1997;  Roz  et  aL,  1996). 
1.3.5  Cancer-related  antigens 
No  perfect  "tumour  marker"  exists  for  oral  cancer  but  a  few  workers 
have  investigated  this  avenue.  A  monoclonal  antibody,  Ca  1,  which 
recognises  the  malignancy  associated  Ca  antigen  was  investigated  in  oral 
premalignant  and  malignant  lesions  (Masouredis  et  aL,  1987).  The 
authors  reported  nearly  three  quarters  of  the  squamous  cell  carcinoma 
cases  were  negative  with  this  antibody  as  were  all  the  dysplastic  lesions. 
One  benign  keratotic  lesion  was  positive  indicating  this  antibody  was 
unreliable. 
Two  monoclonal  antibodies,  17.13  and  63.12,  have  been  generated 
by  immunising  mice  against  human  laryngeal  and  oral  carcinoma  cells 
respectively.  In  oral  epithelial  dysplasia  a  staining  pattern  resembling 
carcinoma  was  observed  (Merrel  et  aL,  1997).  However,  associated 
inflammation  also  produced  a  similar  altered  reactivity  in  non-dysplastic 
lesions  negating  the  prognostic  use  of  these  antibodies. 
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An  increase  in  cell  proliferation  or  a  relative  increase  over  cell  loss 
has  long  been  considered  an  important  component  in  the  pathogenesis  of 
neoplasia.  It  must  be  noted  that  most  of  the  methods  currently  available 
identify  cells  within  a  tissue  at  a  "snap  shot"  in  time  and  therefore  give 
information  on  the  proliferative  "state"  rather  than  the  proliferation  "rate",  a 
term  that  is  often  referred  to  erroneously  in  the  literature  (Dover,  1992). 
Traditionally,  the  numbers  of  mitoses  per  high  power  field  have 
been  assessed  in  conventional  histological  sections.  This  gives  a 
parameter  known  as  the  mitotic  count  at  a  particular  point  in  time  but  gives 
no  indication  as  to  the  duration  of  mitosis,  T,,  or  of  the  cell  cycle,  T, 
(Aherne  et  aL,  1977).  Furthermore,  this  is  a  non-standardised 
measurement,  it  makes  no  account  of  cell  size  or  that  the  area  of  a  high 
power  field  varies  between  microscopes  and  it  is  open  to  interobserver 
variation  (Quinn  and  Wright,  1992). 
Many  workers  have  focused  their  attention  on  markers  of  cell 
proliferation  which  identify  cells  that  are  within  the  cell  cycle  either  at  a 
specific  phase  (or  phases)  or  throughout  all  phases  of  the  cell  cycle.  The 
majority  of  these  provide  a  proliferation  state  rather  than  proliferation  rate. 
Central  to  the  understanding  and  rationale  of  the  use  of  these  agents  is 
the  cell  cycle,  a  review  of  this  follows. 
1.4.1  The  cell  cycle 
The  cell  cycle  is  traditionally  described  as  comprising  of  four 
25 phases  as  follows.  The  presynthesis  gap  phase  (G,  )  is  the  interval  which 
follows  mitosis  and  precedes  the  DNA  synthesis  phase  (S)  which  typically 
lasts  6  to  16  hours  (Dover,  1992).  During  this  phase  the  DNA  is  replicated 
before  the  cell  enters  a  second  gap  phase  (G2)  lasting  between  4  and  8 
hours  (Dover,  1992).  Mitosis  (M)  follows  to  yield  two  daughter  cells  which 
then  enter  the  G,  phase.  In  the  G,  phase  of  the  cell  cycle  the  cell  will 
either  continue  to  cycle  through  the  phases  already  described  or  will  leave 
the  cell  cycle  in  to  a  resting  phase  (GO).  G,  is  the  most  variable  phase  in 
terms  of  length  of  time  spent  and  could  be  very  long  in  the  case  of  stem 
cells. 
From  Go  the  cell  can  either  re-enter  the  cell  cycle  into  G,  phase  or 
become  terminally  differentiated.  The  Go  phase  was  initially  suggested  by 
Lajtha  (1963)  to  describe  stable  liver  cells  which  only  proliferate  when 
stimulated  to  do  so  (a  conditionally  renewing  or  stable  tissue).  The  Go 
phase  may  be  a  phase  of  every  cell  cycle  or  may  be  a  completely 
separate  state  but  in  those  cells  with  a  long  G,  phase  it  is  not  possible  to 
distinguish  between  the  two  (Dover,  1992).  Indeed,  some  authors  doubt 
the  existence  of  Go  at  all  (Cooper,  1991).  The  growth  fraction  (GF)  is  a 
parameter  used  to  describe  the  proportion  of  cells  actually  in  the  cell  cycle 
at  a  particular  point  in  time. 
Heteroprotein  dimers  comprising  a  protein  kinase  (the  cyclin- 
dependent  kinases  or  CDK)  and  a  cyclin  act  as  regulatory  proteins  for 
progression  through  certain  check  points  in  the  cell  cycle  and  ensuring  the 
26 correct  chronological  order  of  events.  The  levels  of  CDKs  remain  relatively 
constant  throughout  the  cell  cycle  and  are  only  activated  by  binding  of  the 
cyclins,  hence  the  cyclins  have  relatively  short  half  lives  and  are  therefore 
potential  markers  of  cells  at  various  stages  of  the  cell  cycle.  The  cell  cycle 
and  its  regulatory  proteins  is  demonstrated  in  Figure  1.1. 
1.4.2  Restriction  point 
The  first  control  point  of  the  cell  lies  in  the  G,  phase  and  the 
continued  passage  through  this  phase  is  influenced  by  growth  factors,  for 
example  PDGF,  EGF,  11-3,  and  adequate  nutrients.  There  is  a  point  in  the 
G,  phase  referred  to  as  the  restriction  point,  or  START,  after  which  the  cell 
is  committed  to  enter  the  S  phase  and  DNA  replication.  Transition  through 
this  point  requires  the  formation  of  a  complex  between  the  D  cyclins  and 
CDK4  or  CDK6  with  the  transcription  factor  E2F  and  pRb  (the 
retinoblastorna  gene  product  and  equivalent  to  p105)  (Goodger  et  al., 
1997).  The  cyclin  D-CDK  complex  phosphorylates  pRb  leading  to  the 
dissociation  of  E217  allowing  transcription  of  genes  for  further  cycle 
progression  (Ewen  et  aL,  1993).  Once  the  cells  have  passed  this  point 
they  become  refractory  to  extrinsic  stimuli  and  further  cell  cycle  events  are 
governed  by  intrinsic  factors. 
1.4.3  S-phase  control 
A  complex  formed  between  cyclin  E  and  CDK2  controls  the 
transition  from  G,  into  S-phase  (Koff  et  at,  1991).  This  complex  may  also 
phosphorylate  pRb  releasing  E2F  as  well  as  being  involved  with  DNA 
27 replication  (Goodger  et  aL,  1997).  Cyclin  A  is  produced  at  the  beginning  of 
S-phase  and  complexes  with  CDK2  appearing  to  control  DNA  replication 
(Goodger  et  aL,  1997). 
1.4.4  Mitosis 
The  CDK  p34cc2  appears  central  to  the  control  of 
G21Mtransition 
(mitosis)  and  is,  in  fact,  a  component  of  the  so-called  maturation 
promoting  factor  (MPF)  as  is  histone  Hl  kinase  (Brooks,  1992).  p34" 
has  a  close  association  with  the  B  cyclins.  Phosphorylation  and 
dephosphorylation  of  MPF  components  controls  this  transition  (Brugere  et 
aL,  1986).  The  complex  moves  from  the  cytosol  to  the  nucleus  to  trigger 
chromosome  condensation,  nuclear  lamina  breakdown  and  the  formation 
of  mitotic  spindles  at  the  onset  of  the  prophase  of  mitosis. 
Following  metaphase,  cyclins  A  and  then  B  are  broken  down  via  a 
ubiquitin-dependent  pathway  (Goodger  et  aL,  1997).  Dividing  cells  then 
continue  through  anaphase  and  telophase  before  the  two  daughter  cells 
exit  from  mitosis  into  G1. 
1.4.5  Inhibition  of  cyclin/CDK  complexes 
The  CDKs  can  be  activated  by  cyclin  binding  and  phosphorylation 
(Morgan,  1995).  Phosphorylation  can  also  inhibit  the  CDK-cyclin 
complexes  as  can  another  group  of  proteins,  the  CDK  inhibitors  (CDKI) 
(Morgan,  1995).  Two  families  of  inhibitory  proteins,  the  ink4  proteins  and 
the  cip/kip  group  of  proteins  exert  negative  effects  upon  the  cyclin/CDK 
complexes  (Goodger  et  aL,  1997). 
28 The  ink4  family  of  proteins,  which  include  p15  and  p16,  has  a 
negative  control  on  CDK4  and  CDK6  therefore  preventing  them  from 
binding  cyclin  D  which  inhibits  the  phosphorylation  of  pRb  and  progression 
through  the  restriction  point  (Hall  et  aL,  1995).  The  loss  of  p16  function  is 
implicated  in  the  process  by  which  neoplastic  cells  develop  an  immortal 
phenotype,  along  with  mutation  or  deletion  of  p53  (Loughran  et  al.,  1994). 
p2l 
wafl/cipl  is  a  member  of  the  cip/kip  group  and  acts  upon  the  cyclin 
component  of  the  complexes  (cyclins  A,  B,  D  and  E),  a  broader  range 
than  the  ink4  group  (Hall  et  aL,  1995).  Overexpression  of  this  protein  is 
associated  with  arrest  of  cells  in  G,  (Harper  et  aL,  1993).  The  tumour 
suppressor  gene,  p53,  causes  G,  arrest  in  cells  with  DNA  damage  by  up- 
regulation  of  p2l*""P'  (Jacks  and  Weinberg,  1996).  p53  will  be  discussed 
further  in  relation  to  apoptosis. 
1.4.6  Apoptosis 
Apoptosis  is  programmed  death  of  individual  cells  in  a  tissue  and  is 
now  known  to  be  important  in  both  physiological  and  pathological 
situations.  Pathologically,  most  apoptosis  occurs  in  non-proliferating 
tissues  but,  particularly  in  regard  to  neoplasia,  it  has  a  strong  association 
with  cell  proliferation  and  is  a  target  for  therapy.  Apoptosis  is  the 
mechanism  by  which  most  cytotoxic  drugs  exert  their  effect  (Evan  et  aL, 
1995).  Paradoxically  it  seems,  some  of  the  inducers  of  cell  proliferation 
such  as  the  adenovirus  early  gene,  ElA,  and  the  oncogene  c-myc,  can 
trigger  apoptosis  in  certain  situations  (Evan  et  aL,  1995).  Indeed,  some  of 
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also  activated  in  apoptosis  (Evan  et  aL,  1995). 
A  number  of  tumour  suppressor  genes  have  been  shown  to  be 
important  in  apoptosis.  pRb  suppresses  apoptosis  by  an,  as  yet,  unknown 
mechanism  but  possibly  by  preventing  transition  through  the  restriction 
point  into  S-phase  (Evan  et  aL,  1995).  Bcl-2,  the  protein  encoded  for  by 
the  tumour  suppressor  gene  bcl-2,  directly  suppresses  apoptosis.  The 
mechanism  by  which  Bcl-2  inhibits  apoptosis  is  unclear.  Alteration  of 
mitochondrial  function  has  been  suggested  (Hockenbery  et  aL,  1990)  as 
has  regulation  of  intracellular  calcium  ions  (Baffy  et  aL,  1993).  Localisation 
of  Bcl-2  to  the  nuclear  membrane  and  mitotic  nuclei  has  lead  to  the 
suggestion  that  it  may  protect  DNA  against  nucleases  (Lu  et  al.,  1994). 
Conversely,  from  the  same  family  as  Bcl-2,  the  oncogene  bax,  promotes 
apoptosis. 
Perhaps  the  most  widely  studied  gene  in  relation  to  apoptosis  is 
p53.  This  turnour  suppressor  gene  is  a  nuclear  phosphoprotein  which 
functions  as  a  transcription  factor.  Other  functions  are  now  being 
attributed  to  it  (Hall  et  aL,  1996).  The  normal  form  (or  wild  type)  is  thought 
to  be  responsible  for  the  arrest  of  the  cell  in  G,  of  the  cell  cycle  when  DNA 
damage  is  detected  and  can  act  to  induce  apoptosis  or  encourage  DNA 
repair  (Lane,  1992).  In  so  doing,  p53  prevents  the  replication  of  cells  with 
damaged  DNA  which  could  be  oncogenic  and  for  this  role  it  has  been 
given  the  title  of  "guardian  of  the  genome"  (Lane,  1992).  Mutation  or  loss 
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transformation  of  cells  (Lane,  1993)  and  p53  has  been  shown  to  be  the 
most  commonly  mutated  gene,  inactivated  in  almost  half  of  all  human 
tumours  (Greenblaft  et  aL,  1994). 
More  recently,  Ambrosini  et  a/  (1997)  have  described  a  gene 
expressed  in  foetal  tissues  and  a  variety  of  human  cancers  but  not  normal 
adult  cells  which  inhibits  apoptosis  which  they  have  designated  survivin. 
As  noted  above  in  regard  to  interpretations  of  proliferation  markers, 
caution  is  required  in  the  interpretation  of  data  on  apoptosis,  in  particular, 
the  widely  quoted  apoptotic  index  (Potten,  1996).  The  duration  of 
apoptosis  is  not  known  precisely,  but  is  thought  to  be  short.  Many 
apoptotic  fragments  are  small  and  on  histological  examination  may  be 
missed.  A  single  cell  undergoing  apoptosis  characteristically  forms  many 
membrane-bound  fragments,  the  number  of  these  observed  histologically 
does  not  necessarily  equate  to  the  number  of  cells  that  have  undergone 
apoptosis  (Poften,  1996). 
In  oral  epithelial  dysplasia  and  squamous  cell  carcinoma,  apoptosis 
was  reported  by  Birchall  et  al  (1996)  to  remain  at  a  static  level  in  relation 
to  mitosis  as  the  severity  of  dysplasia  increased  and  in  carcinomas. 
However,  the  same  authors  previously  reported  an  increase  in  the 
apoptotic  index  to  mitotic  index  ratio  as  the  severity  of  dysplasia  increased 
up  to  carcinoma  in  situ  and  then  a  reduction  in  carcinoma  (Birchall  et  aL, 
1995).  More  recently  the  same  group  have  curiously  reported  a  highly 
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1997).  From  the  limited  number  of  studies  available  it  is  felt  that  the  role  of 
apoptosis  in  oral  epithelial  dysplasia  is  neither  consistent  nor  as  significant 
as  that  of  proliferation. 
1.4.7  The  cell  cycle  and  neoplasia 
When  all  the  above  factors  are  taken  into  account  a  possible 
genetic  pathway  leading  to  increased  cell  proliferation  and  also  cancer 
development  can  be  envisaged  as  proposed  by  Sladek  (1997)  and 
summarised  in  Figure  1.2.  Clearly  alterations  to  any  of  the  factors 
discussed  above  could  potentially  lead  to  an  increase  of  cell  proliferation 
or  a  suppression  of  apoptosis.  Accumulation  of  genetic  damage  and 
replication  of  cells  with  these  defects  could  lead  to  the  formation  of 
carcinoma.  The  cell  cycle,  therefore,  has  an  important  and  central  role  in 
the  development  of  carcinoma. 
In  addition  to  these  events,  the  acquisition  of  an  immortal 
phenotype  is  thought  to  be  the  action  of  telornerase  (Ershler  and  Longo, 
1997).  The  reactivation  of  this  enzyme  prevents  the  shortening  of  the 
telomeres  that  normally  occurs  at  every  cell  division  which  eventually 
leads  to  cellular  senescence  and  growth  arrest. 
1.5  Cell  cycle  associated  markers  in  oral  precancer 
1.5.1  Nucleolar  organisation  regions 
Nucleolar  organiser  regions  (NORs)  are  loops  of  ribosomal  DNA 
32 (rDNA)  found  in  the  nucleolus  that  transcribe  to  rRNA  and  thus  ribosomes 
and  later  to  protein  (Crocker,  1990).  The  relationship  of  NORs  to  cell 
activity  has  prompted  investigations  into  the  size  and  number  of  NORs  as 
possible  indicators  of  cell  proliferation  and  transformation.  Demonstrated 
by  a  colloidal  silver  staining  technique  that  binds  to  NOR-associated 
proteins,  they  are  often  referred  to  as  AgNORs.  A  small  number  of 
investigations  have  looked  at  AgNORs  in  oral  epithelial  clysplasia.  A 
correlation  between  the  DNA  index  (assessed  by  flow  cytometry)  and  the 
mean  number  of  AgNORs  has  been  reported  (Kahn  et  aL,  1993)  and  a 
significant  difference  between  the  mean  AgNORs  in  oral  epithelial 
dysplasia  and  oral  squamous  cell  carcinoma  has  been  demonstrated 
(Kobayashi  et  aL,  1995). 
Migaldi  et  a/  (1998)  reported  significant  differences  in  AgNOR 
values  between  oral  epithelial  clysplastic  lesions  and  benign  epithelial 
lesions  and  squamous  cell  carcinoma.  These  authors  also  described  the 
same  findings  of  another  nucleolar  protein,  p120,  which  can  be  identified 
immunohistochemically. 
MacDonald  and  Milne  (1997)  reported  a  correlation  between 
intranucleolar  AgNOR  counts  and  atypia  scores  in  oral  epithelial  dysplastic 
lesions.  The  overall  AgNOR  counts  however  did  not  show  any  significant 
association  with  the  degree  of  dysplasia. 
1.5.2  Flow  cytometry 
Flow  cytometry  is  a  rapid  and  objective  method  of  analysing  large 
33 numbers  of  cells  or  their  constituents.  For  example,  nuclear  DNA  content, 
S-phase  fraction  and  detection  of  DNA  aneuploid  cell  populations  are 
most  commonly  assessed  with  regard  to  malignancy  (Kahn  et  aL,  1992; 
Kahn  et  aL,  1993).  The  S-phase  fraction  is  simply  the  percentage  of  cells 
in  the  S-phase.  The  DNA  index  is  a  ratio  of  the  peaks,  obtained  from  the 
flow  cytometeric  analysis,  of  a  DNA  aneuploid  GJG,  population  to  normal 
GdG,  cells.  The  flow  cytometer,  with  the  aid  of  monoclonal  antibodies,  can 
be  used  to  assess  the  presence  of  specific  proteins  or  molecules. 
A  correlation  between  DNA  index  and  AgNOR  staining  was 
reported  by  Khan  et  al  (1993)  in  oral  epithelial  dysplasia  but  surprisingly, 
no  correlation  existed  between  Ag  NOR  counts  and  S-phase  fraction.  More 
recently  Saito  et  al  (1995)  reported  a  higher  incidence  of  aneuploidy  in 
severely  dysplastic  leukoplakia  than  in  mildly  dysplastic  lesions.  On  the 
basis  that  those  lesions  showing  a  higher  degree  of  dysplasia  are  more 
likely  to  undergo  malignant  transformation,  these  authors  suggested  that 
these  findings  may  be  of  predictive  value,  but  as  yet,  they  lack  any  follow- 
up  data  to  support  this  (Saito  et  aL,  1995). 
1.5.3  Proliferating  cell  nuclear  antigen 
Proliferating  cell  nuclear  antigen  (PCNA)  is  a  36kD  nuclear  protein, 
an  auxiliary  protein  of  DNA  polymerase-8  which  is  essential  for  DNA 
synthesis  (Bravo  et  aL,  1987).  Originally  it  was  designated  as 
PCNA/cyclin.  Fortunately,  the  latter  suffix  has  been  dropped  by  most 
users,  but  can  lead  to  some  confusion  with  the  cyclins  when  used 
34 incorrectly.  PCNA  is  synthesised  in  late  G,  and  S-phase  of  the  cell  cycle 
and  is detectable  by  immunohistochernical  methods.  However,  although  it 
is  related  to  the  cell  cycle  it  is  not  specific  to  a  particular  aspect  of  the  cell 
cycle.  It  has  a  relatively  long  half-life  of  approximately  20  hours. 
Immunoreactivity  appears  to  be  dependent  upon  fixation  and  it  has  been 
detected  in  cells  that  have  left  the  cell  cycle  (Yu  et  aL,  199Z.  In  oral 
premalignant  lesions,  PCNA  staining  was  reported  to  be  significantly 
higher  than  in  non-dysplastic  mucosa  (Kobayashi  et  aL,  1995;  Tsuji  et  aL, 
1992).  Yama  et  al  (1996)  reported  no  correlation  between  PCNA 
expression  and  the  severity  of  dysplasia  in  lesions  of  the  buccal  mucosa 
and  gingiva  but  an  apparent  confinement  of  staining  to  the  basal  third  of 
the  epithelium  in  severely  clysplastic  lesions.  A  higher  PCNA  labelling 
index  was  found  in  hyperplastic  oral  lesions  compared  with  dysplastic 
lesions  and  squamous  cell  carcinoma  by  Birchall  et  al  (1997). 
1.5.4  p53 
The  p53  literature  in  oral  lesions  is  vast  and  was  comprehensively 
reviewed  in  recent  publications  (Raybaud-Diog6ne  et  aL,  1996;  Slootweg, 
1997).  Only  the  main  points  will  be  discussed  below.  Mutations  of  p53 
have  been  reported  to  be  present  in  most  oral  squamous  cell  carcinomas 
(Sakai  and  Tsuchicla,  1992)  and  to  be  greater  in  the  normal  oral  mucosa 
of  smokers  than  non-smokers  suggesting  that  p53  mutations  may  be  an 
early  event  in  the  pathogenesis  of  oral  cancer  in  these  patients  (Colucci  et 
aL.  1997).  Overexpression  of  the  p53  gene  has  been  reported  in  oral 
35 squamous  cell  carcinoma  (Nylander  et  aL.  1995;  Ogden  et  aL,  1992; 
Sakai  and  Tsuchida,  1992;  Warnakulasuriya  and  Johnson,  1994; 
Warnakulasuriya  and  Johnson,  1992)  and  it  correlated  with  heavy 
smoking  (Field  et  aL,  1991). 
In  oral  epithelial  dysplasia,  p53  overexpression  has  been 
demonstrated  immunohistochernically  (Coltrera  et  aL,  1992;  Girod  et  aL, 
1993;  Kerdpon  et  aL,  1997;  Nishioka  et  aL,  1993;  Regezi  et  aL,  1995;  Shin 
et  aL,  1994;  Warnakulasuriya  and  Johnson,  1994;  Warnakulasuriya  and 
Johnson,  1992).  The  degree  of  p53  expression  has  been  reported  as 
being  greater  in  those  lesions  showing  moderate  or  severe  dysplasia 
compared  to  mild  dysplasia  (Kerdpon  et  aL,  1997;  Sauter  et  aL,  1994; 
Shin  et  aL,  1994).  Regezi  et  a/  (1995)  reported  that  half  of  the  cases 
exhibiting  p53  expression  in  oral  epithelial  dysplasia  progressed  to  p53 
positive  carcinomas  although  one  p53  negative  dysplasia  progressed  to 
carcinoma.  Ogden  et  al  (1992)  failed  to  demonstrate  p53  expression  in 
formalin  fixed  specimens  of  oral  epithelial  dysplasia  but  did  not  use  any 
form  of  antigen  retrieval,  a  factor  the  same  author  has  subsequently 
demonstrated  significantly  increases  the  detection  of  the  protein 
immunohistochernically  (Dowell  and  Ogden,  1996). 
Wild-type  p53  protein  has  a  short  half  life  (Reihsaus  et  al  1990)  and 
therefore  cannot  be  detected  immunohistochemically.  Conversely,  the 
mutated  form  is  a  more  stable  protein  and  is  demonstrable  by 
immunohistochernical  techniques.  It  has  been  suggested  recently  that  p53 
36 positive  tissues  demonstrated  immunohistochernically  do  not  necessarily 
contain  p53  mutations  but  a  stabilised  form  of  the  wild-type  p53  protein 
(Battifora,  1994;  Wynford-Thomas,  1992).  The  wild-type  p53  may  be 
stabilised  by  complexing  with  the  MDM2  protein  and  therefore  is 
demonstrable  by  immunohistochernistry  (Oliner  et  aL,  1992).  MDM2  is  the 
product  of  an  oncogene  which  inactivates  p53-mediated  transcription  as 
part  of  an  autoregulatory  loop  (Levine,  1997).  This  action,  however,  still 
removes  p53  from  its  role  outlined  in  Section  1.4.6  in  a  similar  manner  to 
the  E6  protein  of  the  HPV.  p53  expression  has  also  been  reported  in 
reactive  lesions  with  no  propensity  for  malignant  change  (Kerdpon  et  aL, 
1997).  The  immunohistochemical  results  must  therefore  be  interpreted 
with  some  caution.  Likewise,  a  loss  of  expression  of  the  p53  gene  is 
possible  in  carcinogenesis  and  this  would  result  in  its  failure  to  be 
demonstrated  immunohistochemically,  a  point  not  addressed  in  many 
studies. 
Cruz  et  al  (1998)  recently  showed  that  in  both  dysplastic  and  non- 
dysplastic  oral  precancerous  lesions  suprabasai  p53  expression  was  a 
positive  predictor  of  malignant  transformation  compared  to  those  oral 
mucosae  where  there  was  only  basal  or  no  p53  immunoreactivity. 
1.5.5  bcl-2  and  bax 
Although  originally  studied  extensively  in  haernatopoletic  cell  lines 
there  is  evidence  that  bcl-2  has  a  role  in  regulating  cell  death  in 
epithelium. 
37 The  bcl-2  gene  is  expressed  in  most  developing  tissues  at  specific 
stages  of  differentiation.  High  levels  of  Bcl-2  expression  in  human 
embryonic  skin  have  been  reported  in  the  basal  cells  committed  to  hair 
follicle  development;  whilst  other  skin  areas  express  very  low  or 
undetectable  levels  of  the  protein  (Lu  et  al.,  1993). 
bcl-2  appears  to  be  associated  with  proliferative  compartments  but 
not  directly  associated  with  proliferation.  Lu  et  al  (1996;  1993)  postulate, 
on  the  basis  of  their  observations  of  bcl-2  expression  in  foetal  tissues,  that 
bcl-2  expression  is  associated  with  the  transition  from  undifferentiated 
stem  cell  to  committed  precursor  and  that  bcl-2  is  down  regulated  once 
cells  are  terminally  differentiated. 
bcl-2  expression  in  epithelial  malignancy  appears  to  be  variable; 
high  levels  of  expression  being  reported  in  nasopharyngeal,  breast  and 
prostate  carcinomas  but  lower  levels  of  expression  in  lung,  bladder  and 
gastric  carcinomas  (Lu  et  aL,  1996).  The  topographical  distribution  of  Bcl-2 
expression  in  well  differentiated  tumours,  including  oral  carcinomas, 
closely  resembled  that  in  the  corresponding  normal  epithelium  (Jordan  et 
aL,  1996).  Harada  et  al  (1998)  recently  reported  that  oral  squarnous  cell 
carcinoma  cell  lines  transfected  with  bcl-2  DNA  failed  to  show 
morphological  signs  of  differentiation  in  culture  and  did  not  express  the 
cytokeratins  usually  observed  in  differentiated  epithelial  cells.  The  authors 
postulated  that  bcl-2  is  possibly  more  important  in  preventing 
differentiation  than  preventing  apoptosis. 
38 Jordan  et  a/  (1996)  reported  increased  immunohistochernical 
staining  of  Bcl-2  in  oral  epithelial  dysplasia  adjacent  to  turnours,  often 
throughout  the  full  thickness  of  the  epithelium  compared  to  non  dysplastic 
epithelium  where  staining  was  restricted  to  basal  cells.  This  combined  with 
decreased  expression  of  the  apoptosis  permitting  protein,  bax,  in 
dysplastic  lesions  lead  the  authors  to  believe  that  cells  may  acquire 
selective  growth  advantage  (Jordan  et  aL,  1996).  Birchall  et  a/  (1997) 
found  reduced  bcl-2  expression  in  squamous  cell  carcinoma  and  adjacent 
normal  epithelium  and  suggested  that  this  may  represent  a  constitutive 
suppression  in  the  patients,  possibly  accounting  for  multiple  tumours  in 
patients  with  oral  cancer. 
1.5.6  Tritiated  thymidine 
Thymidine  is  the  nucleoside  of  the  pyrimidine  base  thymine  which 
has  the  advantage  over  the  other  bases  in  that  it  is  only  found  in  DNA  and 
not  in  RNA.  Synthetically  produced  tritiated  thymidine  ('H-thymidine)  can 
be  incorporated  into  DNA  during  the  S-phase  and  the  emission  of  0- 
particles  can  detected  by  means  of  an  autoradiographic  film  placed  over  a 
treated  tissue  section.  Quantification  of  the  'H-thymidine  labelling  index 
gives  an  estimation  of  the  number  of  cells  in  the  S-phase  at  the  time  of 
labelling  and  thus  an  indication  of  the  proliferative  state  of  the  tissue 
(Dover,  1992). 
Regarding  oral  mucosa,  Warnakulasuriya  and  MacDonald  (1993) 
have  demonstrated  a  diurnal  variation  in  the  3  H-thymidine  labelling  index 
39 (LI)  in  normal  buccal  mucosa.  Also  in  buccal  mucosa,  an  increase  in  the 
IH-thymidine  Ll  in  biopsies  of  oral  leukoplakia  has  been  demonstrated 
(Alvares  et  aL,  1972;  Warnakulasuriya  and  MacDonald,  1995a).  These 
investigations  will  be  discussed  further  in  Chapter  2. 
The  rate  of  entry  of  cells  into  the  S-phase  can  be  measured  by  a 
double-labelling  method  which  can  be  achieved  either  by  labelling  the 
same  tissue  with  two  different  isotopes  or  two  differing  concentrations  of 
the  same  isotope.  Alternatively,  two  separate  pieces  of  tissue  can  be 
labelled  at  differing  times  (Dover,  1992).  In  oral  leukoplakia  the  length  of 
time  spent  in  the  S-phase  was  not  significantly  different  to  that  of  normal 
oral  mucosa  (Warnakulasuriya  and  MacDonald,  1995a).  However,  in  the 
tongue  the  length  of  the  S-phase  was  reported  as  being  shorter  in  iron 
deficiency  (Rennie  and  MacDonald,  1984). 
1.5.7  Bromodeoxyuridine 
Bromodeoxyuridine  (BrdU)  is  a  pyrimidine  analogue  that  can  be 
incorporated  into  the  DNA  of  replicating  cells  in  a  similar  manner  to  3  H- 
thymidine  and  therefore  can  be  used  as  a  marker  of  those  cells  in  the  S- 
phase  of  the  cell  cycle.  This  process  has  been  facilitated  by  the 
development  of  a  monoclonal  antibody  to  BrdU  and  negates  the  need  for 
autoradiography  which  can  be  technically  demanding.  BrdU  also  has  the 
potential,  albeit  limited,  to  be  used  in  vivo  as  well  as  in  vitro.  Indeed,  it  is 
used  therapeutically  in  certain  patients  to  enhance  the  sensitivity  of 
tumours  to  radiotherapy  (Barnes  and  Gillett,  1995).  'H-thymidine  has  been 
40 used  in  vivo  but  essentially  only  in  experimental  animal  models. 
In  common  with  'H-thymidine,  the  BrdU  labelling  method  requires 
fresh  tissue  and  cannot  be  used  on  archival  material  unlike  some  of  the 
other  proliferation  markers  discussed  below.  These  potentially  time 
consuming  methods  have  not  been  routinely  adopted  in  diagnostic 
histopathology  as  has  been  the  case  with  some  other  markers  of  cell 
proliferation. 
In  squamous  cell  carcinoma  of  the  oral  cavity,  BrdU  labelling  has 
been  reported  to  be  greater  in  T3  tumours  than  TI  or  T2  tumours  and 
higher  also  in  those  tumours  with  cervical  lymph  node  metastases 
(Hemmer,  1990). 
1.5.8  Ki67 
Much  attention  has  been  paid  to  this  nuclear  protein  since  Gerdes 
et  al  (1983)  described  the  production  of  a  monoclonal  antibody  that 
recognised  an  antigen  in  cycling  cells  but  not  those  in  Go.  It  potentially 
gives  a  marker  of  cells  within  the  growth  fraction  in  a  tissue.  However,  its 
precise  function  within  the  cell  cycle  is  still  poorly  understood  (Ross  and 
Hall,  1995).  Ki67  now  appears  to  be  two  nuclear  proteins  with  molecular 
weights  of  approximately  345  and  395  kDa  that  have  no  detectable 
precursor  (Heidebrecht  et  aL,  1996).  An  association  of  the  protein  with  the 
nucleolus  and  chromosomes  during  mitosis  has  suggested  a  structural 
role  (Ross  and  Hall,  1995).  Recently,  Gerdes'  group  (Gerlach  et  aL,  1998) 
have  demonstrated  that  Ki67  protein  is  a  target  for  autoantibodies  in 
41 systemic  lupus  erythematosis. 
The  gene  for  Ki67,  which  is  located  on  chromosome  10q25 
(Fonatsch  et  aL,  1991),  was  cloned  in  1993  (Schlater  et  aL,  1993).  The 
gene  is  highly  conserved  throughout  mammals  (Falini  et  aL,  1989).  This 
has  enabled  detailed  study  of  the  protein.  Ki67  arises  de  novo  in  cycling 
cells  and  has  a  short  half-life  in  the  region  of  60  to  90  minutes  (Bruno  and 
Darzynkiewicz,  1992;  Heidebrecht  et  aL,  1996).  Synthesis  of  Ki67  appears 
to  begin  at  the  start  of  the  S-phase  rising  to  a  peak  during  mitosis  and 
expression  decreases  during  G,  which  may  correspond  to  degradation 
(Lopez  et  al.,  1991)  or  decreased  synthesis  (Bruno  and  Darzynkiewicz, 
1992).  These  results  support  the  nucleolar  and  mitotic  associations  of  the 
protein.  Furthermore,  cells  with  a  long  G,  phase  may  not  express 
detectable  levels  of  Ki67  which  may  lead  to  an  underestimation  of  cells 
within  the  growth  fraction  (Lopez  et  aL,  1991). 
The  original  Ki67  antibody  described  by  Gerdes  et  al  (1983)  was 
limited  by  nature  of  the  fact  that  it  could  only  be  used  on  fresh  frozen 
tissue.  Subsequently  new  antibodies  (MlB1  and  M1133)  were  developed 
that  could  be  used  on  formalin-fixed,  paraffin  embedded  tissue  following 
antigen  retrieval  methods  (Cattoretti  et  al.,  1992;  Key  et  aL,  1993).  It  has 
been  claimed  that  the  original  Ki67  antibody  is  equally  effective  in 
formalin-fixed  tissue  following  antigen  retrieval  (Cuevas  et  aL,  1993).  The 
development  of  an  antibody  effective  in  formalin  fixed,  paraffin  embedded 
tissues  has  resulted  in  a  multitude  of  reports  utilising  Ki67,  notably  M1131, 
42 in  proliferation  studies  particularly  in  relation  to  neoplasia. 
In  oesophageal  squamous  cell  carcinoma,  the  number  of  M1131 
positive  cells  correlated  with  the  differentiation  as  well  as  with  prognosis  in 
stage  III  tumours  (Lam  et  al.,  1996). 
In  laryngeal  carcinoma  M1131  counts  were  higher  in  more  advanced 
stage  turnours  and  correlated  with  prognosis  as  did  PCNA  and  turnour 
front  grading  (Welkoborsky  et  aL,  1995). 
Premalignant  lesions  of  the  uterine  cervix  are  graded  as  cervical 
intraepithelial  neoplasia  (CIN)  and  graded  1-3  which  roughly  equates  to 
mild  dysplasia  through  to  carcinoma  in  situ  according  to  what  proportion  of 
the  epithelium  is  occupied  by  atypical  cells  and  this  relates  to  some  extent 
to  the  clinical  outcome  of  these  lesions  (Anderson  et  aL,  1991).  Bulten  et 
al  (1996)  reported  that  M1131  labelling  indices  correlated  closely  to  CIN 
grade  and  suggested  it  was  a  useful  adjunct  to  the  traditional  subjective 
assessment.  However,  Payne  et  al  (1996)  observed  a  similar  trend  but 
noted  that  the  M1131  labelling  did  not  correlate  closely  enough  with  the  CIN 
grade  to  be  of  use  in  the  assignment  of  a  grade. 
There  are  relatively  few  studies  of  Ki67  in  oral  mucosa,  particularly 
oral  epithelial  dysplasia  and  normal  mucosa.  Kannan  et  al  (1996)  reported 
similar  Ki67  labelling  indices  in  dysplastic  and  non-dysplastic  lesions  of 
leukoplakia,  the  sites  of  the  lesions  were  not  specified.  In  epithelial 
dysplasia  from  the  floor  of  the  mouth,  Kushner  et  al  (1997)  reported 
significantly  higher  Ki67  labelling  than  in  non-dysplastic  lesions. 
43 1.5.9  D  Cyclins 
In  normal  cells  the  D  cyclins  are  involved  with  cell  progression 
through  G,  and  committing  the  cell  to  DNA  replication  (Hunter  and  Pines, 
1994).  They  associate  with  CDK4  and  CDK6  to  phosphorylate  the  pRb, 
inactivating  it.  This  allows  the  dissociation  of  the  transcription  factor  E2F 
from  this  complex  and  hence  transition  of  the  cell  through  the  restriction 
point  (START)  and  into  the  S-phase  (Weinberg,  1995).  There  are  three 
subtypes  identified  in  the  cyclin  D  group  designated  cyclins  DI,  D2  and 
D3. 
The  D  cyclins  are  reported  as  amplified  and  overexpressed  in  a 
variety  of  turnours  including  head  and  neck  cancers  (Bartkova  et  aL,  1995; 
Callender  et  aL,  1994;  Davidson  et  aL,  1996;  Gimenez-Conti  et  aL,  1996; 
Masuda  et  aL,  1996;  Mineta  et  aL,  1997;  Worsley  et  al.,  1996;  Yatabe  et 
aL,  1996)  where  cyclin  D  is  functionally  inactivating  the  inhibitory  effect  of 
pRb.  Juan  et  al  (1996)  suggest  that  there  is  an  unscheduled  expression  of 
the  D  cyclins  (D1  and  D3)  rather  than  overexpression  in  tumour  cells.  In 
human  tumour  cell  lines  these  workers  demonstrated  expression  of  cyclins 
D1  and  D3  in  the  S,  G2,  and  M  phases  as  well  as  the  G,  phase  of  the  cell 
cycle.  It  was  suggested  that  the  content  of  the  D  cyclins  may  even  be 
lower  than  in  normal  cells  (Juan  et  aL,  1996). 
It  has  been  suggested  that  the  three  D  cyclins  are  cell-type  specific; 
cyclin  D1  predominating  in  fibroblasts,  while  being  negative  in  lymphocytic 
cells  in  which  cyclins  D2  and  D3  are  expressed  (Ando  et  aL,  1993;  Tam  et 
44 aL,  1994).  Skin  keratinocytes  express  cyclin  Dl  in  G,  (Javier  et  aL,  1997). 
Thus,  some  of  the  D  cyclins  may  be  redundant  in  some  cell  types  or  may 
have  separate  but  overlapping  functions  (Lahti  et  aL,  1997). 
The  gene  for  cyclin  DI  (CCND1)  is  located  at  11q13  and  was 
initially  described  as  the  oncogene  Bcl-1,  as  it  was  found  at  the 
translocation  of  B-cell  lymphomas,  and  PRAD  1,  an  oncogene  amplified  in 
parathyroid  adenomas  (Rosenberg  et  aL,  1991).  Later  it  was  shown  that 
both  these  genes  were  in  fact  CCND1. 
In  an  immunohistochernical  study  of  squamous  cell  carcinoma  of 
the  hypopharynx,  Masuda  et  al  (1996)  reported  a  correlation  between 
cyclin  Dl  immunoreactivivty  (interpreted  as  CCND1  gene  overexpression) 
and  regional  lymph  node  metastasis  while  those  with  negative  expression 
had  a  better  prognosis.  In  oral  verrucous  carcinoma  the  positive 
immunohistochernical  expression  of  cyclin  Dl  has  been  shown  to  be 
present  in  moderately  invasive  lesions  but  not  in  more  aggressive  cases 
or  in  normal  oral  mucosa  which  demonstrated  negative  staining  (Gimenez- 
Conti  et  aL,  1996).  Interestingly,  in  none  of  these  cases  was  there  any 
loss  of  expression  of  pRb.  The  interpretation  of  this  was  that  the  gene  was 
functioning  normally  and  it  could  be  postulated  that  in  these  cases 
overexpression  of  CCND1  gene  was  overriding  the  tumour  suppressor 
effects  of  pRb. 
Southern  blotting  was  used  to  investigate  the  amplification  of 
CCND1  in  frozen  specimens  of  head  and  neck  squamous  cell  carcinoma, 
45 including  oral  turnours  (Mineta  et  aL,  1997).  Amplification  of  CCNDI  was 
seen  in  16%  (6  of  39)  of  the  tumours,  all  of  these  having  p53  mutations. 
The  tumours  were  described  as  being  clinically  advanced,  perhaps 
indicating  that  CCND1  abnormalities  are  a  late  event  in  tumour 
progression  as  a  further  12%  of  the  cases  had  p53  mutations  but  no 
CCND1  amplification  (Mineta  et  aL,  1997).  In  a  series  of  cultured  head 
and  neck  turnour  cell  lines,  CCND1  gene  amplification  was  shown  in  some 
cell  lines  but  most  of  these  had  normal  p53  genes  while  most  of  those  with 
p53  mutations  had  a  normal  CCND1  gene  copy  number  leading  to  the 
thought  that  either  p53  mutation  or  CCND1  amplification  may  be  sufficient 
to  overcome  the  cell  cycle  control  (Xu  et  aL,  1994).  Using  Southern 
blofting,  again  on  frozen  head  and  neck  squamous  cell  carcinoma 
samples  (over  half  from  the  oral  cavity),  CCND1  amplification  was 
identified  in  23%  (13  of  57)  of  cases.  This  was  up  to  five-fold  in  two  cases 
which  also  showed  a  significantly  higher  level  of  mRNA  (Davidson  et  aL, 
1996).  In  these  cases,  normal  mucosa  adjacent  to  turnours,  showed  a 
similar  CCNDI  expression  to  those  tumours  without  CCND1  amplification. 
Tobacco  exposure  was  also  significantly  higher  in  those  cases  in  which 
there  was  CCNDI  amplification  (Davidson  et  aL,  1996).  The  cyclin  D1 
gene  was  found  to  be  amplified  in  over  a  third  of  laryngeal  carcinomas 
where  it  correlated  with  advanced  local  invasion  and  lymph  node 
metastasis  as  well  as  with  mRNA  overexpression  (Jares  et  aL,  1994). 
Again,  in  a  series  of  largely  laryngeal  carcinomas,  CCND1  amplification 
46 was  identified  in  a  third  of  cases  (including  one  base  of  tongue  turnour) 
and  this  was  more  noted  in  high  grade  aneuploid  tumours  (Callender  et 
aL,  1994). 
Fewer  investigations  have  been  reported  of  cyclin  D3.  The  precise 
mode  of  action  of  cyclin  D3  has  not  been  fully  elucidated  but  it  has  been 
shown  to  have  a  greater  affinity  for  pRb  in  vitro  (Ewen  et  aL,  1993).  Usuda 
et  al  (1996)  reported  cyclin  D3  positivity  in  71%  of  lung  carcinomas  by 
immunohistochernistry  but  this  did  not  relate  to  any  pathological  variables 
and  the  proportion  of  cyclin  D3  positive  nuclei  was  small  in  many  cases. 
The  authors  also  reported  cyclin  D3  positive  cells  in  normal  tissues 
including  reactive  pneumocytes,  transitional  epithelium,  squamous 
mucosa  from  the  oesophagus  and  endothelium. 
1.5.10  Other  cell  cycle  associated  proteins 
The  retinoblastorna  gene  product  was  infrequently  observed  in  oral 
carcinomas  using  immunohistochernistry  and  western  blotting  indicating  a 
normal  cell  cycle-dependent  function.  However,  those  turnours  not 
expressing  the  protein  were  associated  with  a  poorer  survival  rate  (Pavelic 
et  al.,  1996).  Yoo  et  al  (1994)  reported  that  despite  a  frequent  loss  of 
heterozygosity  in  the  chromosomal  region  of  the  Rb  locus,  there  was 
normal  pRb  suggesting  the  presence  of  another  tumour  suppressor  gene 
in  this  region. 
p16 
INK4a 
,a  member  of  the  INK4  family  of  CDK  inhibitors,  blocks  the 
binding  of  CDK4/6  to  cyclin  DI  causing  G,  arrest.  It  therefore  acts  as  a 
47 tumour  suppressor  gene  (Goodger  et  aL,  1997).  Loss  of  heterozygosity  at 
the  gene  locus  or  loss  of  expression  immunohistochernically  of  p16 
INK4a 
has  been  reported  in  nearly  half  of  the  cases  of  oral  precancerous  lesions 
(Papadimitrakopoulou  et  aL,  1997).  However,  Matsuda  et  al  (1996)  did  not 
find  any  p16  INK4a  abnormalities  in  oral  precancerous  lesions  and  only  10% 
of  advanced  oral  carcinomas  showed  deletions  or  mutations  of  the  gene. 
These  results  are  consistent  with  those  of  Gonzilez  et  al  (1997)  who 
reported  p16""  deletions  in  20%  of  head  and  neck  carcinomas.  LOH  of 
the  locus  at  9p2l  where  the  CDKI,  p16,  is  mapped  to  has  been  shown  to 
be  associated  with  an  immortal  phenotype  in  head  and  neck  cancer  cells 
in  culture  (Loughran  et  al.,  1994). 
Another  CDK  inhibitor,  p2l 
WAFI/CIPI 
,  which  is  the  downstream 
moderator  of  p53  has  not  yet  been  studied  in  oral  epithelia.  In  the  normal 
squamous  epithelia  of  the  tonsil  and  cervix  positive  immunoreactivity  was 
observed  mainly  in  the  suprabasal  cells  with  accompanying  p53  positivity 
but  no  Ki67  reactivity  (Mateo  et  aL,  1997).  This  suggests  p2l 
WAFI/CIPI 
may 
be  a  marker  for  those  cells  in  Go.  In  cells  with  mutant  p53,  p2 
1WAFI/CIPI 
expression  was  not  seen  in  carcinoma  of  the  skin  (Inohara  et  aL,  1996)  or 
the  oesophagus  (Ohashi  et  aL,  1997).  In  the  latter  case,  the  distribution  of 
p2  1 
WAF1/CIPI 
positive  cells  was  almost  the  same  as  that  of  apoptotic  cells 
(Ohashi  et  al,  1997).  However,  p2 
1WAFI/CIPI 
expression  has  been  reported 
in  carcinomas  of  the  larynx  independent  of  p53  suggesting  an  alternative 
trigger  for  the  expression  of  the  gene  (Cox,  1997). 
48 Jordan  et  al  (1998)  recently  reported  reduced  levels  of  p27 
KipI/CIpI 
determined  immunohistochernically  in  oral  epithelial  clysplastic  lesions  and 
squamous  cell  carcinoma  compared  with  normal  epithelium  from  the  floor 
of  the  mouth.  These  authors  reported  a  significant  decrease  in  p27 
KiPIMPI 
expression  between  low  and  high  grade  dysplasias  with  a  concurrent 
increase  in  Ki67  and  cyclin  A  expression  and  suggested  that  the  loss  of 
expression  of  p27 
KIpI/CIpI 
may  be  an  early  event  in  carcinogenesis  of  these 
lesions. 
The  CDK,  p34cdc2,  which  forms  part  of  the  MPF  is  observed 
throughout  the  cell  cycle  of  dividing  cells  but  shows  low  levels  in  non- 
dividing  cells.  In  normal  oral  epithelia  it  was  observed  in  the  progenitor 
compartment  and  into  the  prickle  cell  layers  and  a  similar  pattern  of 
immunoreactivity  was  seen  in  well  differentiated  carcinomas  (Goodger  et 
aL,  1996).  In  this  study  (Goodger  et  aL,  1996),  a  higher  intensity  of 
staining  and  a  higher  proportion  of  positive  cells  were  observed  in  poorly 
differentiated  carcinomas.  However,  there  seems  to  be  little  value  of  this 
parameter  in  regard  to  assessing  premalignant  lesions. 
A  relatively  new  proliferation  marker,  HSMCM2,  a  member  of  the 
family  of  minichromosome  maintenance  proteins  thought  to  be  involved 
with  DNA  replication,  has  recently  been  studied  in  normal  and  neoplastic 
tissues  (Toclorov  et  aL,  1998).  These  authors,  interestingly,  reported  a 
labelling  index  for  antibodies  against  this  antigen  between  those  of  Ki67 
and  PCNA  which  sounds  promising  and  may  prove  to  truly  represent 
49 cycling  cells,  something  which  Ki67  and  PCNA  appear  not  to  do. 
Furthermore,  antibodies  raised  against  the  protein  did  not  require  antigen 
retrieval.  However,  until  commercial  antibodies  become  available  and  more 
comparative  studies  have  been  carried  out  its  usefulness  in  proliferation 
studies  will  be  limited. 
1.6  Conclusions 
From  the  data  presented  in  the  literature  review  it  can  be  seen  that 
there  are  many  limitations  in  the  previous  work  in  the  field  of  oral  precancer. 
There  has  been  a  lack  of  standardisation  by  many  workers  in  the 
presentation  of  their  results  making  comparisons  between  centres  difficult. 
There  are  clearly  problems  associated  with  the  assessment  of 
dysplasia.  Although  Smith  and  Pindborg  (1969)  attempted  to  address  this, 
the  technique  is  laborious  and,  judging  from  the  few  studies  that  have  used 
the  method,  unlikely  to  be  used  widely.  Some  aspects  of  the  research  in  the 
present  thesis  will  attempt  to  address  this. 
One  approach  has  been  to  be  use  immunohistochemistry  the 
interpretation  of  which  is  inherently  subjective;  this  is  often  compounded  by 
workers  expressing  their  results  based  on  a  subjective  assessment  alone. 
In  the  studies  presented  in  this  thesis  the  author  will  attempt  to  make  these 
results  more  objective. 
Many  of  the  oncogenes  involved  in  the  carcinogenic  process  are 
related  to  the  cell  cycle  or  intimately  involved  in  the  cell  cycle.  With  division 
of  the  cell  necessary  in  the  development  of  malignancy  it  would  appear 
appropriate  to  study  the  cell  cycle  in  more  detail.  This  motivated  the  cell 
cycle  work  in  this  thesis. 
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51 Figure  1.1  The  eukaryotic  cell  cycle 
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52 Gene  and  pathway  Effect  of  component  on  cell 
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Cyclin  dependent  kinase  inhibitors 
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Figure  1.2  A  possible  genetic  pathway  to  carcinoma  (Sladek,  1997) 
The  effects  in  the  right-hand  column  occur  in  normal  cells  to  control  cell 
proliferation.  In  the  carcinogenic  process,  those  factors  with  a  plus  sign 
effectively  increase  their  stimulatory  effect  on  the  cell  cycle,  therefore 
acting  as  oncogenes.  Those  factors  associated  with  a  negative  sign 
normally  exert  a  negative  effect  on  the  progression  of  the  cell  cycle,  if 
these  effects  are  lost  through  deletion,  mutation  or  loss  of  expression,  this 
inhibitory  effect  is  lost.  These  therefore  act  as  tumour  suppressor  genes. 
In  the  schema  of  events  above  it  can  be  seen  that  alterations  to  these 
factors  may  lead  to  an  increase  in  cell  proliferation  and  eventually 
carcinoma 
53 Chapter  2 
Growth  fraction  and  S-phase  analysis  in  oral  epithelial 
dysplasia 
54 2.1  Introduction 
2.1.1  Objective  assessment  of  oral  epithelial  dysplasia 
In  the  practice  of  histopathology  there  is  clearly  a  requirement  for 
more  objective  methods  of  assessment  of  oral  epithelial  dysplasia.  It  has 
been  shown  that  it  is  difficult  for  pathologists  to  reach  a  consensus  and 
even  the  same  pathologist  viewing  the  same  section  at  different  times  can 
assess  dysplasia  differently  (Abbey  et  aL,  1995;  Abbey  et  aL,  1998; 
Pindborg  et  aL,  1985).  Abbey  et  a/  (1998)  recently  showed  that  consensus 
was  not  improved  by  the  inclusion  of  clinical  information  and  in  their  study 
may  have  even  decreased  the  accuracy  attained  by  a  series  of  examiners. 
A  semi-objective  method  of  assessing  oral  epithelial  dysplasia  is 
available  (Smith  and  Pindborg,  1969)  which  has  been  shown  to  offer  more 
standardisation  in  assessing  such  lesions  (Katz  et  at,  1985).  However,  it 
is  rather  time  consuming  and  has  not  been  adopted  by  the  majority  of 
histopathologists,  or  indeed  researchers,  as  a  means  of  comparison  for 
parameters  being  investigated  with  the  histological  severity  of  dysplasia. 
Furthermore,  there  is  no  histological  or  other  reliable  marker  of 
those  lesions  that  will  progress  to  frank  malignancy  although,  in  the 
recognised  precancerous  lesions  of  leukoplakia  and  erythroplakia,  there 
appears  to  be  a  higher  incidence  of  malignant  transformation  in  those 
lesions  which  show  dysplasia  histologically  (Lummerman  et  al.,  1996). 
2.1.2  Prediction  of  malignant  change  and  cell  proliferation 
An  increased  rate  of  cell  proliferation  is  associated  with  an 
55 increased  risk  of  malignant  transformation  and  potentially  more  aggressive 
behaviour  (Iversen,  1993).  An  increased  or  uncontrolled  cycling  of  cells 
allows  replication  of  cells  which  may  harbour  genetic  mutations  or 
aberrations;  one  of  the  necessary  steps  in  the  process  of  carcinogenesis. 
To  bring  this  into  context  Farber  (1995)  doubted  the  concept  of  an 
increase  in  cell  proliferation  as  a  risk  in  cancer  development.  The  author 
pointed  out  that  many  genotoxic  agents  are  actually  inhibitors  of 
proliferation  and  observed  that  cell  proliferation  is  increased  in  many 
organs  and  diseases  not  considered  to  be  precancerous  notably  the 
lactating  breast,  the  endometrium  and  the  skin  in  psoriasis. 
'H  thymidine  was  one  of  the  earliest  markers  to  be  used  in  the 
investigation  of  the  cell  cycle.  It  labels  cells  in  the  S-phase  of  the  cell  cycle 
being  incorporated  into  newly  formed  DNA.  As  well  as  giving  information 
on  the  cell  proliferation  state  it  can  also  give  information  on  the  rate  of 
entry  into  S-phase  and  mitosis  by  the  use  of  double  labelling  techniques 
(Dover,  1992).  However,  the  technique  requires  the  process  of 
ý\; 
autoradiography  for  the  demonstration  of  'H  thymidine  labelled  nuclei 
which  can  be  both  time  consuming  and  a  technique  sensitive  procedure 
In  lesions  of  leukoplakia  from  the  buccal  mucosa,  the  3H  thymidine 
labelling  index  (LI)  has  been  reported  as  being  increased  (Alvares  et  al., 
1972a;  Warnakulasuriya  and  MacDonald,  1995a). 
Bromodeoxyuridine  (BrdU)  is  another  thymidine  analogue  which 
can  be  incorporated  into  the  replicating  DNA,  labelling  cells  in  the  S- 
) 
56 phase.  Using  a  monoclonal  antibody  against  BrdU  an  estimate  of  the  cells 
in  the  cells  in  the  S-phase  can  be  achieved  and  give  another  parameter  of 
the  proliferative  state  of  the  tissue  (Gratzner,  1982).  The  relative  ease  of 
use  of  immunohistochernistry  in  the  detection  of  incorporated  BrdU  over 
autoradiography  makes  this  method  a  potentially  more  attractive  and 
simpler  option  for  the  study  of  the  S-phase.  The  studies  of  oral  epithelial 
dysplasia  to  date  have  been  based  upon  in  vivo  administration  of  BrdU 
(Kotelnikov  et  aL,  1996).  There  are  no  reported  studies  using  the  in  vitro 
method  described  below. 
The  cell  cycle  associated  and  endogenously  produced  antigen  Ki67 
can  be  detected  immunohistochernically.  Ki67  is  reported  to  be  expressed 
by  all  cells  within  the  cell  cycle  (the  growth  fraction)  but  not  those  cells 
resting  or  which  have  left  the  cell  cycle  in  the  Go  phase  (Gerdes  et  aL, 
1983).  The  advent  of  the  production  of  an  antibody  against  Ki67  which  can 
be  detected  in  formalin-fixed,  paraffin-embedded  tissue  (Caftorefti  et  aL, 
1992;  Key  et  aL,  1993)  has  made  this  parameter  very  popular  among 
investigators  for  the  study  of  cell  proliferation.  However,  the  studies  of  oral 
epithelia  are  limited  in  both  quantity  and  quality. 
2.1.3  Aims 
The  aims  of  the  studies  described  in  this  chapter  were  to 
investigate  the  S-phase  fraction  and  growth  fraction  in  a  series  of  oral 
epithelial  clysplastic  lesions  using  BrdU  and  Ki67  and  to  attempt  to 
correlate  these  parameters  with  the  semi-objective  dysplasia  scoring 
57 system  of  Smith  and  Pindborg  as  a  way  of  developing  a  more  objective 
assessment.  By  attempting  to  correlate  these  indices  with  clinical 
outcome,  their  use  as  prognostic  indicators  of  malignant  transformation 
was  investigated. 
2.2  Materials  and  Methods 
2.2.1  Collection  of  samples 
Incisional  biopsies  of  20  cases  were  taken  from  19  patients  with  lesions  of 
the  tongue  or  floor  of  mouth  who  presented  at  the  Oral  Medicine 
Department  at  the  Glasgow  Dental  Hospital.  The  lesions  were  clinically 
diagnosed  as  leukoplakia,  erythroplakia  or  smokers  keratosis.  The  tissue 
obtained  was  divided  into  two  halves;  the  first  half  was  routinely  formalin 
fixed  and  paraffin-embedded  for  the  diagnostic  histopathology  service  and 
used  subsequently  for  Ki67  investigation.  The  other  half  was  transported 
in  the  minimal  essential  medium  (MEM)  with  glutamax  (Gibco  BRL, 
41090-028)  for  the  BrdU  labelling  which  was  started  promptly  within  20 
minutes.  Sections  were  examined  for  the  presence  of  fungal  mycelia  using 
diastase  PAS. 
2.2.2  Bromodeoxyuridine  incubation 
The  method  for  incubation  of  the  tissue  with  BrdU  was  adapted 
from  that  previously  described  by  Thornton  et  a/  (1988).  Each  individual 
block  of  tissue  was  incubated  in  15ml  of  MEM  containing  4x  10-4M  BrdU 
(5'-b  romo-2-deoxyu  rid  ine,  Sigma  B5002)  at  370C  for  15  minutes  and  95% 
58 oxygen/  5%  carbon  dioxide  was  bubbled  through  the  solution.  The  tissue 
was  then  fixed  in  Carnoy's  solution  (Appendix  2)  for  one  hour  and 
processed  through  graded  alcohols  to  xylene  and  embedded  in  paraffin 
wax. 
Four  micrometre  sections  were  cut  from  the  BrdU  and  routinely 
processed  blocks,  mounted  on  silane-coated  slides  (Polysine  BDH, 
406/0178/00)  and  dried  overnight  in  a  600C  oven. 
2.2.3  Preliminary  studies 
Prior  to  progressing,  the  optimal  concentrations  and  incubation 
times  of  the  anti-BrdU  and  anti-Ki67  antibodies  and  antigen  retrieval 
conditions  for  Ki67  detection  were  established  as  follows. 
Monoclonal  mouse  anti-bromodeoxyu  rid  ine  antibody  (M0744, 
DAKO  clone  Bu20a  (Magaud  et  aL,  1989))  was  used.  To  determine  the 
optimum  antibody  concentration  and  incubation  time  a  series  of 
experiments  was  undertaken  with  the  following  variables: 
Primary  antibody  concentration  Time  and  temperature  of 
incubation 
1:  20  1  or  2  hours  at  room  temperature 
1:  50  or 
1:  100  overnight  (approx.  16  hours)  at  40C 
1:  150 
A  qualitative  assessment  of  the  staining  appearances  with  these  primary 
antibody  dilutions  and  incubation  times  was  performed  to  determine  the 
optimal  conditions  for  the  tissue  studied. 
Similarly  for  Ki67  immunohistochernistry  a  range  of  times  of  antigen 
59 retrieval  of  between  5  and  50  minutes  in  five  minute  intervals  was 
undertaken.  Antibody  concentrations  and  incubation  times  were  as  for 
anti-BrdU  above. 
2.2.4  Bromodeoxyuridine  immunohistochemistry 
For  BrdU  immunohistochernistry,  slides  were  dewaxed  in  xylene 
and  then  rehydrated  through  graded  alcohols  to  water.  Endogenous 
peroxidase  was  blocked  by  incubating  the  sections  in  3%  hydrogen 
peroxide  in  methanol  for  20  minutes.  The  sections  were  washed  in  water 
for  10  minutes  which  was  followed  by  a2x5  minute  wash  in  Tris-buffered 
saline  (TBS,  pH  7.6,  Appendix  2).  DNA  denaturation  was  performed  by 
immersing  the  slides  in  1M  hydrochloric  acid  at  600C  for  8  minutes  and 
this  was  followed  by  two  5  minute  washes  in  TBS.  Non-specific  antibody 
binding  was  blocked  by  incubation  of  the  sections  with  normal  horse 
serum  for  20  minutes  at  room  temperature  in  a  humidified  chamber. 
The  primary  antibody  was  applied  to  the  BrdU  processed  sections 
at  the  optimal  antibody  concentration  (1:  50)  for  the  optimal  incubation  time 
(overnight  at  4*C)  as  assessed  above. 
Following  primary  antibody  incubation,  the  sections  were  rinsed  in 
TBS  for  10  minutes  and  incubated  in  biotinylated  anti-mouse  IgG  antibody 
(Vectastain  ABC  elite,  Vector  PK6102)  for  30  minutes  at  room 
temperature.  Following  washing  in  TBS  they  were  incubated  in  avidin- 
biotinylated  horseradish  peroxiclase  complex  for  30  minutes  at  room 
temperature. 
60 Sections  were  then  developed  in  0.1%  3,3'diaminobenzidine 
(D5905,  Sigma)  in  TBS  containing  0.1  %  hydrogen  peroxide  for  5  minutes. 
The  sections  were  counterstained  in  Mayers  haernatoxylin 
(Appendix  3)  for  2  minutes  and  dehydrated  through  graded  alcohols, 
cleared  in  xylene  and  mounted  . 
2.2.5  Antigen  retrieval 
For  Ki67  immunohistochernistry,  the  sections  were  dewaxed  and 
rehydrated  through  graded  alcohols  to  distilled  water.  Microwave  antigen 
retrieval  was  performed  by  placing  the  sections  in  a  plastic  slide  rack  in  a 
plastic  beaker  containing  0.01M  sodium  citrate  buffer  (pH  6.0).  Sections 
were  heated  in  a  microwave  oven  (Tricity  MT930,60OW)  for  the  optimal 
time  (15  minutes)  as  described  above  in  periods  of  5  minutes.  After  each 
5  minute  period  the  level  of  the  buffer  was  restored  to  a  predetermined 
level  with  distilled  water.  After  heating,  the  container  was  removed  from 
the  oven  and  allowed  to  cool  at  room  temperature  for  30  minutes. 
2.2.6  Ki67  immunohistochemistry 
Sections  were  washed  in  TBS  buffer  for  5  minutes  before 
endogenous  peroxidase  was  blocked  by  incubation  in  3%  hydrogen 
peroxide  in  methanol  for  20  minutes.  Sections  were  washed  in  distilled 
water  for  2x5  minutes  followed  by  TBS  for  2x5  minutes. 
Non-specific  antibody  binding  was  blocked  by  incubation  of  the 
sections  with  normal  horse  serum  for  20  minutes  at  room  temperature  in  a 
humidified  chamber. 
61 The  Ki67  antibody  (NCL-Ki67-MM1,  Novocastra,  clone  MM1)  was 
applied  to  the  microwave  treated  sections  at  the  optimal  antibody 
concentration  (1:  100)  and  incubation  time  (2  hours). 
Following  primary  antibody  incubation,  the  sections  were  rinsed  in 
TBS  for  10  minutes  and  incubated  in  biotinylated  anti-mouse  IgG  antibody 
(Vectastain  ABC  elite)  for  30  minutes  at  room  temperature.  Following 
washing  in  TBS  they  were  incubated  in  avid  in-biotinylated  horseradish 
peroxidase  complex  for  30  minutes  at  room  temperature. 
Sections  were  then  developed  in  3,3'diaminobenzidine  and 
counterstained,  dehydrated  cleared  and  mounted  as  described  above. 
2.2.7  Controls 
Positive  controls  were  sections  of  tissue  previously  incubated  with 
BrdU  in  this  laboratory  and  sections  of  human  tonsil  were  used  for  Ki67 
staining.  Negative  controls  were  prepared  by  way  of  omitting  the  primary 
antibody  from  the  sections. 
2.2.8  Quantification 
The  quantitative  assessment  of  the  labelled  nuclei  was  performed 
using  a  Leitz  Ortholux  microscope  and  a  locally  developed  computerised 
planimetry  system  (image  Analysis  System  version  4.01,  @Video  Vector 
Dynamics  Ltd  1989).  An  eye-piece  graticule  was  used  to  select  a  column 
of  the  epithelium  at  right  angles  to  the  epithelial  surface,  the  width  of  one 
graticule  in  from  the  left  hand  side  of  the  section,  at  an  objective 
magnification  of  x16.  Three  adjacent,  non-overlapping  columns  were 
62 counted  in  three  levels  of  the  tissue  in  each  case  according  to  a  method 
previously  reported  (A[-Damouk  and  MacDonald,  1987).  The  same 
selection  procedure  was  adopted  for  the  subsequent  studies  in  the  thesis. 
The  immunohistochernically  labelled  cells,  total  number  of  viable 
keratinocyte  nuclei  and  the  number  of  labelled  suprabasal  cells  (i.  e.  those 
not  in  contact  with  the  basement  membrane)  were  counted.  The  length  of 
the  basement  membrane  (BL)  in  the  field  was  measured  by  means  of  a 
light  spot  projected  into  the  microscope  field  from  a  mouse  on  a  digitiser 
pad.  The  labelling  index  (LI)  for  BrdU  was  expressed  in  terms  of  the  total 
nucleated  cells  (Ll%)  and  per  millimetre  (mm)  basement  membrane  length 
(LI/BL).  The  percentage  of  suprabasal  labelled  cells  was  calculated 
(%SB).  Likewise,  the  growth  fraction  (GF)  for  Ki67  was  expressed  in  the 
same  units.  In  order  to  ensure  consistency  of  counting  the  first  five  cases 
were  re-quantified  at  the  end  of  the  initial  quantification. 
A  compartment  analysis  was  performed  on  haematoxylin  and  eosin 
(H&E)  stained  (Appendix  3)  sections  of  the  same  blocks,  preceding  those 
used  for  the  growth  fraction  analysis.  Using  the  computerised  planimetry 
system  at  an  objective  magnification  of  x25,  again  in  defined  fields  and 
close  to  those  used  for  the  GF  analysis,  the  cells  of  the  progenitor  (PC) 
and  maturation  (MC)  compartments  were  identified  on  morphological 
grounds  as  previously  described  (Eveson  and  MacDonald,  1978)  and  then 
counted.  A  distinction  was  made  in  the  progenitor  compartment  between 
cells  which  were  basal  and  those  which  were  suprabasal  and  the  length  of 
63 the  basement  membrane  was  measured.  The  areas  of  the  viable  cell 
compartments  were  measured.  The  area  values  were  divided  by  the  width 
of  the  counting  graticule  to  provide  values  for  mean  epithelial  thickness  as 
well  as  for  the  individual  compartments.  The  keratinised  layer  was  not 
quantified  (when  present)  as  it  was  frequently  observed  to  be  partially 
absent  or  fragmented. 
The  degree  of  dysplasia  was  assessed  using  the  semi-objective 
atypia  scoring  technique  of  Smith  and  Pindborg  (1969).  Sections  stained 
with  H&E  from  both  the  BrdU  processed  and  routinely  processed  tissue 
blocks  were  scored.  The  sections  were  examined  by  the  author  and 
another  examiner.  For  each  case,  the  mean  score  for  each  of  the 
individual  features  from  each  observer  was  used  to  reach  the  final  atypia 
score.  The  details  of  the  relative  weightings  applied  to  each  of  the  13 
features  of  dysplasia  assessed  are  listed  in  Appendix  4.  A  subjective 
report  was  provided  by  the  routine  diagnostic  service  assessing  the 
degree  of  dysplasia  as  mild,  moderate,  severe  or  carcinoma  in-situ. 
Sections  were  examined  for  the  presence  of  fungal  mycelia  using  diastase 
PAS  (Appendix  3). 
Correlations  between  the  LI,  GF,  compartment  sizes  and  atypia 
scores  were  investigated  statistically  using  the  "Spearman-Rank" 
correlation  test.  The  values  of  significance  were  all  taken  from  the 
monograph  by  Siegel  and  Castellan  (1988). 
64 2.2.9  Shrinkage  of  Carnoy's  fixed  tissue 
Whilst  quantification  was  being  performed  an  appreciable  shrinkage 
of  the  Carnoy's  fixed  tissue  was  observed  compared  to  the  formalin  fixed 
tissue.  To  quantify  this  process  the  areas  of  20  lymphocyte  nuclei  were 
measured  in  both  the  Carnoy's  fixed  and  formalin  fixed  tissues  using  the 
interactive  mode  of  the  Kontron  KS300  image  analysis  software 
(described  in  more  detail  in  Chapter  4).  Lymphocytes  were  chosen  as  it 
was  assumed  these  would  be  the  most  consistent  cells  in  terms  of  size. 
The  means  of  these  measurements  were  calculated  for  each  tissue. 
2.2.10  Clinical  parameters 
The  following  clinical  details  of  the  patients  were  obtained  at  the 
time  of  biopsy:  smoking  and  alcohol  habits,  medical  history  and  drug 
history.  Additionally,  haernatologic  and  biochemical  profiles  for  each 
patient  were  available.  The  patients  records  were  consulted  at  regular 
intervals  throughout  the  study  period  to  determine  the  progression  or 
regression  of  the  lesions. 
2.3  Results 
2.3.1  Preliminary  studies 
For  BrdU  immunohistochemistry,  an  antibody  concentration  of  1:  50 
was  deemed  the  minimum  dilution  to  give  optimal  and  consistent  staining 
results  and  this  was  best  after  an  overnight  incubation  at  40C. 
Immunohistochernical  staining  of  the  sections  with  BrdU  gave  little 
65 discernible  background  staining,  generalised  crisp  nuclear  staining  was 
observed  as  demonstrated  in  Figure  2.1. 
The  Ki67  staining  was  deemed  optimal  with  an  antibody 
concentration  of  1  in  100  incubated  at  room  temperature  for  2  hours  but 
was  more  variable  than  BrdU  staining  with  a  number  of  differing  patterns 
being  observed;  a  nucleoplasmic  staining,  strong  nucleolar  staining  and 
finely  speckled  cytoplasmic  staining  (Figure  2.2).  In  several  cases,  a  clear 
lack  of  Ki67  positivity  was  evident  in  the  basal  layers  of  the  epithelium 
(Figure  2.3)  and  occasionally  mitoses  were  conspicuously  lacking  in 
positivity  (Figure  2.4) 
.  Positive  Ki67  cells  were  counted  if  they  exhibited 
the  staining  patterns  of  strong  nucleolar  and  nucleoplasmic  staining  but 
not  when  they  showed  only  weak  cytoplasmic  staining.  Occasional 
positively  stained  lymphocytes  were  observed  in  the  epithelium  and  these 
were  excluded  from  the  counts. 
2.3.2  Patient  details 
The  patient  clinical  details,  subjective  grading  of  dysplasia,  atypia 
scores  and  epithelial  thickness  are  presented  in  Table  2.1.  The  mean  age 
of  the  patients  was  59.6  years  (range  31  to  84  years),  12  of  whom  were 
female  (mean  age  56-5)  and  7  male  (mean  age  65.6).  All  the  patients 
except  case  12  admitted  to  being  smokers  or  previous  smokers 
consuming  at  least  five  cigarteftes  per  day  or  half  an  ounce  of  tobacco  per 
day.  Alcohol  consumption  was  admitted  by  half  of  the  patient  group.  Mild 
iron  deficiency  was  found  in  Case  2,  all  of  the  other  cases  had 
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cases  showed  the  presence  of  fungal  mycelia  (Cases  11  and  15)  which 
were  from  the  same  patient  taken  four  months  apart. 
2.3.3  Quantitative  results 
An  example  of  how  the  results  were  obtained  is  shown  in  Table  2.2. 
The  BrdU  labelling  indices,  growth  fraction  and  compartment  analysis  are 
shown  in  Table  2.3.  These  results  were  obtained  by  adding  the 
measurements  obtained  for  each  of  the  three  fields  at  each  level  and 
taking  an  average  for  the  three  levels. 
The  mean  BrdU  Ll%  was  10.80%  (SD  3.23)  and  the  mean  LI/BL 
was  46.58/mm  (SID  20.75)  and  an  average  of  40.51%  (SID  14.30)  labelled 
cells  were  suprabasal. 
The  mean  GF%,  as  identified  by  K67,  was  27.82%  (SD  16.31)  and 
the  GF/BL  was  141.31/mm  (SD  116.58)  with  a  mean  of  71.49%  (SD  6.05) 
Ki67  stained  cells  being  suprabasal. 
The  mean  measurements  and  indices  were  similar  for  each  of  the 
three  levels,  it  was  therefore  deemed  unnecessary  in  further  studies  to 
quantify  at  three  levels. 
From  the  compartment  analysis  it  was  possible  to  calculate  a  mean 
epithelial  thickness  as  described  above  which  gave  an  average  value  of 
229.09prn  (SD  104.73).  The  mean  PC%  was  71.49  (SD  6.05)  and  the 
mean  PC  thickness  was  127.53pm  (SID  69.85)  while  the  mean  MC%  was 
28.51  (SD  6.05)  and  mean  MC  thickness  was  101.56pm  (SD  48.72).  The 
67 mean  ratio  of  the  PC:  MC  was  2.72  (SD  1.08).  The  morphological  PC  was 
clearly  greater  than  the  GF  identified  by  Ki67  and  is  illustrated  in  Figures 
2.5  and  2.6. 
Using  the  Spearman  rank  correlation  test,  significant  correlations 
were  demonstrated  between  the  BrdU  labelling  index  per  mm  basement 
membrane  length  (LI/BL)  and  the  atypia  score  (rs=0.6836,  p<0.01).  The 
GF/BL  correlated  with  the  1-1/131-  (r,  =0.7292,  p<0.001)  but  the  growth 
fraction  did  not  correlate  with  the  atypia  scores.  By  contrast,  the  PC% 
correlated  with  the  atypia  score  (p<0.02). 
The  mean  ratio  of  labelling  index  to  growth  fraction  using  the  data 
Ll%  and  GF%  was  0.46  within  a  wide  range  of  0.11  to  0.94.  This  index  did 
not  correlate  with  the  atypia  scores.  Comparisons  of  the  indices 
expressed  in  relation  to  the  basement  membrane  length  were  not  felt  to 
be  valid  because  of  the  varied  shrinkage  due  to  the  two  fixatives. 
2.3.4  Shrinkage  of  Carnoy's  fixed  tissue 
The  mean  areas  of  the  lymphocytes  in  the  Carnoy's  fixed  tissues 
and  the  formalin-fixed  tissues  were  18.54  pM2  and  23.23  pM2  respectively 
equating  to  mean  diameters  of  4.85  pm  and  5.43  pm.  The  mean  ratio  of 
the  Carnoy's  fixed  tissues  to  the  formalin  fixed  tissues  was  0.89  indicating 
an  average  linear  shrinkage  of  11  %  of  the  Carnoy's  fixed  tissues  more 
than  the  formalin  fixed  tissues. 
2.3.5  Clinical  follow-ul? 
The  20  patients  of  this  series  were  followed  up  for  at  least  12 
68 months,  the  first  eight  patients  for  a  period  in  excess  of  40  months.  Cases 
4,7,12,14  and  15  underwent  surgical  excision  of  their  lesions.  Case  6 
whose  lesion  showed  severe  dysplasia  refused  further  treatment  and  has 
been  lost  to  follow-up. 
Of  the  patient  series,  one  lesion  (Case  14)  has  undergone  clinically 
evident  malignant  transformation  at  the  same  site  as  the  biopsy  over  a 
period  of  6  months  (Figures  2.7a  and  2.7b).  This  case  had  a  LI:  GF  of  0.6 
which  was  one  of  the  higher  of  the  series  despite  having  low  atypia  score, 
labelling  index  and  growth  fraction  in  comparison  to  the  rest  of  the  series. 
One  case  (Case  12)  had  early  invasive  squamous  cell  carcinoma 
evident  on  surgical  excision  of  the  lesion.  The  Ll:  GF  of  this  case  was 
0.49,  again  above  average.  Interestingly,  this  was  the  patient  who  did  not 
report  to  any  previous  or  current  smoking  habits. 
Two  of  the  lesions  studied  were  taken  from  the  same  patient 
(Cases  11  and  15).  Over  the  four  month  period  between  the  two  biopsies, 
the  lesion  progressed  from  homogenous  leukoplakia  to 
erythroleukoplakia.  The  histology  of  the  two  biopsies  was  similar  but  the 
LI:  GF  reduced  by  half  during  this  period  from  0.40  to  0.20. 
2.4  Discussion 
2.4.1  S-phase  analysis 
The  pyrymidine  analogue,  BrdU  was  used  to  label  cells  undergoing 
DNA  synthesis  to  enable  an  estimate  of  those  cycling  cells  which  were  in 
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Previous  proliferation  studies  in  oral  leukoplakia  of  the  buccal 
mucosa  using  tritiated  thymidine  have  reported  a  higher  Ll%  compared  to 
clinically  normal  epithelium  (Alvares  et  aL,  1972a;  Warnakulasuriya  and 
MacDonald,  1995a).  In  addition  Warnakulasuriya  and  MacDonald  (1995a) 
reported  a  significant  correlation  between  a  raised  Ll  and  the  severity  of 
dysplasia  which  is  supported  by  the  results  of  the  present  study  where  it 
has  also  been  demonstrated  that  the  1-1/131-  was  correlated  with  the  atypia 
score.  The  Ll%  in  the  present  study  was  higher  than  that  reported  for 
tritiated  thymidine  labelling,  but  this  could  reflect  differing  cell  turnover 
rates  of  buccal  mucosa  and  tongue/  floor  of  mouth. 
A  diurnal  variation  in  the  labelling  index  in  human  buccal  epithelium 
was  demonstrated  using  tritiated  thymidine  (Warnakulasuriya  and 
MacDonald,  1993).  This  has  been  shown  to  relate  to  a  variable  rate  of 
transition  of  cells  from  G,  to  S-phase  (Warnakulasuriya  and  MacDonald, 
1995b).  Since  all  of  the  biopsies  in  the  present  series  were  taken  during  a 
small  window  of  time  (approximately  1  Oarn  to  12  midday)  it  is  unlikely  this 
phenomenon  would  have  influenced  the  labelling  indices. 
A  recent  study  investigated  the  Ll%  of  non-involved  oral  mucosa 
adjacent  to  tumours  using  in  vivo  administration  of  BrdU  or 
iododeoxyuridine  (IrdU)  (Kotelnikov  et  aL,  1996).  These  workers  reported 
a  low  Ll%  (1.6%)  for  the  basal  cell  layers  but  much  higher  Ll%  for  the 
suprabasal  layers  (31.6%)  in  cytologically  normal  epithelia  in  14  untreated 
70 patients.  Seven  cases  of  dysplastic  epithelium  showed  a  mean  Ll%  of 
1.4%  and  of  36.6%  for  the  basal  and  suprabasal  layers  respectively. 
These  figures  were  significantly  different  from  those  calculated  for  the 
present  study  of  6.26%  and  4.54%  for  the  two  respective  layers  and 
probably  reflects  the  different  mode  of  administration  of  halogenated 
pyrimidines  to  the  samples.  In  vitro  labelling  may  underestimate  that  of  in 
vivo  labelling  (Chavaudra  et  aL,  1979)  but  the  duration  of  in  vivo 
administration  is  longer  than  the  short  pulse  labelling  technique  in  vitro. 
Also,  there  is  a  delay  in  harvesting  of  the  tissues  following  administration 
of  BrdU  in  most  in  vivo  studies  and  it  could  be  expected  that  the  basal 
cells  would  have  moved  into  suprabasal  positions  by  this  time  to  account 
for  this.  There  may  also  possibly  be  differences  in  sampling  for 
quantification.  The  study  of  Kotelnikov  et  al  (1996)  used  both  enzymatic 
digestion  and  4M  HCI  for  the  denaturation  of  the  DNA  compared  to  the 
present  study  using  1M  HCI  only.  The  use  of  the  former  has  been  shown 
to  produce  more  intense  staining  than  1M  HCI  in  other  studies  (Frank  et 
aL,  1995). 
Using  homogenised  samples  of  oral  squamous  cell  carcinoma,  one 
study  found  a  median  BrdU  Ll%  of  2.6%  (Hemmer,  1990),  much  less  than 
the  present  study  (9-89%).  Kotelnikov  et  al  (1995)  using  in  vivo  BrdU 
administration  reported  a  mean  Ll%  almost  double  that  of  previous 
investigations  they  reviewed  using  similar  techniques,  with  a  BrdU  Ll%  of 
over  50%  for  one  poorly  differentiated  carcinoma.  The  authors  did  not 
71 comment  upon  the  clinical  behaviour  of  such  lesions 
2.4.2  Growth  fraction  analysis 
The  present  study  utilised  an  antibody  against  the  proliferation 
antigen  Ki67,  which  is  said  to  be  expressed  only  in  cells  within  the  cell 
cycle,  to  give  an  estimate  of  the  growth  fraction  of  the  lesions.  The  vast 
majority  of  studies  involving  Ki67  to  date  have  utilised  the  MlB1  antibody. 
The  present  study  used  a  relatively  new  Ki67  antibody  said  by  the 
manufacturers  to  be  equivalent  to  M1133  as  characterised  by  Key  et  a/ 
(1993). 
The  distribution  of  Ki67  during  the  cell  cycle  has  been  described 
(van  Dierendonck  et  aL,  1989)  and  shows  a  very  distinct  localisation 
pattern.  During  interphase  there  is  prominent  nucleolar  staining  with 
diffuse  nucleoplasmic  staining.  As  the  chromosomes  condense,  staining 
becomes  nucleoplasmic  and  concentrated  around  the  chromosomes.  In 
metaphase,  there  is  staining  of  a  reticular  network  of  fibrils  around  the 
chromosomes  which  has  a  more  granular  appearance.  The  density  of 
Ki67  staining  is  greatest  during  anaphase,  still  granular  around  the 
chromosomal  network.  As  the  daughter  nuclei  form  and  the  chromosomes 
condense  in  telophase,  the  staining  becomes  speckled  throughout  the 
nucleoplasm  and  returns  to  become  nucleolar  as  the  cell  enters  the 
interphase.  These  observations  suggest  an  association  of  Ki67  with  the 
RNA  of  the  nucleolus  and  a  structural  role  in  nucleoli  and  during  mitosis  in 
association  with  the  chromosomes  (Ross  and  Hall,  1995). 
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formalin  fixed,  paraffin  embedded  material  by  the  use  of  antigen  retrieval 
either  by  microwave,  autoclave  or  pressure  cooker  (Shi  et  aL,  1991).  A 
degree  of  caution  should  be  exercised  when  interpreting  results  following 
antigen  retrieval  as  varying  staining  patterns  have  been  reported  (Dowell 
and  Ogden,  1996;  Gee  et  aL,  1995;  Mighell  et  aL,  1995).  Indeed,  in  the 
present  study,  Ki67  demonstrated  variable  staining  patterns  as  described 
above.  The  subject  of  antigen  retrieval  for  immunohistochemistry  is 
discussed  further  in  Chapter  3. 
Ki67  is  reported  to  be  expressed  in  all  phases  of  the  cell  cycle 
except  Go  and  early  G,  (Gerdes  et  aL,  1983).  Hence,  it  can  provide  an 
estimate  of  the  growth  fraction  defined  as  those  cells  proliferating  or 
growing  in  a  population.  Clearly  in  this  series  of  cases  the  GF  identified  by 
Ki67  was  less  than  that  identified  morphologically  by  means  of  the 
compartment  analysis.  As  will  be  discussed  in  more  detail  in  Chapter  4,  it 
is  becoming  evident  that  Ki67  has  a  shorter  half-life  than  originally 
believed  and  is  actively  produced  from  the  beginning  of  the  S-phase 
reaching  a  peak  around  the  GýM  transition;  thereafter  its  production  being 
below  immunohistochemically  detectable  levels  (Bruno  and 
Darzynkiewicz,  1992;  Lopez  et  al.,  1991).  Therefore  cells  in  the  G,  phase 
may  not  be  detected  by  Ki67  antibodies  and  this  may  account  for  the 
discrepancy  noted  in  the  present  study.  Cells  in  the  Go  phase  and  early 
post-mitotic  maturing  cells  are  not  part  of  the  growth  fraction  but  are 
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1981).  Furthermore,  stem  cells  are  slowly  cycling  cells  with  a  long  G, 
phase  (Lajtha,  1983)  found  in  the  basal  epithelial  layers  and  therefore  on 
the  basis  of  the  information  presented  above  may  not  express  detectable 
Ki67. 
A  high  proportion  (68%)  of  the  cycling  cells  were  demonstrated  to 
be  suprabasal  using  the  Ki67  antigen  in  the  present  study.  Also,  it  was 
observed  that  several  cases  demonstrated  areas  lacking  Ki67  positivity  in 
the  basal  layers  (Figure  2.3).  This  has  been  reported  previously  in 
clysplastic  oral  epithelium  (Bryne  et  aL,  1995;  Girod  et  aL,  1993;  Kannan 
et  aL,  1996)  and  in  both  normal  and  dysplastic  cervical  epithelia 
(Steinbeck,  1997)  but  the  significance  of  this  is  not  known.  It  is  also  not 
known  whether  this  phenomenon  occurs  in  normal  oral  epithelium 
although  it  was  frequently  observed  in  the  epithelium  of  the  tonsils  in  the 
positive  controls.  The  studies  in  Chapter  4  will  attempt  to  address  this. 
Kushner  et  al  (1997)  recently  studied  Ki67  labelling  indices  in  oral 
epithelial  dysplasia  of  the  floor  of  the  mouth.  A  mean  GF/BL  of  85.06  was 
reported  by  the  authors  which  is  considerably  less  than  the  present  study. 
However,  this  may  be  accounted  for  by  the  differing  sampling  methods. 
Kushner  et  al  (1997)  measured  the  basement  membrane  length  and 
performed  cell  counts  of  the  entire  length  of  the  epithelium.  The  biopsy 
specimens  would  have  been  different  sizes  and  measuring  the  epithelium 
in  its  entirety  may  have  included  areas  of  normal  mucosa,  a  phenomenon 
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1996).  Additionally,  measuring  and  expressing  such  indices  per  millimetre 
basement  membrane  length  takes  no  account  of  the  epithelial  thickness. 
Indeed,  in  the  present  study  a  wide  range  of  epithelial  thickness  was 
observed  from  59.51  to  437.57  pm. 
The  progenitor  compartments  were  large  in  the  present  study, 
being  as  much  as  six  times  as  large  as  the  maturation  compartments,  and 
correlated  with  the  atypia  scores.  Histologically,  this  would  be  reflected  in 
the  observation  of  basal  cell  hyperplasia.  A  high  incidence  of  basal  cell 
hyperplasia  was  reported  by  Wright  and  Shear  (1985)  in  their  series  of 
cases  of  oral  epithelial  dysplasia  adjacent  to  squamous  cell  carcinomas. 
This  epithelial  feature  has  a  relatively  low  weighting  in  the  atypia  scoring 
system  of  Smith  and  Pindborg  (1969)  used  in  the  present  study  (Appendix 
4) 
2.4.3  Relation  of  the  S-phase  to  growth  fraction 
Using  the  labelling  index  as  an  estimate  of  cells  in  the  S-phase  it 
was  possible  to  estimate  the  proportion  of  cycling  cells  that  were  in  the  S- 
phase.  The  cases  that  have  progressed  to  clinically  overt  malignancy 
(Cases  12  and  14)  had  a  higher  than  average  proportion  of  cycling  cells  in 
the  S-phase  despite  case  14  having  a  labelling  index,  growth  fraction  and 
atypia  score  in  the  middle  of  the  range.  The  Ll:  GF  may  therefore  be  of 
prognostic  significance.  There  are  certain  shortcomings  to  this 
assumption;  firstly  the  two  parameters  were  measured  on  different  blocks 
75 of  tissue,  albeit  from  the  same  biopsy,  and  shrinkage  was  observed  in  the 
Carnoy's  fixed  tissue.  Secondly,  the  variation  in  antigen  detection  using 
microwave  antigen  retrieval  has  already  been  mentioned  above.  The 
follow-up  period  of  the  cases  in  the  present  study  was  relatively  short,  it  is 
well  known  that  the  natural  history  of  leukoplakia  is  very  variable  and  often 
protracted  with  some  lesions  undergoing  malignant  transformation  over 
time  periods  in  excess  of  20  years  (Lummerman  et  a/.,  1996).  A  further 
consideration  is  that  of  sampling  of  lesions  for  the  biopsy  as  it  was 
possible  that  a  carcinoma  was  already  present  in  the  lesion  shown  in 
Figure  2.7a  at  a  different  site  to  that  of  the  biopsy.  In  lesions  of  this 
appearance  and  size  there  maybe  an  indication  for  more  than  one  biopsy 
from  different  parts  of  the  lesion.  Interestingly,  from  another  study 
performed  in  Glasgow  which  included  some  of  the  same  cases  as  the 
present  study,  cells  from  the  original  biopsy  of  Case  14  proved  to  have  an 
immortal  phenotype  when  grown  in  culture  (F-McGregor,  personal 
communication). 
Warnakulasuriya  and  Johnson  (1993)  on  studies  of  murine  ventral 
tongue  epithelium  using  in  vitro  BrdU  and  PCNA  (estimating  the  growth 
fraction)  reported  a  LI:  GF  of  0.25,  approximately  half  of  that  obtained  in 
the  present  study.  However,  PCNA  has  the  Opposite  drawback  to  Ki67  in 
overestimating  cycling  cells  and  may  account  for  this  discrepancy. 
In  the  present  study,  case  12  was  found  to  have  early  invasive 
carcinoma  on  excision  of  the  entire  lesion.  This  is  a  case  which  clinically 
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that  there  was  no  association  of  the  lesion  with  tobacco  or  any  other 
agent(van  der  Waal  et  aL,  1997).  The  most  recent  WHO  classification  of 
leukoplakia  (Ax6ll  et  aL,  1996)  has  dismissed  this  term  for  reasons  of 
clarity  and  consistency.  However,  as  this  case  demonstrates,  the  aetiology 
of  such  lesions  clearly  differs  from  the  so-called  toba=o-assodated 
lesions  and  the  natural  history  differs,  with  the  possibility  that  such  lesions 
have  a  greater  tendency  towards  malignant  transformation.  There  appears 
to  be  a  justification  for  retaining  the  use  of  this  term.  With  this  being  only 
one  case  out  of  a  series  of  20,  it  also  demonstrates  that  such  idiopathic 
leukoplakias  are  much  fewer  in  number  making  larger  scale  studies 
potentially  more  difficult.  It  certainly  warrants  further  study.  Koch  and 
McQuone  (1997)  recently  reviewed  and  discussed  the  subject  of  oral 
squamous  cell  carcinoma  development  in  the  non-smoker  and  non- 
drinker.  These  authors  quoted  studies  where  development  of  carcinoma 
was  significantly  greater  in  non-smoking  females  and  it  was  suggested 
this  may  be  due  to  chronic  anaernia  associated  with  menstruation.  Also, 
there  may  be  inherited  defects  in  enzymes  required  for  metabolising 
carcinogens  and  DNA  repair  as  well  as  a  family  history  of  cancer  but  the 
association  is  not  as  strong  as  in  other  sites  such  as  the  colon  and  breast 
(Koch  and  McQuone,  1997). 
Fungal  mycelia  were  demonstrated  in  two  lesions  (111  and  15)  and 
as  may  be  expected  the  proliferative  indices  of  these  cases  were  above 
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demonstrable  fungal  infection  was  comparable  with  the  studies  of  Barreft 
et  al  (1998)  who  recently  found  12.3%  of  dysplastic  lesions  showed  fungal 
infection  in  a  series  of  nearly  600  cases.  These  authors  also  noted  that  in 
subsequent  biopsies  of  such  lesions  the  degree  of  dysplasia  worsened  in 
severity  in  more  instances  compared  to  cases  in  which  fungi  were  never 
demonstrated. 
Cruchley  et  a/  (1998)  investigated  cell  proliferation  in  oral  hairy 
leukoplakia  using  the  same  markers  as  the  present  study.  These  workers 
reported  mean  LI/BL  and  GF/BL  values  substantially  lower  than  the 
present  series  and  found  no  difference  between  lesional  and  normal 
mucosae  but  observed  a  reduction  of  basal  BrdU  positive  cells  in  the 
presence  of  EBV.  By  contrast,  cytomegalovirus  (CMV)  has  been  shown  to 
increase  immunohistochernically  detectable  Ki67  (Mate  et  aL,  1998a). 
In  primary  squamous  cell  carcinoma  of  the  head  and  neck,  an  in 
vivo  BrdU  Ll  accounted  for  up  to  half  the  growth  fraction  as  assessed  by 
Ki67  in  one  study  (Wilson  et  aL,  1996).  These  workers  also  noted  a  wide 
intra-  and  inter-patient  variation  in  the  BrdU  Ll  particularly.  This,  again, 
raises  the  problem  in  studies  of  this  kind  of  adequate  and  representative 
sampling  of  lesions. 
The  GF/BL  correlated  with  the  LIM  but  these  indices  did  not 
correlate  with  each  other  when  expressed  as  a  percentage  of  the  total  cell 
numbers.  This  may  be  due  to  the  fact  that  the  length  of  the  basement 
78 membrane  does  not  take  into  account  the  wide  variation  in  epithelial 
thickness  which  was  observed  in  these  cases. 
Recent  investigations  using  Ki67  and  E3rdU  in  prostate  carcinoma 
demonstrated  a  correlation  between  Ll  and  GF  (Limas  and  Frizelle,  1994) 
and  a  high  GF  measured  by  Ki67  was  predictive  for  clinical  progression 
(Bubendorf  et  at,  1996).  The  prostate  is  a  stable  tissue  In  terms  of  cell 
proliferation  whereas  the  oral  epithelium  is  labile  and  perhaps  these 
results  are  not  surprising.  In  a  separate  publication  Limas  et  a/  (1993) 
inferred  that  the  variable  staining  intensity  of  Ki67  positive  nuclei  may 
have  introduced  inconsistencies  and  subjectivity  even  when  performed  In 
fresh  frozen  tissue. 
Langford  et  a/  (1996)  reported  a  correlation  between  GF  and  LI 
assessed  by  Ki67  and  BrdU  in  meningiomas.  However  this  study  was 
primarily  concerned  with  investigating  the  use  of  Ki67  as  an  alternative 
marker  of  proliferation  to  BrdU  rather  than  for  interpreting  the  cell  cycle  In 
detail. 
2.5  Summary  and  conclusions 
In  the  present  chapter,  the  BrdU  labelling  index  has  provided  a 
further  objective  parameter  in  the  assessment  of  oral  epithelial  dysplasia. 
The  use  of  this  in  a  routine  laboratory  may  be  limited  due  to  the  lengthy 
processing  time,  however,  formalin  fixation  of  the  tissue  would  reduce  this 
somewhat  and  will  be  investigated  in  Chapters  3  and  6. 
79 The  Ll:  GF  ratio  may  prove  useful  as  a  prognostic  indicator  with 
regard  to  malignant  transformation  in  the  lesions  of  leukoplakia.  Due  to 
the  nature  of  such  lesions,  longer-term  follow-up  is  required  to  support  this 
further.  Also,  these  deductions  were  made  upon  tissue  sections  some 
distance  from  each  other  with  an  appreciable  tissue  shrinkage  occurring  in 
the  Carnoy's  fixed  tissue.  Again,  formalin  fixation  of  the  BrdU  processed 
tissue  would  overcome  this  shortfall. 
Lesions  of  leukoplakia  that  are  not  associated  with  tobacco  usage 
may  behave  in  a  more  aggressive  manner  undergoing  malignant 
transformation  relatively  early  in  their  natural  history.  A  larger  study  of  a 
cohort  of  such  lesions  would  be  useful. 
Finally,  the  immunohistochernical  staining  obtained  following 
antigen  retrieval  for  Ki67  was  not  ideal.  This  may  be  overcome  by  further 
experimentation  with  this  technique  including  the  use  of  alternative 
retrieval  buffers  and  methods  of  heating.  This  will  be  addressed  in 
Chapter  3. 
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81 Table  2.2  Derivation  of  labelling  indices 
Case  Level  One  Summary 
Total  BL  Total  Total  LC  Total 
LC  SB  Cells 
1  3150.71  158  55  1162 
2  1968.55  67  25  613 
3  2321.68  229  77  928 
Case  Level  Two  Summary 
Total  Total  Total  LC  Total 
BL  LC  SB  Cells 
1  3133.82  108  48  1420 
2  2508.16  133  59  1200 
3  2896.09  138  66  958 
Case  Level  Three  Summary 
Total  Total  Total  LC  Total 
BL  LC  SB  Cells 
1  4256.70  149  43  1385 
2  2220.08  71  14  859 
3  2957.58  239  115  1034 
Case  BrdU  Summary:  Average  of  3 
Levels 
BL  LC  LC  SB  TNC 
1  3513.74  138.33  48.67  1322.33 
2  2232.26  90.33  32.67  890.67 
3  2725.12  202.00  86.00  973.33 
BrdU  Summary 
Case  Ll%  1-1/131-  %SB 
_  1  10.46  39.37  35.18 
2  10.14  40.47  36.16 
3  20.75  74.13  42.57 
BL:  basement  membrane  length  (pm) 
LC:  E3rdU  labelled  cells 
SB:  suprabasal 
TNC:  total  viable  nucleated  cells 
Ll%:  BrdU  labelling  index  expressed  per  100  viable  nucleated  cells 
Ll/BL:  BrdU  labelling  index  expressed  per  millimetre  basement  membrane 
length 
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Figure  2.1  Demonstration  of  BrdU  immunohistochernistry  in  Case  7 
(magnification  x478) 
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Figure  2.2  Demonstration  of  Ki67  immunohistochernistry  in  Case  4 
(magnification  x478) 
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Figure  2.3  Lack  of  basal  staining  with  K167  antibody  in  case  12 
(magnification  x478) 
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Figure  2.4  Lack  of  Ki67  Positivity  of  a  mitosis  in  Case  9 
(magnification  x478) 
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Figure  2.5  Haernatoxylin  and  eosin  stained  section  of  Case12 
(magnification  x236) 
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Figure  2.6  Corresponding  field  of  Case  12  demonstrating  the  growth 
fraction  identified  by  Ki67  ((magnification  x236) 
86 B.  Clinical  appearance  six  months  after  initial  presentation 
Figure  2.7  Leukoplakia  of  left  lateral  border  of  the  tongue  of  case  14 
which  underwent  malignant  transformation 
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A.  At  initial  presentation Chapter  3 
Investigation  of  methods 
88 3.1  Introduction 
3.1.1  Fixation 
In  Chapter  2,  the  comparisons  of  the  BrdU  I-I  and  the  GF  identified 
by  Ki67  were  performed  on  different  tissue  blocks  and  hence  some 
distance  apart  and  clearly  on  different  cell  populations  despite  coming 
from  the  same  biopsy  specimen.  Carnoy's  solution  was  initially  chosen  as 
it  is  said  to  give  clearer  nuclear  detail  and  is  recommended  for  the  study  of 
nucleic  acids  (Pearse,  1980),  a  factor  important  when  assessing  labelled 
nuclei.  However,  such  fixation  does  not  allow  the  rather  rigorous 
procedure  of  antigen  retrieval  required  for  Ki67  immunohistochemistry  and 
results  in  loss  of  the  tissue  section  from  the  slide.  For  convenience  of 
processing  formalin  would  be  a  desirable  alternative  but  it  is  known  to 
mask  antigens  in  tissues,  a  potential  problem  for  immunohistochernistry. 
3.1.2  Antigen  retrieval 
Shi  et  al  in  1991  first  reported  a  new  method  of  unmasking 
antigens  in  formalin-fixed,  paraffin-embedded  tissues  and  allowing  their 
demonstration  by  immunohistochernistry  following  microwave  oven 
heating  of  tissue  sections.  Antigen  retrieval  has  recently  been  extensively 
reviewed  by  the  original  author  (Shi  et  aL,  1997). 
The  subject  of  antigen  retrieval  has  received  much  attention 
recently  in  the  literature  with  many  varied  methods  being  proposed.  It  is 
evident  that  conditions  must  be  optimised  by  laboratories  for  each 
different  tissue  and  antibody  used  rather  than  employing  the  same  method 
89 for  every  study  (Shi  et  aL,  1997). 
3.1.3  Aims 
The  first  aim  of  the  studies  in  the  present  chapter  was  to  attempt  to 
develop  a  method  whereby  formalin  fixation  could  be  used  in  the 
preparation  of  BrdU  labelled  tissues. 
Secondly,  a  qualitative  study  was  undertaken  to  determine  the 
optimum  heating  conditions  and  solutions  for  antigen  retrieval  in  the 
tissues  used  in  the  studies  reported  in  this  thesis. 
3.2  Materials  and  Methods 
3.2.1  Formalin  fixation  of  BrdU  processed  tissue 
Incisional  or  punch  biopsies  were  obtained  from  4  patients  (2  male, 
2  female)  presenting  with  the  clinical  lesions  of  leukoplakia  of  the  buccal 
mucosa  or  tongue,  the  details  are  presented  in  Table  3.1. 
Table  3.1  Patient  details 
Case  I  Age  Sex  Site  of  biopsy  Histology 
1  80  m  tongue  frictional  keratosis 
2  45  M  tongue  keratosis 
3  74  IF  buccal  keratosis 
4  46  F  tongue  frictional  keratosis 
The  tissue  was  divided  and  one  half  pulse  labelled  with  BrdU  as  described 
in  Section  2.2.2,  the  other  half  being  processed  for  the  routine  diagnostic 
service.  The  BrdU  incubated  tissue  was  then  further  divided;  half  was 
fixed  in  Carnoy's  solution  and  processed  as  described  previously  (Section 
2.2.2)  and  the  other  half  fixed  in  10%  buffered  formalin  and  routinely 
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Vacuum  Infiltration  Processor  (VIP,  Bayer  Diagnostics).  The  tissue  was 
embedded  in  paraffin  wax  and  4pm  sections  were  cut  and  mounted  on 
silane  coated  slides. 
3.2.2  Immunohistochemistry 
To  enable  the  incorporated  BrdU  to  be  identified  a  number  of 
procedures  were  investigated.  Firstly,  incubation  in  2M  HCI  at  60T  was 
performed  as  previously  on  both  the  Carnoy's  fixed  and  formalin  fixed 
tissue  sections.  Microwave  antigen  retrieval  was  performed  on  further 
tissue  sections,  fixed  in  each  fixative.  The  buffers  used  were  0.01M 
sodium  citrate  buffer  and  lmM  ethylenediaminetetra-acetic  acid  (EDTA, 
pH  8.0)  for  periods  of  3,5,7,10,15  and  20  minutes  followed  by  cooling  at 
room  temperature  for  30  minutes.  Also,  a  combination  of  microwave 
antigen  retrieval  and  hydrochloric  acid  denaturation  was  attempted. 
The  remainder  of  the  immunohistochernistry  procedure  has  been 
described  previously  in  Chapter  2. 
once  optimum  conditions  for  antigen  retrieval  in  the  formalin  fixed 
6 
BrdU  processed  tissue  were  established  the  process  was  repeated  on 
further  tissue  sections  with  Ki67  immunohistochernistry  being  performed 
on  adjacent  sections  as  previously  described  to  ensure  there  was  no 
contraindication  to  the  use  of  this  antibody  on  these  tissues. 
3.2.3  Quantification 
For  each  case  the  stained  sections  were  quantified  as  previously 
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(Version  2.0,  Kontron,  Germany)  on  a  standard  IBM-compatible  computer 
coupled  to  an  Olympus  BX50  microscope  via  a  JVC  KYF30E  colour  video 
camera.  The  BrdU  labelled  nuclei  were  counted  in  three  defined  fields  at 
an  objective  magnification  of  x20  and  expressed  as  cells  per  100  total 
nucleated  cells  (Ll%)  and  per  millimetre  basement  membrane  length 
(LUBL). 
3.2.4  Comparison  of  antigen  retrieval  techniques 
The  following  tissues  were  selected  for  the  analysis,  normal  human 
tonsil,  oral  squamous  cell  carcinoma  and  oral  epithelial  dysplastic  lesions 
from  the  routinely  processed  blocks  used  in  Chapter  2. 
The  buffers  used  for  antigen  retrieval  were  as  follows,  0.01M 
sodium  citrate  (pH  6.0),  lmM  EDTA  (pH  8.0)  and  acetic  acid  (pH  2.0)  as 
previously  described  in  the  literature  (Shi  et  aL,  1996a).  The  detailed 
constituents  of  these  buffer  are  listed  in  Appendix  2. 
Four  micrometre  sections  of  each  of  the  above  tissues  were  cut 
and  mounted  on  silane  coated  slides.  Following  dewaxing  in  xylene  and 
rehydrating  through  graded  alcohols,  slides  were  placed  in  each  of  the 
three  buffers  and  heated  in  either  a  microwave  oven  for  three  periods  of  5 
minutes  or  in  a  domestic  pressure  cooker  (Model  number  6182,  Prestige 
Ltd,  UK).  The  procedure  for  the  latter  was  as  follows;  600  ml  of  buffer  was 
brought  to  the  boil  on  a  gas  ring,  the  sections,  held  in  a  metal  staining 
rack,  were  then  placed  in  the  boiling  buffer  and  the  lid  placed  on  to  seal 
92 the  container.  Once  both  of  the  pressure  valves  had  risen  to  indicate  the 
vessel  had  reached  maximum  pressure,  it  was  held  at  pressure,  in 
separate  experiments,  for  periods  of  1,2  and  5  minutes.  The  vessel  was 
then  placed  under  cold  running  water  until  the  pressure  valves  fell,  the  lid 
removed  and  the  vessel  filled  with  cold  water.  The  slide  rack  was  removed 
and  placed  in  TBS  for  5  minutes.  The  manufacturer's  operating 
instructions  quote  an  operating  pressure  of  103  kPa  for  this  device 
although  the  temperature  achieved  is  not  known. 
Immunohistochemistry  was  then  performed  on  the  sections  using  a 
Ki67  antibody  (NCL-Ki67-MMl)  and  the  procedure  as  described  in  Section 
2.2.6. 
The  stained  sections  were  evaluated  subjectively  and  qualitatively 
for  intensity  of  staining,  crispness  of  nuclear  detail,  background  staining 
and  other  artefacts. 
3.3  Results 
3.3.1  Formalin  fixation  of  BrdU  processed  tissue 
Very  weak  BrdU  staining  was  observed  in  the  formalin  fixed  tissue 
when  pre-treated  with  hydrochloric  acid.  The  staining  was  considered 
inadequate  for  quantification.  Microwave  treatment  of  the  Carnoy's  fixed 
tissue  caused  severe  tissue  destruction  and  loss  of  tissue  from  the  slide. 
Weak  BrdU  reactivity  was  observed  after  3  Minutes  of  microwave  antigen 
retrieval  and  became  optimal  after  7  minutes  remaining  at  a  similar 
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minutes.  The  immunohistochernical  staining  intensity  and  crispness  of  the 
formalin  fixed  material  following  antigen  retrieval  were  similar  the  Carnoy's 
fixed  material  (Figure  3.1).  Indeed,  in  some  cases  the  intensity  of  the 
staining  following  antigen  retrieval  was  superior  to  that  of  the  Carnoy's 
fixed  material.  Regarding  the  formalin  fixed  material  and  antigen  retrieval, 
the  results  were  similar  for  both  buffers  studied,  although  there  was  a 
marginal  increase  in  intensity  using  EDTA.  Figure  3.1  also  demonstrates 
the  shrinkage  of  the  Carnoy's  fixed  material  in  comparison  to  the  formalin 
fixed  tissue. 
Table  3.2  BrdU  labelling  indices 
Case  Carnoy's  fixed  Formalin  fixed/  antigen  retrieval 
HCI  Citrate  EDTA 
denaturation 
LIITNC  LIIBL  LI/TNC  LI/BL  LIITNC  LIIBL 
1  7.45  35.27  8.65  57.75  9.16  59.38 
2  8.02  23.14  8.74  37.70  10.18  39.86 
3  11.19  48.87  5.62  20.49  6.76  23.68 
4  12.43  50.95  8.07  31.37  14.59  36.32 
Mean  9.77  39.56  7.77  36.83  10.17  39.81 
SD  2.42  12.97  1.46  15.65  3.28  14.78 
The  quantitative  results  for  the  four  cases  are  summarised  in  Table 
3.2.  The  mean  labelling  indices  are  in  a  close  range  in  each  of  the  groups. 
The  Carnoy's  fixed  tissue  had  labelling  indices  and  standard  deviation 
closest  to  the  formalin-fixed  tissue  that  underwent  microwave  antigen 
retrieval  using  EDTA.  Using  the  Mann-Whitney  U  test,  no  pairs  of  these 
sets  reached  significance  (p>0.443)  indicating  they  are  from  similar 
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possible,  but,  using  the  Kendall  rank  correlation  test  a  tendency  towards 
correlation  was  observed  between  the  Carnoy's-fixed  group  and  the 
formalin-fixed  group  using  EDTA  as  an  antigen  retrieval  buffer  (p=0.375). 
Immunohistochernistry  using  Ki67  on  BrdU  incubated  formalin-fixed 
sections  was  positive  and  qualitatively  similar  to  previously  observed 
cases. 
3.3.2  Antigen  retrieval 
Immunohistochernistry  with  Ki67  following  microwave  antigen 
retrieval  using  the  three  buffers  can  be  seen  in  Figure  3.2.  EDTA  buffer 
resulted  in  the  strongest  staining  at  the  expense  of  some  increase  in 
background  staining.  Acetate  buffer  gave  inferior  antigen  retrieval  to  the 
two  other  buffers. 
Citrate,  buffer  combined  with  pressure  cooker  heat  treatment  gave 
the  next  best  antigen  retrieval,  slightly  superior  to  the  same  buffer  used 
with  the  microwave,  at  the  expense  of  some  increase  in  background 
staining  (Figure  3.3).  EDTA  using  the  pressure  cooker  tended  to  produce 
tissue  destruction  and  loss  of  the  tissue  from  the  microscope  slide  and 
acetate  buffer  gave  inferior  results  to  the  microwave  treatment. 
Heating  in  the  pressure  cooker  for  periods  of  1  and  2  minutes  gave 
equivocal  staining  results.  Heating  for  longer  periods  produced  tissue 
destruction  and  loss  of  tissue  from  the  slide. 
95 3.4  Discussion 
3.4.1  Formalin  fixation  of  BrdU  processed  tissue 
In  the  present  chapter  a  method  was  developed  by  which  formalin 
fixation  of  BrdU  processed  tissue  was  seen  to  give  qualitatively  equivalent 
staining  to  that  of  Carnoy's  fixed  tissue  when  microwave  antigen  retrieval 
was  applied.  The  protocol  upon  which  this  study  was  initially  based 
reported  that  Camoy's  fixative  was  superior  to  formalin  with  regard  to 
identification  of  immunohistochernical  demonstration  of  BrdU  labelled  cells 
(Thornton  et  aL,  1988);  this  was  based  upon  using  hydrochloric  acid  as 
the  DNA  denaturation  agent  without  any  other  form  of  antigen  retrieval. 
Magaud  et  al  (1989)  who  developed  the  monoclonal  anti-BrdU  antibody 
(Bu20a)  used  in  the  present  study  also  reported  a  lack  of  staining  of 
formalin  fixed  tissue  sections  using  hydrochloric  acid  alone.  Other  workers 
have  successfully  utilised  hydrochloric  acid  to  denature  DNA  in  formalin 
fixed  tissues  but  in  these  cases  the  BrdU  was  administered  in  vivo  (Frank 
et  aL,  1995;  Kotelnikov  et  aL,  1996;  Langford  et  al.,  1996;  Wilson  et  al., 
1996).  Tischler  (1995)  reported  the  use  of  microwave  antigen  retrieval  In 
citrate  buffer  for  the  demonstration  of  BrdU  In  formalin  fixed  tissue,  but 
again  this  was  in  an  in  vivo  model. 
Other  studies  fixed  BrdU  processed  tissue  in  ethanol  prior  to 
embedding  in  paraffin  wax  (Browman  et  aL,  1991;  Limas  et  al.,  1993; 
Limas  and  Frizelle,  1994).  While  this  negates  the  use  of  antigen  retrieval 
its  potential  use  in  a  diagnostic  laboratory  would  be  limited  because  of  the 
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as  formalin  fixation  would  allow. 
Although  not  attempted  in  this  study,  enzymatic  antigen  recovery  is 
possible  in  formalin  fixed  tissue  but  has  been  reported  to  decrease  the 
specificity  of  some  anti-BrdU  antibodies  (Bak  and  Panos.  1997). 
Interestingly,  Bak  and  Panos  (1997)  reported  more  specificity  using  the 
Bu20a  clone  (as  used  in  the  present  study)  compared  to  other  antibodies 
when  protease  digestion  was  used. 
3.4.2  Antigen  retrieval 
Formalin  (formaldehyde)  is  probably  the  most  popular  fixative  in 
use  today  and  continues  to  be  used  for  the  fixation  of  specimens  for 
histological  examination  as  most  of  the  criteria  for  diagnosis  have  been 
established  by  the  examination  of  sections  fixed  this  way  (ShI  et  al, 
1997).  Formalin  appears  to  act  by  forming  intermolecular  bridges  between 
proteins  and  formalin  as  well  as  cross-links  between  protein  end-groups 
(Pearse,  1980).  Consequently,  there  is  a  loss  of  antigen  expression  for 
many  forms  of  immunohistochemistry  when  tissues  are  fixed  in  formalin. 
Williams  et  al  (11997)  conducted  an  elaborate  series  of  experiments 
to  investigate  variable  factors  in  the  whole  course  of  tissue  processing  on 
the  immunostaining  of  a  panel  of  antibodies.  These  authors  reported 
various  traditional  preparations  of  formalin  to  be  superior  to  some 
preparations  recommended  for  immunohistochernistry  such  as  B5  fixative 
and  Bouin's  fixative.  Optimal  immunoreactivity  was  obtained  after  12 
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the  fixative,  particularly  those  of  high  pH  values.  Interestingly,  the 
temperature  and  duration  of  tissue  section  drying  was  found  to  affect  the 
immunoreactivity  of  some  antibodies,  a  factor  that  is  not  normally 
considered  important.  Many  variables  in  the  processing  procedure  had  no 
effect  including,  delay  prior  to  fixation,  use  of  vacuum,  xylene 
contamination  of  formalin  and  prolonged  storage  of  cut  sections. 
Since  the  original  report  by  Shi  et  a/  (1991),  a  vast  range  of 
publications  has  appeared  featuring  microwave  antigen  retrieval;  it  has 
been  particularly  instrumental  in  allowing  proliferation  studies  using  Ki67 
notably  using  the  MlB1  antibody  (Key  et  aL,  1993). 
The  precise  mechanism  by  which  the  epitopes  are  unmasked  by 
this  method  is  unclear,  although  the  heat  element  is  believed  to  be  the 
most  critical  factor  (Shi  et  aL,  1996b).  Heat  may  provide  the  energy  to  free 
protein  bound  calcium  from  the  complexes  formed  during  formalin  fixation 
(Morgan  et  aL,  1994).  The  degree  of  antigen  retrieval  appears  to  be  a 
function  of  temperature  M  and  time  (t)  in  the  relationship  "T  xV  (Shi  et  aL, 
1996a). 
3.4.3  The  pH  and  buffer  constituents  in  antigen  retrieval 
More  recently  the  pH  of  the  antigen  retrieval  solution  has  been 
investigated  and  appears  to  be  important  for  certain  antigens  (Evers  and 
Uylings,  1994;  Shi  et  aL,  1996).  Low  pH  solutions  tend  to  increase 
background  staining  when  used  for  antigen  retrieval  of  some  antigens  and 
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probably  the  most  widely  used  buffer  for  antigen  retrieval  was  sodium 
citrate  buffer  at  pH  6.0  (Shi  et  aL,  1991),  however,  subsequent  reports 
suggest  chelating  agents  such  as  EDTA,  pH  8.0,  may  be  more  effective 
as  antigen retrieval  solutions  (Morgan  et  aL,  1994).  Other  buffers  including 
distilled  water,  Tris  buffered  saline  and  even  simple  commercially 
available  surfactants  have  all  been  used  in  certain  situations  with  success 
(Shi  et  aL,  1997).  The  molarity  of  such  buffers  is  thought  not  to  be  critical 
(Shi  et  aL,  1997).  Norton  et  al  (1994)  reported  fluctuation  of  pH  from  6.0  to 
9.1  when  using  citrate  buffer  in  an  aluminium  pressure  cooker,  thought  to 
be  due  to  the  liberation  of  aluminiurn  ions  from  the  vessel,  but  this 
appeared  not  to  affect  the  results  suggesting  pH  control  was  not  critical. 
In  the  present  study,  antigen  retrieval  of  Ki67  in  oral  epithelium 
appeared  to  be  optimal  with  the  use  of  EDTA  at  pH  8.0.  Morgan  et  al 
(1994)  also  reported  EDTA  to  be  more  effective  than  citrate  for  the 
retrieval  of  Ki67  in  formalin  fixed  tissue  sections  of  human  tonsil  and 
suggested  chelation  or  precipitation  of  calcium  ions  was  the  critical  step  in 
the  antigen  retrieval  process.  These  workers  used  an  autoclave  for 
administration  of  heat.  EDTA  has  also  been  reported  to  be  superior  to 
citrate  when  using  a  panel  of  antibodies,  including  Ki67,  and  pressure 
cooker  (Pileri  et  aL,  1997). 
3.4.4  Methods  of  heat  application 
Antigen  retrieval  has  also  been  achieved  using  other  forms  of  heat 
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Mighell  et  at,  1995;  Piffk6  et  at,  1995;  Shi  et  at,  1996)  and  a  domestic 
pressure  cooker  (Kushner  et  aL,  1997;  Norton  et  aL,  1994).  These 
methods  are  claimed  to  have  an  advantage  over  the  microwave  method  in 
that  they  preserve  the  nuclear  morphology  (Hunt  et  aL,  1996)  which  may 
be  advantageous  when  quantifying  proliferation  by  the  use  of  nuclear 
antigens  such  as  BrdU,  Ki67  and  the  cyclins. 
Bussolati  et  al  (1997)  recently  reported  restoration  of  the  reactivity 
of  endogenous  biotin  following  antigen  retrieval,  particularly  with  the 
pressure  cooker,  resulting  in  an  intense  and  finely  granular  staining  of  the 
cytoplasm  when  using  the  streptavidin-biotin  peroxidase  method.  This 
effect  was  most  pronounced  in  liver,  kidney,  adrenal  cortex,  adipose 
tissue  and  in  tissues  or  turnours  rich  in  mitochondria  but  was  not  observed 
in  normal  skin  or  skin  tumours  (Bussolati  et  aL,  1997)  and  therefore  would 
probably  not  be  a  significant  problem  in  oral  mucosa. 
For  convenience  and  practicality,  the  use  of  the  microwave  or 
pressure  cooker  is  recommended  for  most  research  and  diagnostic 
applications  (Shi  et  aL,  1997).  Indeed,  the  pressure  cooker  method  has  a 
number  of  advantages  over  the  microwave;  larger  batches  of  slides  are 
capable  of  being  processed  simultaneously,  the  equipment  is  cheap  and 
easy  to  use,  and  it  avoids  the  occurrence  of  hot  and  cold  spots  that  are 
found  during  microwave  heating  (Pileri  et  aL,  1997).  It  was  noted  in  the 
present  studies  that  over  a  period  of  time  the  rubber  seals  in  the  pressure 
100 cooker  appear  to  become  less  effective.  Therefore,  these  probably  require 
regular  replacement  to  ensure  adequate  pressure  is  maintained  within  the 
vessel,  something  that  does  not  appear  to  have  been  addressed  in  the 
literature.  Autoclave  antigen  retrieval  was  attempted  in  this  study  but 
resulted  in  tissue  destruction,  was  more  difficult  to  control  and  was 
considered  inappropriate  for  use  (data  not  shown). 
3.4.5  Stanclardisation  of  antigen  retrieval 
When  using  antigen  retrieval  it  is  sometimes  observed  that  a  range 
of  staining  intensities  is  produced  which  makes  the  interpretation  of 
positively  stained  cells  more  difficult  (Dowell  and  Ogden, 1996;  Gee  et  aL, 
1995)  and  makes  a  subjective  elimination  of  the  weakly  staining  cells 
necessary  (Gee  et  aL,  1995).  Indeed,  for  each  antigen  and  tissue  studied, 
the  optimum  antigen  retrieval  conditions  both  in  terms  of  time  of  heating 
and  the  buffer  used  as  well  as  on  occasion  enzymatic  pre-treatment 
should  be  thoroughly  investigated  to  minimise  these  difficulties  in 
interpretation  and  introduce  a  degree  of  standardisation  between 
investigators  (Caftorefti,  1994;  Mighell  et  aL,  1995).  One  technique  is  to 
introduce  a  "test  battery"  approach  for  each  new  antibody  studied  as 
recently  described  (Shi  et  aL,  1996a)  in  which  three  levels  of  heating  times 
and  three  pH  values  of  buffer  are  used  to  determine  the  optimal  antigen 
retrieval  for  each  antibody  used.  Ideally,  additional  studies  comparing  the 
intensity  of  staining  following  antigen  retrieval  with  that  of  frozen 
specimens  of  the  same  tissue  should  be  performed  for  each  antibody  (Shi 
101 et  aL,  1997).  Gee  et  al  (1995)  performed  such  a  study  using  Ki67  on 
breast  carcinoma  tissue  and  suggested  a  cut-off  point  of  staining  intensity 
be  applied.  This  would,  however,  further  increase  the  degree  of 
subjectivity  of  assessment  of  immunohistochernically  stained  sections. 
3.4.6  Signal  amplification  in  immunohistochernistry 
The  avidin-biotin  complex  (ABC)  method  (Hsu  et  aL,  1981)  utilised 
in  the  present  studies  is  perhaps  the  most  widely  used  technique  for 
amplification  of  antibody  labelled  cells  in  tissue  sections.  Other  methods 
are  available  and  have  recently  been  reviewed  by  McNicol  and  Richmond 
(1998).  A  reversed  ABC  technique  has  been  developed  in  which  there  is 
an  excess  of  biotinylated  peroxidase  rather  than  avidin  which  has  been 
shown  to  be  superior  to  the  original  technique  (Grumbach  and  Veh,  1995). 
Additionally,  heavy  metals  such  as  nickel  can  be  used  to  enhance  DAB 
staining  (McNicol  and  Richmond,  1998). 
A  newer  approach  to  amplification  of  signals  is  that  of  catalysed 
reporter  deposition  (CARD)  whereby  horseradish  peroxidase  catalyses  the 
deposition  of  biotinylated  tyramine  at  and  around  antibody  binding  sites. 
This  can  then  be  detected  using  already  established  enzyme  methods 
(von  Wasielewski  et  aL,  1997).  A  number  of  studies  have  demonstrated 
the  increased  sensitivity  and  reproducibility  of  this  method  which  has  even 
enabled  antigens  to  be  visualised  in  formalin  fixed  tissues  that  had 
previously  been  apparently  unreactive  (King  et  aL,  1997;  Van  heusden  et 
aL,  1997;  von  Wasielewski  et  aL,  1997).  Additionally,  with  the  emergence 
102 of  commercially  available  kit  forms  of  this  method  (Merz  et  aL,  1995)  this 
is  likely  to  become  increasingly  utilised  in  immunohistochemistry. 
3.5  Summary  and  conclusions 
BrdU  immunohistochernistry  was  demonstrated  in  formalin  fixed 
oral  epithelium  following  antigen  retrieval.  To  the  author's  knowledge  this 
has  not  been  performed  before  using  in-vitro  administration  of  BrdU  to 
biopsy  specimens.  This  allows  the  use  of  automated  tissue  processing, 
therefore,  reducing  manual  laboratory  time.  The  use  of  formalin  fixation 
will  permit  other  antibodies  to  be  used  on  sequential  sections  of  the  same 
tissue  block,  perhaps  enabling  more  meaningful  comparisons  of  the 
parameters  being  measured.  This  aspect  will  be  further  investigated  in 
Chapter  6. 
Antigen  retrieval  in  oral  epithelia  was  investigated  by  a  variety  of 
methods  to  enable  optimal  results  for  the  Ki67  antibody  which  has  been 
widely  reported  as  being  problematic.  The  underlying  methods  employed 
for  this  investigation  will  be  of  value  in  optimising  antigen  retrieval 
involving  other  antibodies  in  this  thesis. 
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106 Chapter  4 
Growth  fraction  and  compartment  analysis  in  post-mortern 
oral  mucosa 
107 4.1  Introduction 
4.1.1  Ki67 
In  the  study  of  dysplastic  oral  epithelium  in  Chapter  2  it  was 
observed  that  Ki67  antibody  did  not  identify  all  the  cells  which  would  be 
categorised  morphologically  as  progenitor  compartment  cells  and 
therefore  be  expected  to  be  in  the  cell  cycle.  Ki67  antibody  is  claimed  to 
identify  the  growth  fraction  (GF)  by  reacting  with  cells  at  all  stages  within 
the  cell  cycle  (Gerdes  et  aL,  1983).  However,  from  the  studies  of 
dysplastic  lesions  in  Chapter  2  this  clearly  was  not  the  case  and  there  may 
be  a  significant  proportion  of  cells,  probably  those  in  the  G,  phase  of  the 
cell  cycle  that  are  not  identified  by  Ki67  (Bruno  and  Darzynkiewicz,  1992; 
Tsurusawa  and  Fujimoto,  1995). 
4.1.2  Post-mortem  tissues 
In  order  to  investigate  the  apparent  discrepancy  of  Ki67  reactivity,  a 
study  of  normal  oral  epithelium  was  an  option.  Many  workers  utilise  tissue 
from  benign,  often  hyperplastic,  lesions  of  the  oral  cavity  as  surrogates  for 
normal  tissue.  However,  such  tissues  by  the  nature  of  their  aetiology 
would  be  expected  to  have  higher  proliferation  rates  compared  to  truly 
normal  oral  mucosa.  Obtaining  biopsies  of  normal  tissue  is  difficult  and 
would  ideally  require  subjects  without  any  oral  mucosal  pathology.  Post- 
mortem  tissue  is  an  alternative  which  is  relatively  readily  available. 
However,  to  date  there  are  no  reports  of  studies  using  Ki67  on  post- 
mortem  tissues.  It  is  known  that  Ki67  has  a  relatively  short  half-life  in 
108 normal  cells  and  might  be  broken  down  before  harvesting  of  tissue  post- 
mortem.  Similarly,  cells  undergo  autolysis  post-mortem  which  could  have 
deleterious  effects  both  on  the  Ki67  protein  and  the  overall  tissue 
architecture. 
4.1.3  Alms 
The  aims  of  the  present  study  were  to  investigate  the  GF  identified 
by  Ki67  and  perform  a  compartment  analysis  in  normal  oral  mucosa  to  see 
if,  as  in  dysplastic  oral  epithelium,  Ki67  significantly  underestimates  the 
morphological  progenitor  compartment.  Secondly  the  use  of  post-mortem 
tissue  as  a  possible  source  of  material  for  the  study  of  Ki67  and  as  future 
normal  control  epithelium  was  investigated. 
4.2  Material  and  methods 
4.2.1  Collection  of  material 
Samples  of  lining  mucosa  were  obtained  from  the  lateral  border  of 
the  tongue  from  20  cadavers  at  post-mortem  and  routinely  formalin  fixed 
and  processed.  Five  micrometre  sections  were  cut  and  stained  with 
haernatoxylin  and  eosin  (H&E).  These  were  examined  to  exclude  the 
possibility  of  any  mucosal  pathology.  Consecutive  sections  were  cut  and 
mounted  on  silane-coated  slides  (BDH)  for  Ki67  immunohistochernistry. 
4.2.2  Preliminary  studies 
As  described  in  Chapter  3,  prior  to  progressing  with  the  main  study, 
a  modified  test  battery  approach  was  applied  to  determine  the  optimal 
109 conditions  for  antigen  retrieval.  Sections  were  subjected  to  each  of  the 
following  four  combinations  prior  to  immunohistochemistry. 
Buffer  I  Method  of  heat  application 
0.01M  sodium  citrate 
or 
I  mM  EDTA 
microwave  oven  for  multiples  of  5  minutes 
or 
domestic  pressure  cooker  for  1,2  or  5  minutes 
The  sections  were  assessed  qualitatively  following  Ki67 
immunohistochemistry  for  clarity  and  intensity  of  staining  and  the 
go 
presence  and  degree  of  artefacts.  Once  the  optimal  conditions  had  been 
achieved  the  procedure  was  continued  as  described  below. 
4.2.3  Immunohistochemistry 
Following  antigen  retrieval  the  Ki67  antibody  (NCL-Ki67-MM1, 
Novocastra,  clone  MM1)  was  applied  to  the  sections  at  a  dilution  of  1  in 
100  for  2  hours  at  room  temperature.  The  remainder  of  the  procedure  was 
as  previously  described  in  Section  2.2.6. 
Positive  controls  were  sections  of  human  tonsil  and  negative 
controls  were  the  test  tissue  omitting  the  primary  antibody  from  the 
incubation  sequence. 
4.2.4  Quantification 
Quantification  was  undertaken  using  the  interactive  mode  of  the 
Kontron  KS300  image  analysis  system.  Keratinocyte  compartments  were 
identified  morphologically  in  the  H&E  stained  sections  on  the  basis  of 
110 nuclear-cytoplasm  ratio  and  orientation  of  nuclei  as  previously  described 
(Eveson  and  MacDonald,  1978).  Nuclear  counts  were  undertaken  in  the 
progenitor  compartment  (PC)  and  maturation  compartment  (MC)  and  the 
basement  membrane  length  was  measured.  The  corresponding  fields 
were  identified  in  the  immunohistochemically  stained  sections  for  the  GF 
analysis.  The  labelled  nuclei  and  the  total  number  of  viable  keratinocyte 
nuclei  were  counted  and  the  length  of  the  basement  membrane  measured 
as  previously.  Distinction  was  made  between  those  cells  which  were 
basal,  i.  e.  in  contact  with  the  basement  membrane,  and  those  which  were 
suprabasal.  Three  non-overlapping  fields  were  examined  at  two  levels 
from  one  block  in  each  case  to  provide  adequate  sampling. 
4.3  Results 
4.3.1  Sample  material 
Histological  examination  of  the  sections  showed  two  cases  had 
keratinised  epithelium  and  features  of  mild  clysplasia.  These  were 
therefore  excluded.  Of  the  remaining  18  cases,  tissues  were  obtained 
between  3  and  108  hours  (mean  38.36  hours)  post-mortem  from  subjects 
with  an  average  age  of  73.28  years.  Eleven  of  the  subjects  were  female 
and  seven  were  male.  The  details  are  listed  in  Table  4.1. 
4.3.2  Preliminary  studies 
The  optimal  antigen  retrieval  conditions  were  deemed  to  be  heating 
the  sections  in  lmM  EDTA  buffer  for  three  periods  of  5  minutes  in  a 
ill microwave  oven.  Use  of  the  pressure  cooker  consistently  caused  loss  of 
tissue  sections  from  the  slide  either  in  part  or  completely.  Generally  it  was 
observed  that  there  was  an  increase  in  background  in  the  necropsy  tissue 
staining  compared  with  biopsy  material.  H&E  stained  sections  and  the 
immunohistochemical  stained  sections  of  the  corresponding  fields  are 
demonstrated  in  Figures  4.1  to  4.4. 
4.3.3  Quantitative  results 
The  results  are  summarised  in  the  Table  4.1.  The  mean  epithelial 
thickness  was  176.81  pm.  The  morphologic  PC  comprised  68.17%  of  the 
total  nucleated  cells  in  the  epithelium  compared  with  the  GF  26.23% 
identified  by  Ki67.  The  mean  ratio  of  GF:  PC,  therefore,  being  0.40. 
Expressed  per  millimetre  basement  membrane  length  these  figures  were 
330.05/mm  and  123.93/mm  respectively.  Of  the  total  basal  cell  population, 
Ki67  identified  just  26.70%  of  cells  to  be  in  the  GF.  No  correlation  was 
demonstrated  between  the  GF  and  the  number  of  hours  post-mortem. 
Figures  4.1  and  4.3  shows  the  location  of  Ki67  positivity  in  the 
progenitor  compartment  and  Figure  4.3  demonstrates  the  lack  of  staining 
of  many  cells  in  the  basal  layer. 
4.4  Discussion 
4.4.1  Ki67 
The  monoclonal  antibody  Ki67  reacts  with  a  nuclear  antigen  said  to 
be  expressed  in  cycling  cells,  but  not  those  in  the  resting  state  (GO) 
112 (Gerdes  et  aL,  1983).  Despite  widespread  use  for  a  number  of  years  the 
molecular  characterisation  of  the  antigen  recognised  by  Ki67  has  only 
recently  been  identified  (Duchrow  et  aL,  1995)  and  its  function  is  still  not 
completely  understood.  Ki67  appears  to  be  an  absolute  requirement  for 
cell  proliferation  (SchlOter  et  aL,  1993).  It  has  even  been  suggested  that  it 
is  a  potential  oncogene  or  involved  in  apoptosis  (Duchrow  et  aL,  1995) 
and  because  of  the  location  of  the  gene  at  1  Oq25-ter  (Fonatsch  et  aL, 
1991)  close  to  the  end  of  the  chromosome,  translocations  or 
rearrangements  are  quite  likely.  Another  proposed  function  is  a  role  in 
rRNA  metabolism  since  Ki67  is  located  predominantly  in  the  nucleolus 
(Bruno  and  Darzynkiewicz,  1992) 
If  Ki67  is  expressed  in  all  cycling  cells  it  would  be  expected  it  to  be 
present  in  all  the  cells  in  a  progenitor  compartment  of  a  tissue  and  hence 
the  growth  fraction.  In  the  present  study,  the  mean  ratio  of  the  GF:  PC  was 
0.40,  so  clearly  in  normal  oral  mucosal  epithelium  Ki67  antibody  is 
identifying  significantly  less  cells  than  in  the  progenitor  compartment 
morphologically.  A  similar  proportion  (GF:  PC  0.39)  was  also  found  in  the 
studies  in  clysplastic  oral  epithelium  of  Chapter  2. 
More  detailed  analysis  of  the  expression  of  Ki67.  at  various  stages 
in  the  cell  cycle  has  revealed  that  the  half  life  of  the  antigen  is  about  one 
hour  and  the  level  of  the  protein  synthesis  increases  during  the  S-phase 
reaching  a  peak  during  the  G2/M  transition  (Bruno  and  Darzynkiewicz, 
1992;  Lopez  et  al.,  1991).  In  cells  with  a  long  G,  phase,  when  production 
113 of  the  K67  antigen  is  minimal,  the  antigen  may  be  below 
immunohistochernical  detection  levels  (Tsurusawa  and  Fujimoto,  1995). 
Therefore,  cells  not  demonstrating  Ki67  immunoreactivity  may  still  be 
cycling,  but  erroneously  identified  as  in  the  resting  state  (Bruno  and 
Darzynkiewicz,  1992;  van  Dierendonck  et  aL,  1989).  Oral  epithelial  cells 
probably  are  in  this  category  with  a  long  G,  phase. 
4.4.2  Post-mortem  tissues 
To  the  authors  knowledge,  there  are  no  previous  reports  of  the  use 
of  Ki67  in  post-mortern  tissues.  Its  reactivity  and  staining  properties 
appear  to  be  similar  to  those  in  biopsies  of  oral  mucosa.  It  is  not  known 
how  long  individual  cells  of  different  tissues  continue  to  cycle  after  death 
of  the  patient.  The  continued  presence  of  immunoreactivity  in  the  cases  in 
this  series  would  suggest  either  that  cells  continue  to  cycle  for  some 
considerable  time  or  alternatively  that  the  Ki67  antigen  avoids  the  normal 
breakdown  mechanisms  in  the  cell  post-mortem. 
Post-mortems  tend  to  be  performed  largely  on  older  age  groups  as 
is  evidenced  in  Table  4.1.  This  may  influence  results  slightly  with  regard  to 
proliferation  studies. 
4.5  Summary  and  conclusions 
As  in  dysplastic  mucosa,  Ki67  immunostaining  appears  to 
significantly  underestimate  the  progenitor  cells  of  the  morphologically 
identified  progenitor  compartment.  It  remains  possible  to  detect  the  Ki67 
114 antigen  in  post-mortem  oral  mucosa.  The  latter  point  may  prove  useful  for 
providing  normal  tissue  for  comparison  with  dysplastic  oral  epithelium  in 
future  studies. 
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Figure  4.1  Case  1  demonstrating  the  growth  fraction  identified  by 
Ki67  (magnification  x236) 
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Figure  4.2  Corresponding  field  of  Casel  stained  with  haernatoxylin 
and  eosin  (magnification  x236) 
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Figure  4.3  Case  6  demonstrating  the  growth  fraction  identified  by 
Ki67  (magnification  x478) 
Figure  4.4  Corresponding  field  of  Case  6  stained  with  haernatoxylin 
and  eosin  demonstrating  the  morphological  progenitor 
compartment  (magnification  x478) 
118 Chapter  5 
The  G,  cyclins  in  oral  epithelial  dysplasia 
119 5.1  Introduction 
The  cyclins  are  part  of  an  elaborate  and  highly  conserved  group  of 
proteins  concerned  with  the  progression  of  the  cell  through  the  cell  cycle. 
In  association  with  CDKs  they  control  the  passage  of  the  cell  through  the 
four  active  phases  of  the  cell  cycle  and  maintain  the  correct  sequence  of 
events.  A  further  family  of  proteins,  the  CDK  inhibitors  (CDKI),  exert  a 
negative  control  upon  the  CDK-cyclin  complexes.  Unlike  the  CDKs,  the 
cyclins  are  only  transcribed  and  expressed  at  specific  points  within  the  cell 
cycle. 
At  least  two  of  the  cyclins  have  been  shown  to  be  important  in  the 
G,  phase  of  the  cell  cycle,  cyclins  D  and  E.  These  two  cyclins  are 
concerned  with  overcoming  the  inhibitory  effect  of  pRb  and  allowing 
progression  through  the  restriction  point  and  entry  into  S-phase. 
5.1.1  The  D  cyclins 
The  family  of  D  cyclins  are,  perhaps,  the  most  studied  of  the 
cyclins.  They  specifically  associate  with  CDK4  or  CDK6  and 
phosphorylate  pRb  thereby  releasing  the  transcription  factor  E2F  during 
the  mid  to  late  G,  phase  (Sherr,  1994).  The  CDK-cyclin  activation  by 
phosphorylation  is  catalysed  by  an  upstream  enzyme,  CDK-activating 
kinase  (CAK)  comprising  CDK7  and  cyclin  H  (Sherr,  1994).  CDKIs  can 
also  bind  to  the  CDK-cyclin  complex  to  inhibit  the  phosphorylation  of  pRb 
and  prevent  transition  through  the  restriction  point  and  hence  the 
progression  into  S-phase. 
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expression  of  which  may  be  cell  type  specific  (Ando  et  aL,  1993;  Tam  et 
al.,  1994).  To  date  the  majority  of  investigators  have  studied  cyclin  Dl 
which  was  initially  discovered  as  a  putative  oncogene  in  parathyroid 
adenomas  and  located  at  a  translocation  break  point  in  B-cell  lymphomas 
hence  the  earlier  names  of  PRAID1  and  Bcl-1  (Rosenberg  et  aL,  1991). 
Cyclin  D1  is  also  reported  as  being  overexpressed  or  amplified  in  head 
and  neck  squamous  cell  carcinomas  in  a  growing  number  of  papers,  as 
cited  in  Section  1.5.9,  supporting  its  role  as  an  oncogene.  The  role  of 
cyclin  D1  in  human  neoplasia  has  recently  been  reviewed  by  Donellan 
and  Chetty  (1998).  Additionally,  it  has  been  suggested  that  cyclin  D1  may 
have  a  role  in  apoptosis  (Kotelnikov  et  aL,  1997). 
5.1.2  Cyclin  E 
Cyclin  E  appears  later  in  the  G,  phase  of  the  cell  cycle  than  the  D 
cyclins  and  associates  with  CDK2  which  then  phosphorylates  pRb 
enabling  the  release  of  E217  (Sherr,  1993).  Maximal  levels  of  cyclin  E- 
CDK2  activity  are  observed  at  the  GI-S-phase  transition  and  this  appears 
to  act  as  the  rate  limiting  step  for  this  progression;  overexpression  of 
cyclin  E  shortens  the  duration  of  the  G,  phase  but  not  the  overall  cell-cycle 
time  (Sherr,  1993).  It  is  not  yet  known  if  cyclin  E  acts  upstream  of  the  D 
cyclins  or  in  parallel  with  them.  Indeed,  Gong  et  a/  (1  995b)  suggested  the 
D  cyclins  may  have  additional  roles  in  the  cell  and  showed  either  an 
invariable  expression  of  D  cyclins  throughout  the  cell  cycle  or  some  D- 
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G,  -S-phase  transition. 
It  has  been  suggested  that  the  three  CDK-cyclin  complexes  that 
interact  with  pRb,  namely  CDK4-cyclin  D1,  CDK2-cyclin  E  and  CDK2- 
cyclin  A,  all  have  a  role  in  the  differential  phosphorylation  of  pRb  which  is 
necessary  for  the  transition  through  the  restriction  point  (Zarkowska  and 
Miftnacht,  1997). 
5.1.3  Aims 
The  studies  in  the  present  chapter  investigated  the  expression  of 
the  G,  cyclins,  D1,  D3  and  E,  in  oral  epithelial  dysplastic  lesions.  The  aim 
of  this  was  to  see  if  these  were  truly  representative  of  the  G,  phase  and  in 
this  capacity  if  they  were  useful  as  markers  of  this  phase  where  Ki67 
expression  may  be  lacking  as  found  in  Chapters  2  and  4.  The  results  were 
related  to  Ki67  expression.  In  an  attempt  to  further  the  objective 
assessment  of  such  lesions  the  correlations  with  the  atypia  scores  were 
also  investigated. 
5.2  Materials  and  Methods 
5.2.1  Case  details 
From  the  diagnostic  histopathology  files  of  Glasgow  Dental 
Hospital,  18  cases  of  dysplastic  lesions  from  the  floor  of  mouth  or  tongue 
were  selected.  Because  the  use  of  the  antibodies  did  not  require 
prospective  collection  of  tissues  archival  specimens  were  used  in  the  first 
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lesions,  the  20  cases  used  in  Chapter  2  were  included  and  compared  for 
part  of  this  study. 
5.2.2  Immunohistochemistry 
Preliminary  studies  were  performed  to  optimise  the  antigen  retrieval 
conditions  using  a  modified  test  battery  approach  as  described  in  Chapter 
3.  This  involved  the  use  of  either  microwave  or  pressure  cooker  heating 
and  either  citrate  or  EDTA  as  the  buffers 
The  primary  antibodies  applied  are  listed  in  Table  5.1,  along  with 
the  clone  and  recommended  working  dilution.  All  the  antibodies  used  were 
supplied  by  Novocastra  (Newcastle,  UK).  The  sections  were  incubated  for 
periods  of  1,2  or  4  hours  at  room  temperature  or  overnight  at  40C  in  a 
humidified  chamber  at  varying  concentrations  to  optimise  the  antibody 
concentrations  and  incubation  times. 
Sections  of  human  tonsil,  lymph  node,  lymphoma  and  oral 
squamous  cell  carcinoma  with  overlying  normal  epithelium  were  used  as 
positive  controls  and  omission  of  the  primary  antibody  was  a  negative 
control. 
6.2.3  Quantification 
Once  the  optimal  antigen  retrieval  and  staining  was  achieved,  the 
sections  of  oral  epithelial  dysplasia  were  immunohistochernically  stained. 
Sequential  sections  from  each  tissue  block  were  used  for  the  18  archival 
cases,  the  antibodies  being  applied  in  the  following  order:  cyclin  DI,  cyclin 
123 D3,  Ki67,  cyclin  E.  Quantification  was  performed  using  the  KS300  image 
analysis  software  and  an  objective  magnification  of  x20.  The  contrast  of 
the  digitally  acquired  images  required  enhancement  in  order  to  confidently 
quantify  the  cyclin  antibody  immunohistochernically  stained  cells  in  the 
majority  of  cases  as  demonstrated  in  Figure  5.1. 
Three  corresponding  fields  were  selected  for  each  case  and  the 
antibody  labelled  cells  counted  and  expressed  per  total  nucleated  cell 
population  (Ll%)  and  per  millimetre  basement  membrane  length  (LI/BL). 
This  was  facilitated  by  the  virtue  of  the  software  used  having  an  image 
gallery  in  which  the  previous  images  could  be  viewed  in  order  to 
accurately  locate  corresponding  fields  as  demonstrated  in  Figure  5.2.  To 
aid  the  quantification  of  the  large  number  of  sections  in  the  study  part  of 
the  procedure  was  automated  by  the  use  of  a  macro  custom  written  by  the 
author.  Essentially  this  is  a  short  program  written  to  run  under  the  KS300 
software  to  consistently  reproduce  the  software  functions  (Appendix  6). 
The  degree  of  dysplasia  for  each  case  was  assessed  on 
haernatoxylin  and  eosin  stained  sections  both  subjectively  and  by  the 
method  of  Smith  and  Pindborg  (1969).  The  first  third  of  the  cases  were 
quantified  by  another  observer  in  order  to  ensure  consistency. 
The  Spearman-Rank  correlation  test  was  used  to  assess  the 
existence  of  correlation  between  the  labelling  indices  and  atypia  scores. 
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5.3.1  Case  details 
The  clinical  details  of  the  series  of  IS  cases  studied  are  shown  in 
Table  5.2.  The  mean  age  of  the  patients  was  57.56  (range  31  to  85). 
There  were  eight  females  (mean  age  57.5)  and  10  males  (mean  age 
57.6).  Ten  of  the  lesions  were  from  the  lateral  border  of  the  tongue  and 
eight  were  from  the  floor  of  the  mouth.  Since  these  lesions  were  archival 
and  obtained  from  a  number  of  different  centres  in  the  West  of  Scotland, 
data  were  not  readily  available  regarding  the  clinical  follow-up  and 
subsequent  behaviour. 
5.3.2  Immunohistochemistry 
Antigen  retrieval  for  the  D  cyclin  antibodies  was  deemed  optimal 
following  heating  in  the  pressure  cooker  with  citrate  buffer  for  two  minutes 
under  pressure.  Using  microwave  antigen  retrieval,  periods  in  excess  of 
35  minutes  were  required  for  any  detectable  immunoreactivity  of  the  D 
cyclins.  This  also  resulted  in  some  tissue  destruction  particularly  of  the 
underlying  connective  tissue.  The  conditions  deemed  optimal  for  cyclin  E 
were  heating  in  EDTA  buffer  for  20  minutes  (4  x5  minutes)  with  the 
microwave  as  the  heat  source.  The  intensity  of  the  D  cyclins  and  cyclin  E 
staining  overall  was  low  relative  to  Ki67  (Figures  5.3  to  5.6).  The  staining 
intensity  was  not  noticeably  improved  by  increasing  the  primary  antibody 
concentration  or  length  of  incubation  times.  Also,  in  some  cases  the 
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the  same  time  and  even  between  different  regions  of  the  same  slide. 
Whether  this  is  a  function  of  the  antigen  retrieval  or  a  true  variation  in 
protein  expression  is  not  known.  Quantification  was  only  possible  following 
the  enhancement  of  contrast  which  improved  the  image  beyond  what 
even  the  naked  eye  could  detect  prior  to  this  operation  (Figure  5.1). 
An  interesting  observation  was  made  with  regard  to  cyclin  D3 
immunoreactivity  in  that  positivity  was  seen  in  the  smooth  muscle  layer 
around  blood  vessels,  interpreted  as  arteries  (Figure  5.7).  This  was 
thought  to  be  cross-reactivity  of  the  antibody  with  this  tissue.  Interestingly, 
the  nuclei  of  the  endothelial  cells  were  also  positive  for  cyclin  D3  in  some 
cases. 
The  distribution  of  cyclin  E  was  unexpected.  In  the  majority  of 
cases  reactivity  was  confined  to  cells  which  would  be  classified  as 
belonging  to  the  maturation  compartment  (Figure  5.8).  In  some  of  the 
more  clysplastic  lesions  the  intensity  of  the  cyclin  E  staining  was 
particularly  marked  (Figure  5.9). 
Ki67  imm  u  no  reactivity  was  consistent  with  previously  observed 
cases  following  antigen  retrieval  for  1  minute  in  EDTA  using  the  pressure 
cooker  (Figure  5.5). 
5.3.3  Quantitative  results:  Ll% 
The  results  for  the  18  archival  cases  are  surnmarised  in  Table  5.3. 
The  mean  Ll%  for  cyclin  Dl  was  32-05%  (SD  11 
.  72),  for  cyclin  D3  34.36% 
126 (SD  15.93),  for  cyclin  E  was  24.06%  (SD  12.31)  and  31.57%  (SD  9.22)  for 
Ki67.  The  D  cyclin  labelling  indices  were  highly  significantly  correlated  with 
each  other  (p<0.005)  while  cyclin  D1  correlated  with  Ki67  (p<0.01)  and 
cyclin  D3  correlated  with  Ki67  (p<0.05).  The  cyclin  E  indices  did  not 
correlate  significantly  with  any  of  the  other  indices  but  there  was  a 
tendency  for  a  correlation  with  the  atypia  scores  (r,  =0.3333,  p<0.1).  These 
correlations  are  detailed  in  Table  5.4a. 
The  labelling  indices  of  the  cases  from  the  series  studied  in 
Chapter  2  are  summarised  in  Table  5.5.  The  mean  Ll%  indices  were  not 
appreciably  different  than  those  for  the  18  case  group. 
When  the  results  of  the  two  groups  were  combined  to  form  a  larger 
group  (38  cases),  the  mean  labelling  indices  were  as  follows.  The  mean 
Ll%  for  cyclin  Dl  was  31.28%  (SD  12.34),  for  cyclin  D3  was  31.32%  (SD 
14.74),  for  cyclin  E  was  26.39%  (SD  12.11)  and  29.60%  (SD  13.39)  for 
Ki67.  In  this  larger  group  the  D  cyclin  indices  per  total  nucleated  cells  no 
longer  correlated  with  Ki67  or  with  the  atypia  scores.  Again  in  this  larger 
group  the  cyclin  E  Ll%  did  not  correlate  with  any  of  the  other  indices. 
These  correlations  are  surnmarised  in  Table  5.6a. 
6.3.4  Quantitative  results:  1-1/131- 
For  the  archival  group  of  18  cases  the  results  are  surnmarised  in 
Table  5.3.  The  mean  1-1/131-  for  cyclin  D1  was  139.61/mm  (SD  62.75),  for 
cyclin  D3  was  153.03/mm  (SD  96.86),  90.30/mm  (SD  51.63)  for  cyclin  E 
and  143.03/mm  (SD  53.80)  for  Ki67.  These  labelling  indices  all  correlated 
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correlations  are  surnmarised  in  Table  5.4b. 
The  LI/BL  indices  for  the  series  of  cases  from  Chapter  2  are 
summarised  in  Table  5.5.  The  LI/BL  for  the  D  cyclins  were  noticeably 
different  in  this  group  compared  to  those  of  the  group  of  18  cases  (Table 
5.3).  This  could  be  accounted  for  at  least  in  part  by  the  fact  that  Case  6  of 
this  series  was  consistently  negative  when  stained  with  D  cyclin 
antibodies.  There  may  also  be  a  contribution  to  this  difference  due  to 
differing  basement  membrane  lengths. 
When  the  two  groups  were  combined  to  give  a  larger  group  of  38 
cases  the  mean  labelling  indices  were  as  follows.  The  mean  LI/BL  for 
cyclin  Dl  was  127.19/mm  (SD  62.48),  for  cyclin  D3  was  129.34/mm  (SD 
80.17),  for  cyclin  E  was  99.29/mm  (SD  55.04)  and  for  Ki67  was 
142.12/mm  (SID  91.16).  The  Ki67  LIM  correlated  significantly  with  all  of 
the  cyclin  1-1/131-  indices  and  the  D  cyclin  indices  correlated  with  each 
other.  Only  the  cyclin  E  1-1/131-  correlated  with  the  atypia  scores  in  this 
group.  The  details  of  these  correlations  are  shown  in  Table  5.6b. 
6.3.5  Quantitative  results:  ratios  and  distributions 
The  percentages  of  the  total  basal  cell  population  labelled  with 
cyclin  D1  and  D3  were  29.14%  (SID  17.87)  and  33.25%  (SID  14-36) 
respectively  compared  with  40.26%  (SID  14.19)  of  the  basal  cell 
population  identified  with  Ki67.  When  the  larger  group  was  considered, 
these  figures  did  not  alter  significantly.  These  results  are  summarised  in 
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few  of  the  basal  cells  (8.24%)  identified  by  this  antibody  compared  to  the 
other  antibodies.  It  was  not  possible  to  make  the  same  comparison  with 
the  earlier  group  as  the  Ki67  labelling  indices  were  counted  differently, 
viz.,  the  total  number  of  basal  cells  was  not  assessed  as  a  single 
parameter. 
To  further  investigate  the  relationship  between  the  D  cyclins  and 
Ki67,  the  ratios  of  the  Ki67  and  cyclin  labelling  indices  were  examined  and 
are  shown  in  Table  5.8.  These  ratios  were  close  to  unity  for  the  labelling 
indices  expressed  as  a  percentage.  However,  when  the  labelling  indices 
per  mm  basement  membrane  length  were  expressed  as  a  ratio  the  values 
were  higher.  These  findings  are  not  readily  explainable. 
When  the  results  of  the  group  of  38  cases  was  examined  by  the 
two  sites  of  origin  of  the  biopsies  the  mean  labelling  indices  are  shown  in 
Table  5.9.  Using  the  Mann-Whitney  U  test,  the  only  significant  differences 
between  the  two  groups  were  for  the  cyclin  E  LUBL. 
5.4  Discussion 
6.4.1  The  D  cyclins 
Although  designated  as  G,  cyclins,  there  is  evidence  that  the 
expression  of  the  D  cyclins  continues  throughout  much  of  the  cell  cycle 
(Gong  et  A,  1995a).  However,  some  workers  have  demonstrated  a  clear 
association  of  cyclin  Dl  with  the  G,  phase  (Baldin  et  aL,  1993;  Bartkova  et 
129 aL,  1994).  Unlike  cyclin  E,  there  appears  to  be  no  threshold  level  of 
expression  required  for  entry  into  S-phase  (Gong  et  al.,  1995b).  Certainly, 
in  the  present  study  the  level  of  D  cyclin  expression  was  demonstrated  to 
be  roughly  equivalent  to  that  of  Ki67. 
The  degree  of  expression  of  the  D  cyclins  in  the  present  study 
could  be  interpreted  a  number  of  ways.  Firstly,  it  could  represent  a  true 
overexpression  of  the  protein.  This  could  be  determined  by  assessing  the 
mRNA  content  of  the  cells  either  by  in  situ  hybridisation  or  reverse 
transcriptase  PCR.  Indeed,  the  latter  approach  was  attempted  (data  not 
shown)  but  it  was  not  possible  to  successfully  extract  RNA  from  the 
paraffin-embedded  tissues.  Secondly,  it  could  represent  a  continued 
production  of  the  protein  through  other  phases  of  the  cell  cycle  in  addition 
to  the  G,  phase.  Peters  (1994)  suggested  that  there  was  a  redistribution  of 
the  protein  through  the  S-phase  rather  than  an  apparent  enhanced  activity 
in  the  G,  phase.  A  further  assumption  could  be  that  the  protein  half  life  is 
increased.  At  the  gene  level  this  could  be  due  to  an  up-regulation  of  the 
gene  expression  or  the  expression  of  a  modified  gene  product  due  to  point 
mutation,  chromosomal  rearrangement  or  DNA  amplification  with  the  D 
cyclins,  therefore,  acting  as  an  oncogene  (Bates  and  Peters,  1995).  In  the 
present  study,  in  the  majority  of  cases,  the  intensity  of 
immunohistochemical  staining  was  not  strong  when  compared  to  other 
antigens  studied  and  therefore  was  not  thought  likely  to  be  due  to 
overexpression.  It  could  be  speculated  that  this  represented  a  continuing 
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a  true  overexpression. 
A  recent  paper  by  Mate  et  al  (1  998b)  demonstrated  similar  staining 
intensities,  using  the  same  cyclin  Dl  antibody  as  the  present  study,  when 
investigating  psoriasis  in  the  skin  but  failed  to  detect  the  protein  in 
condyloma  acuminatum  and  normal  human  foreskin  epithelium. 
Rey  et  al  (1998)  recently  reported  a  strong  association  between 
cyclin  Dl  expression  and  that  of  p2 
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CDKI,  in  breast  carcinoma. 
These  authors  found  this  to  be  independent  of  p53  expression  and 
suggested  a  possible  role  for  the  CDKI  in  the  modulation  of  cyclin  D1. 
The  role  of  cyclin  D1  within  cells  is  slowly  becoming  clearer  and 
appears  to  be  more  than  just  responsible  for  the  G,  /S-phase  transition.  In 
a  series  of  elaborate  experiments  involving  spliced  forms  of  cyclin  D1 
protein  Sawa  et  al  (Sawa  et  aL,  1998)  recently  reported  some  significant 
findings.  These  workers  found  some  forms  of  the  cyclin  Dl  protein  caused 
suppression  of  cell  growth  in  culture  by  preventing  entry  into  the  S-phase 
as  evidenced  by  the  cells  lack  of  BrdU  uptake  and  Ki67  expression.  The 
mechanism  for  this  appeared  to  be  related  to  up-regulation  of  pRb,  p53  or 
p2l"I  depending  on  the  conditions.  These  genes  are  intimately  involved 
with  apoptosis  supporting  a  role  for  cyclin  D1  in  this  process  as  suggested 
by  Kotelnikov  et  al  (Kotelnikov  et  aL,  1997).  Sawa  et  al  (Sawa  et  aL,  1998) 
also  cite  evidence  that  cyclin  D1  is  involved  in  senescence. 
It  is  not  yet  clear  what  the  functions  of  the  three  D  cyclins  are  within 
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Cyclin  D1  has  been  confirmed  to  be  present  in  oral  keratinocytes.  Cyclin 
D3  has  been  demonstrated  in  all  cell  lines  studied  so  far  (Bates  and 
Peters,  1995). 
Already  cited  above,  cyclin  DI  is  overexpressed  or  amplified  in  oral 
carcinoma  where  it  is  often  associated  with  advanced  clinical  stage.  At 
other  sites  overexpression  of  cyclin  Dl  has  been  associated  with  a  poor 
prognosis.  For  example,  in  bladder  carcinoma  it  correlated  with  early 
recurrence  (Shin  et  aL,  1997),  in  pancreatic  carcinoma  it  was  associated 
with  reduced  survival  periods  (Gansauge  et  aL,  1997)  and  in  oesophageal 
squamous  cell  carcinoma  cyclin  DII  overexpression  correlated  with 
reduced  survival,  particularly  in  patients  with  simultaneous  pRb  expression 
(Ishikawa  et  aL,  1998).  In  hormone-dependent  breast  carcinoma, 
however,  cyclin  D1  overexpression  appears  to  correlate  with  increased 
survival  and  patients  who  responded  well  to  anti-oestrogen  therapy 
(Barnes,  1997).  Indeed,  the  anti-oestrogen  drugs,  such  as  tamoxifen, 
appear  to  exert  their  action  via  oestrogen  receptors  on  the  cyclin 
DIICDK/pRb  complex  thereby  preventing  the  phosphorylation  of  pRb  and 
transition  into  the  S-phase  (Barnes,  1997). 
Nichols  et  al  (1996)  used  in  situ  hybridisation  to  demonstrate  cyclin 
DI  mRNA  overexpression  in  cervical  malignant  and  premalignant  lesions 
in  the  absence  of  immunohistochemically  detectable  protein.  This 
approach  would  be  an  option  for  studying  the  apparent  overexpression  of 
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hybridisation  are  difficult  to  interpret  and  difficult  to  quantify  compared  to 
immunohistochemistry. 
Less  is  known  regarding  cyclin  D3  although  Bartkova  et  al  (1996) 
suggest  from  their  studies  that  overexpression  of  cyclin  D3  is less  frequent 
than  cyclin  DI.  These  authors,  who  developed  the  antibody  against  cyclin 
D3  used  in  the  present  study,  showed  a  clear  overexpression  of  the 
protein  in  ductal  and  lobular  breast  carcinomas.  In  squamous  cell 
carcinomas  of  the  head  and  neck,  however,  only  weak  or  moderately 
intense  immunoreactivity  was  demonstrated  (Bartkova  et  aL,  1996)  which 
equates  to  the  findings  in  the  present  study. 
The  gene  encoding  cyclin  D3  is  located  at  chromosome  6p2l  (Hall 
and  Peters,  1996).  However,  as  yet  there  are  no  known  alterations  or 
I 
translocations  mapped  to  this  site  in  human  cancers. 
Like  cyclin  D1  the  levels  of  cyclin  D3  protein  throughout  the  cell 
cycle  are  not  phase  specific  and  it  may  be  present  at  all  stages  of  the  cell 
cycle  suggesting  an  additional  role  other  than  in  the  G,  phase  transition 
into  S-phase  (Gong  et  aL,  1995a).  However,  these  studies  used 
immunocytochernical  and  immunoblotting  methods  rather  than 
immunohistochernistry  for  detection  of  the  proteins.  Kang  et  al  (1997) 
suggested  cyclin  D3  may  have  a  role  in  meiosis  in  male  germ  cells. 
The  observation  of  cyclin  D3  immunoreactivity  in  the  smooth 
muscle  of  blood  vessels  appears  to  be  a  novel  finding.  It  was  interpreted 
133 as  cross-reactivity  of  the  antibody  with  these  tissues.  The  significance  of 
cell  nuclei  staining  positive  with  cyclin  D3  is  less  clear. 
5.4.2  Cyclin  E 
Unlike  the  D  cyclins,  there  is  a  clear  increase  in  cyclin  E  expression 
towards  the  late  G,  phase  before  entry  into  S-phase  and  a  discontinuous 
expression  of  this  cyclin  through  the  rest  of  the  cell  cycle  (Gong  et  aL, 
1995b) 
Mate  et  al  (1998b)  studied  cyclin  E  in  their  series  of  skin  lesions. 
These  workers  demonstrated  cyclin  E  in  the  suprabasal  layers  but  not  the 
basal  layers  in  condyloma  acurninaturn  and  psoriasis.  They  failed  to 
demonstrate  cyclin  E  immunoreactivity  in  normal  human  foreskin.  The 
pattern  and  intensity  of  immunoreactivity  pictured  in  their  paper  were  very 
similar  to  that  seen  in  the  present  study.  The  significance  of  cyclin  E 
imm  u  no  reactivity  predominantly  in  cells  that  are  in  the  maturation 
compartment  is  not  known.  Indeed,  this  appears  contrary  to  their 
supposed  function. 
Patel  et  al  (1997)  reported  overexpression  of  cyclin  E  in  head  and 
neck  squamous  cell  carcinoma  cell  lines  with  additional  overexpression  of 
its  related  CDK,  CDK2.  These  authors  also  demonstrated  increased  levels 
of  CDK4  and  CDK6  as  well  as  cyclin  A  but  surprisingly,  contrary  to  many 
other  reports,  failed  to  find  any  abnormalities  of  cyclin  D1. 
In  breast  tissue,  cyclin  E  immunoreactivity  was  lacking  in  normal 
and  benign  tissues  but  was  significantly  correlated  with  poor  differentiation 
134 in  carcinomas  (Scoft  and  Walker,  1997).  Cyclin  E  immunoreactivity 
correlated  with  the  degree  of  dysplasia  in  colorectal  adenomas  and  was 
significantly  greater  in  adenocarcinomas  (Yasui  et  aL,  1996). 
5.4.3  Correlations  with  K167 
In  the  present  study,  the  D  cyclin  and  Ki67  labelling  indices 
correlated  with  each  other.  The  indices  were  also  quantitatively  similar; 
this  could  be  interpreted  as  a  continued  expression  of  the  D  cyclins 
through  the  cell  cycle  as  the  D  cyclin  positive  cells  were  almost  exclusively 
observed  in  the  progenitor  compartment.  Or,  it  could  be  that  the  D  cyclins 
were  identifying  a  population  of  cells  in  the  G,  phase  that  were  not 
identified  by  Ki67  in  addition  to  a  population  of  cells  also  identified  by 
Ki67.  In  support  of  the  former  theory  is  the  finding  that  the  D  cyclin  and 
Ki67  labelling  indices  correlated  with  each  other  and  the  fact  that  fewer 
basal  cells  were  identified  by  the  D  cyclin  antibodies  than  with  Ki67.  This 
could  be  investigated  by  the  use  of  a  double  immunohistochernical 
staining  applying  the  two  antibodies  sequentially.  As  cyclin  D1  is 
commonly  overexpressed  in  malignancy,  this  could  be  interpreted  as  an 
overexpression  of  the  gene.  However,  this  seems  unlikely  here. 
Kotelnikov  et  al  (1997)  failed  to  demonstrate  a  correlation  between 
cyclin  DI  and  the  S-phase  fraction,  as  assessed  by  in  vivo  administration 
of  IrdU,  but  demonstrated  apoptosis,  identified  by  in  situ  end  labelling  was 
significantly  more  prevalent  in  cyclin  D1  positive  carcinomas  of  the  head 
and  neck.  These  authors  suggested  this  finding  might  indicate  a  role  for 
135 cyclin  D1  in  apoptosis.  In  normal  oral  mucosa  from  the  uvula  the  authors 
noted  that  cyclin  DII  staining  was  predominantly  suprabasal  and 
surprisingly  labelling  indices  were  higher  in  these  mucosae  compared  with 
non-involved  mucosa  from  the  carcinoma  patients. 
Using  the  same  antibodies  as  the  present  study  in  non-small  cell 
carcinoma  of  the  lung,  Mate  et  a/  (1996)  demonstrated  a  correlation 
between  cyclin  D1  and  Ki67  labelling  indices  but  there  was  no  association 
of  cyclin  D1  with  cell  cycle  phase  as  assessed  by  flow  cytometry. 
5.5  Summary  and  conclusions 
The  expression  of  the  D  cyclins  in  oral  epithelial  dysplasia  was  high 
and  correlated  with  that  of  Ki67  but  this  was  weaker  and  not  correlated  in 
the  larger  group.  This  may  be  due  to  a  continued  expression  of  the  D 
cyclins  through  phases  of  the  cell  cycle  in  addition  to  G,.  It  appears 
unlikely  that  the  D  cyclins  are  identifying  those  cells  in  G,  that  were  not 
identified  by  Ki67  described  previously  for  two  reasons.  Firstly,  the  ratios 
of  the  labelling  indices  for  the  D  cyclins  and  Ki67  were  close  to  unity 
suggesting  they  are  identifying  similar  groups  of  cells.  Secondly,  in 
support  of  this  theory,  the  D  cyclin  antibodies  were  identifying  less  cells  in 
the  basal  layer  than  Ki67. 
Cyclin  D3  appears  to  cross-react  with  the  smooth  muscle  of  blood 
vessels,  a  previously  unreported  phenomenon. 
The  distribution  of  cyclin  E  immunoreactivity  was  unexpected,  being 
chiefly  in  cells  of  the  maturation  compartment.  Such  cells  are  normally 
136 considered  to  have  left  the  cell  cycle  and  be  terminally  differentiated.  This 
suggests  that  there  might  be  an  additional  role  for  this  cyclin  in  addition  to 
G,  /S-phase  transition. 
There  was  some  association  of  the  cyclin  labelling  indices  with  the 
degree  of  atypia.  However,  this  was  not  as  strong  as  BrdU  in  Chapter  2 
and  with  the  inferior  staining  intensities  using  these  antibodies,  was  not 
considered  a  useful  adjunct  in  the  objective  assessment  of  oral  epithelial 
dysplasia. 
137 Table  5.1  Primary  antibodies 
Antibody  I  Catalogue  Number  Clone 
Cyclin  DI  NCL-CYCLIN  Dl 
Cyclin  D3  NCL-CYCLIN  D3 
Cyclin  E  NCL-CYCLIN  E 
Ki67  NCL-Ki67 
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mmi  1:  100 
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139 Table  5.3  Summary  of  results  for  18  archival  cases 
Ll%  LI/BL 
Case  Dl  D3  E  K167  DI  D3  E  K167 
1  38.97  43.52  48.58  32.95'  191.80  220.59  180.15  146.74 
2  54.96  41.77  17.05  52.28  312.09  187.83  93.21  208.61 
3  59.41  53.96  47.97  50.32  182.33  212.10  127.26  166.62 
4  32.63  33.33  22.01  22.54  123.77  122.20  68.49  96.32 
5  49.09  27.42  13.78  39.58  212.85  120.26  51.93  151.80 
6  34.63  23.40  23.93  35.14  124.31  77.98  75.56  109.54 
7  27.63  27.11  43.32  21.97  127.71  129.95  201.96  136.07 
8  20.26  13.68  10-98  18-15  66.36  41.04  31.07  63.12 
9  30.21  27.24  17.24  40.79  187.89  159.35  72.94  292.12 
10  31.17  76.24  16.16  28.30  182.51  449.01  77.44  162.24 
11  23.63  33.05  13.56  26.18  110.30  134.34  50.26  124.86 
12  18.93  22.72  39.43  30.24  88.02  98.14  193.77  181.25 
13  24.06  37.16  19.02  30.22  102.85  155.08  66.51  160.26 
14  27.12  20.39  20.90  24.27  78.28  54.06  60.64  75.37 
15  27.96  49.30  23.82  26.63  113.13  230.28  90.50  134.64 
16  20.55  22.58  26.11  29.81  80.09  80.01  78.72  101.99 
17  23.40  14.99  10.85  26.90  75.91  48.61  36.52  91.32 
18  32.35  50.52  18.36  32.08  152.78  233.68  68.53  171.75 
Mean  32.05  34.36  24.06  31.57  139.61  153.03  90.30  143.03 
SD  11.72  15.93  12.31  9.22  62.75  96.86  51.63  53.80 
Min  18.93  13.68  10.85  18.15  66.36  41.04  31.07  63.12 
Max  59.41  76.24  48.58  52.28  312.09  449.01  201.96  292.12 
140 Table  5.4  Values  of  the  Spearman-Rank  correlation  coefficient  for 
the  18  archival  cases 
a.  percentage  labelling  indices 
Ll%  I  Cyclin  DI  Cyclin  D3  Cyclin  E  Ki67 
Cyclin  D3  0.69871 
Cyclin  E  0.2002  0.3117 
Ki67  0.61305  0.4665*  0.1620 
Atypia  0.4252*  0.3653  0.3333  0.5521 
b.  labelling  indices  per  mm  basement  membrane  length 
1-1/131-  1  Cyclin  DI  Cyclin  D3  Cyclin  E  K167 
Cyclin  D3  0.687311 
Cyclin  E  0.4262*  0.4912ý 
Ki67  0.68946  0.68836  0.5160* 
Atypia  0.4572*  0.4314*  0.4180*  0.54491 
p<0.005 
P<0.01 
p<0.025 
p<0.05 
141 Table  6.5  Summary  of  results  for  20  cases  from  Chapter  2 
Ll%  LI/BL 
Case  DI  D3  E  K167  Dl  D3  E  Ki67 
1  29.18  38.06  28.57  18.38  125.75  152.42  94.41  79.62 
2  29.71  39.37  24.19  20.89  127.51  188.02  78.60  122.71 
3  42.84  29.06  37.42  21.97  158.08  114.53  109.83  111.21 
4  36.72  29.49  26.67  21.64  167.41  127.03  109.26  99.75 
6  37.76  24.28  39.41  28.44  178.10  105.84  199.13  158.30 
6  0.00  0.00  30.08  73.12  0.00  0.00  143.99  553.35 
7  50.16  47.01  5.24  25.14  112.99  108.91  12.63  90-11 
8  53.50  53.53  18.92  23.92  241.32  235.67  79.40  132.01 
9  17.54  31.34  36.38  56.15  58.28  103.33  193.03  283.43 
10  45.23  22.06  40.50  23.40  238.82  96.14  193.69  130.86 
11  45.84  47.56  48.02  36.73  136.46  158.13  169.10  153.07 
12  20.31  24.65  32.39  18.70  70.87  95.23  119.32  89.53 
13  28.46  13.09  5.19  19.11  123.48  51.68  19.29  90.06 
14  25.66  7.62  33.00  12.63  61.42  20.63  92.60  65.75 
15  26.64  27.86  34.31  60.05  85.50  87.31  87.82  294.99 
16  27.11  23.41  33.12  14.21  79.34  74.11  86.90  69.74 
17  23.58  15.55  22.08  21.74  77.90  47.92  46.40  58.68 
18  31.42  27.47  22.81  21.99  139.49  105.41  82.74  84.19 
19  28.31  37.08  41.69  22.99  99.54  165.75  190.57  97.90 
20  11.76  33.44  9.96  15.17  37.99  122.29  38.67  60.85 
Mean  30.59  28.60  28.50  27.82  116.01  108.02  107.37  141.31 
SD  13.13  13.38  11.85  16.31  61.65  55.79  58.04  116.58 
Min  0.00  0.00  5.19  12.63  0.00  0.00  12.63  58.68 
Max  53.50  53.53  48.02  73.12  241.32  235.67  199.13  553.35 
142 Table  6.6  Values  of  the  Spearman-Rank  correlation  coefficient  for 
the  combined  group  of  38  cases 
a.  percentage  labelling  indices 
Ll%  Cyclin  DI  Cyclin  D3  Cyclin  E  Ki67 
Cyclin  D3  0.5434" 
Cyclin  E  0.0942  0.0453 
Ki67  0.2049  0.2328  0.1406 
Atypia  0.1285  0.0073  0.2996*  0.1873 
b.  labelling  indices  per  mm  basement  membrane  length 
1-1/131-  1  Cyclin  D1  Cyclin  D3  Cyclin  E  Ki67 
Cyclin  D3  0.679311 
Cyclin  E  0.2140  0.1905 
Ki67  0.40235  0.427211  0.42897 
Atypia  0.0236  -0.0782  0.3122*  0.2057 
p<0.005 
P<0.01 
p<0.05 
143 Table  5.7  Percentages  of  basal  cells  identified  by  the  antibodies 
1  18  cases  38  cases 
cyclin  DI  29.14%  (5.24-60.29) 
cyclin  D3  33.25%  (9.66-69.03) 
cyclin  E  8.24%  (1.57-17.42) 
Ki67  40.26  (18.59-78.82) 
N/A  not  available 
31.80%  (5.24-90.29) 
32.17%  (9.66-69.03) 
9.83%  (1.57-17.42) 
N/A 
Table  5.8  Ratios  of  Ki67  to  cyclin  labelled  cell  cells  (38  cases) 
I  Ll%  1-1/131- 
Ki67:  cyclin  DI  0.97  1.15 
Ki67:  cyclin  D3  1.00  1.21 
Ki67:  cyclin  E  1.43  1.82 
cyclin  Dl:  cyclin  D3  1.15  1.17 
144 Table  5.9  Mean  labelling  indices  by  site 
A.  Tongue  (17  cases) 
Ll%  LIIBL 
DI  D3  E  Ki67  DI  D3  E*  Ki67 
Mean  30.91  33.31  27.35  28.56  128.63  141.87  112.80  148.80 
SD  11.74  16.02  11.03  13.14  56.26  92.21  59.60  103.87 
Min  0.00  0.00  5.24  14.21  0.00  0.00  12.63  69.74 
Max  53.50  76.24  43.32  73.12  241.32  449.01  201.96  553.35 
B.  Floor  of  mouth  (21  cases) 
Ll%  LIIBL 
Dl  D3  E  Ki67  DI  D3  E*  Ki67 
Mean  31.74  28.87  25.21  30.88  125.41  113.86  82.60  133.87 
SD  13.39  13.02  13.59  13.98  71.15  61.44  45.05  74.82 
Min  11.76  7.62  5.19  12.63  37.99  20.63  19.29  58.68 
Max  59.41  53.96  48.58  60.05  312.09  220.59  180.15  294.99 
*significantly  different  groups  (p=0.0401) 
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Figure  5.1  Enhancement  of  digital  image  by  the  Kontron  KS300 
image  analysis  software.  (Anti-cyclin  E,  magnification  x478) 
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Figure  5.3  Demonstration  of  cyclin  Dl  immunoreactivity  in  Case  8 
(magnification  x478) 
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Figure  5.4  Demonstration  of  cyclin  D3  immunoreactivity  in  Case  8 
(magnification  x478) 
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Figure  5.5  Demonstration  of  Ki67  immunoreactivity  in  Case  8 
(magnification  x478) 
Figure  5.6  Demonstration  of  cyclin  E  immunoreactivity  in  Case  8 
(magnification  x478) 
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B.  A  blood  vessel  within  squamous  cell  carcinoma  of  a  positive 
control  (magnification  x478) 
Figure  5.7  Cyclin  D3  cross-reactivity  in  the  smooth  muscle  layer  of 
blood  vessels 
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Figure  5.8  Demonstration  of  cyclin  E  immunoreactivity  in  the 
maturation  compartment  of  the  epithelium  of  Case  7  (magnification 
x478) 
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Figure  5.9  Increased  cyclin  E  immunoreactivity  in  Case  3 
(magnification  x478) 
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Further  investigation  of  the  S-phase  and  growth  fraction 
152 6.1  Introduction 
6.1.1  Cyclin  A 
One  of  the  S-phase  cyclins,  cyclin  A,  is  concerned  with  the 
transition  of  the  cell  through  the  S-phase,  into  G2and  into  mitosis.  Cyclin 
A,  like  cyclin  E,  complexes  with  CDK2  but  unlike  the  other  complexes 
appears  to  bind  directly  to  the  transcription  factor  E2F  (Pines,  1995). 
Cyclin  A  also  binds  to  p34clc2involved  in  the  transition  from  G2  tOM-phase 
(Pagano  et  al.,  1992;  Roy  et  aL,  1991).  It  has  been  suggested  that  cyclin 
A  transcription  is  stimulated  by  a  signal  from  surface  adhesion  molecules 
late  in  the  G,  /early  S-phase  (Pines,  1995).  The  levels  of  cyclin  A  increase 
from  the  beginning  of  the  S-phase  reaching  a  peak  in  G2  (Gong  et  aL, 
1995a)  and  it  is  then  broken  down  by  the  ubiquitin-proteasome  pathway 
just  prior  to  metaphase  (Spataro  et  aL,  1998).  At  this  stage  cyclin  Bl 
becomes  associated  with  p3411  and  the  cell  continues  through  mitosis. 
Compared  to  the  other  cyclins  there  are  only  a  limited  number  of 
publications  on  cyclin  A,  particularly  in  regard  to  the  histopathology  of 
neoplasms. 
6.1.2  Cyclin  A  and  the  S-phase 
Cyclin  A  production  begins  early  in  the  S-phase  and  has  been 
shown  to  correlate  strongly  with  DNA  synthesis  as  assessed  by  BrdU 
incorporation  (Juan  et  aL,  1997).  Overexpression  of  cyclin  A  has  been 
shown  to  advance  cells  into  the  S-phase,  shortening  the  cell  cycle  time 
(Rosenberg  et  aL,  1995) 
153 The  specificity  of  cyclin  A  to  the  S-phase  makes  it  a  possible 
alternative  to  BrdU  labelling. 
6.1.3  Aims 
The  aims  of  the  studies  in  this  chapter  are  two-fold;  firstly  a 
comparison  of  BrdU  and  cyclin  A,  as  another  potential  marker  of  cells  in 
the  S-phase  with  the  possibility  of  utilising  this  marker  in  place  of  BrdU 
with  the  advantage  of  being  able  to  use  it  on  archival  tissues.  At  the  same 
time  a  further  study  upon  the  relationship  between  the  S-phase  and  the 
growth  fraction  was  carried  out  to  continue  the  work  of  Chapter  2. 
Following  the  development  of  the  methods  in  Chapter  3,  these  cases  were 
all  fixed  in  formalin  subsequent  to  BrdU  incubation.  This,  therefore, 
allowed  sequential  sections  to  be  studied  with  other  proliferation  markers. 
6.2  Materials  and  Methods 
6.2.1  Case  selection 
A  series  of  15  biopsies  of  oral  leukoplakia  or  erythroplakia  from  the 
floor  of  the  mouth  or  tongue  were  collected  prospectively  from  patients 
attending  the  Oral  Medicine  Department  at  Glasgow  Dental  Hospital.  The 
tissue  was  divided  at  the  time  of  biopsy  as  described  in  Chapter  2.  The 
fresh  tissue  was  transported  to  the  laboratory  In  MEM  and  BrdU 
incubation  commenced  within  20  minutes.  In  order  to  Investigate  the 
findings  of  these  studies  further,  the  series  of  patients  from  Chapter  2 
were  also  included  in  parts  of  the  study. 
154 6.2.2  BrdU 
The  BrdU  administration  was  performed  as  previously  described  in 
Section  2.2.2  but  the  tissues  were  fixed  in  10%  buffered  formalin. 
Sequential  sections  were  cut  from  the  paraffin  embedded  tissues  and 
mounted  on  silane  coated  slides.  Immunohistochernistry  was  performed 
following  optimisation  of  antigen  retrieval  as  described  in  Section  3.2.3. 
6.2.3  Cyclin  A  immunohistochemistry 
Sequential  sections  were  cut  from  BrdU  processed  blocks  and 
preliminary  studies  were  performed  to  optimise  antigen  retrieval,  antibody 
concentration  and  incubation  times  as  previously  described. 
Immunohistochemistry  was  then  performed  as  described  in  Chapter  2. 
The  primary  antibody  used  in  this  instance  was  a  monoclonal  mouse  anti- 
cyclin  A  antibody  (NCL-CYCLIN  A,  clone  6E6,  Novocastra,  Newcastle, 
UK). 
The  section  in  between  the  BrdU  and  cyclin  A  was  stained  with 
Ki67  as  described  previously.  Additionally,  to  the  two  series  of  cases 
described  above,  the  series  of  cases  described  in  Chapter  5  was  available 
for  the  evaluation  of  cyclin  A  and  Ki67  but  not  the  BrdU. 
6.2.4  Quantification 
The  procedure  described  in  Chapter  5  was  adopted  for  the 
quantification  of  the  immunohistochemically  stained  sections.  The  sections 
were  quantified  in  the  following  order:  BrdU,  Ki67,  cyclin  A.  For  each  case 
three  corresponding  fields  were  identified  and  measured  at  an  objective 
155 magnification  of  x20.  The  quantification  of  labelled  cells  was  expressed  as 
a  percentage  of  the  total  nucleated  cell  population  (Ll%)  and  per  mm 
basement  membrane  length  (1-1/13L).  For  ease  of  use,  the  term  labelling 
index  was  used  to  express  the  quantified  cyclin  A  cells,  although  this  is 
not  strictly  a  labelling  index  as  in  the  case  of  BrdU  labelled  cells.  As 
previously,  the  labelling  indices  for  Ki67  were  expressed  as  the  growth 
fraction  (GF).  An  H&E  section  from  each  case  was  graded  according  to 
the  method  of  Smith  and  Pindborg  (1969) 
Statistical  analysis  was  performed  on  the  data  using  the  Spearman 
rank  correlation  coefficient,  the  Wilcoxon  matched-pairs  signed-ranks  test 
and  the  Mann-Whitney  U  test  as  appropriate. 
6.3  Results 
6.3.1  Case  details 
The  clinical  details  of  the  15  new  patients  studied  are  shown  in 
Table  6.1.  The  mean  age  was  51.9  (range  31  to  78  years).  Eight  of  the 
patients  were  male  (mean  age  54.0)  and  seven  of  the  patients  were 
female  (mean  age  49.4).  The  histology  of  four  of  the  lesions  (cases  3,7, 
10  and  15)  showed  no  or  minimal  dysplasia  when  graded  subjectively. 
These  were  still  included  in  the  study.  Three  of  the  biopsies  of  this  series 
(cases  6,10  and  12)  were  from  the  same  patients  as  those  studied  in 
Chapter  2.  These  will  be  highlighted  in  the  results  below. 
156 6.3.2  lmmunohistochemistry 
BrdU  immunohistochernistry  was  optimal  following  antigen  retrieval 
in  EDTA  for  15  minutes  using  microwave  heating  as  was  that  for  Ki67. 
Cyclin  A  required  15  minutes  of  microwave  antigen  retrieval  in 
EDTA  and  an  antibody  concentration  of  1  in  100  at  room  temperature  for 
I  hour  for  optimal  staining  results.  The  intensity  was  equivalent  to  that  of 
BrdU  immunostaining  (Figure  6.1).  The  staining  pattern  was  notable  for 
this  antibody;  there  was  strong  nuclear  staining  but  also  a  fine  granular 
staining  throughout  the  cytoplasm  of  most  positive  cells  (Figure  6.2). 
When  cells  were  apparently  suprabasal,  often  an  extension  of  their 
cytoplasm  to  the  basement  membrane  was  observed.  Figure  6.3  shows 
an  apparent  over  expression  of  cyclin  A. 
6.3.3  Quantitative  results:  Ll% 
The  results  for  the  two  series  of  cases  are  summarised  in  Tables 
6.2  and  6.3.  Considering  first  the  group  of  15  new  cases,  the  mean  Ll% 
for  the  BrdU  labelled  cells  was  11.24%  (SD  2.83)  and  for  cyclin  A  12.76% 
(SID  3.88).  These  indices  correlated  with  each  other  significantly 
(r.,  =0.5268,  z=1.971  1,  p=0.0244).  The  GF%  for  Ki67  of  this  series  was 
29.25%  (SID  11.88).  There  was  no  significant  correlation  between  the 
GF%  and  BrdU  Ll%  (rs=0.1571,  z=0.5880,  p=0.2810)  nor  between  GF% 
and  cyclin  A  Ll%  (r,  =0.3911,  z=1.4633,  p=0.0721).  This  indicates  that  a 
variable  fraction  of  the  GF  are  in  the  S-phase.  As  in  the  series  described 
in  Chapter  2,  the  BrdU  and  Ki67  indices  did  not  correlate  (p=0.2810).  The 
atypia  scores  of  this  group  ranged  from  three  to  22.  Of  these  indices,  only 
157 the  GF%  correlated  with  the  atypia  scores  significantly  (rs=0.7802, 
Z=2.9193,  P=0.0018). 
The  mean  Ll%  for  BrdU  of  the  original  series  of  20  cases  was 
10-80%  as  determined  in  Chapter  2.  The  mean  Ll%  for  cyclin  A  of  this 
series  was  19.84%  (SD  9.96).  The  quantification  here,  it  should  be  noted, 
was  performed  on  different  tissue  blocks,  the  former  Carnoy's  fixed  and 
the  latter  formalin  fixed.  These  indices  did  not  correlate  with  each  other 
significantly  (r,  =0.3165,  z=1.3798,  p=0.0853)  nor  with  the  atypia  scores 
(P<0.1).  These  results  show  a  quantitatively  similar  mean  BrdU  Ll%  for 
both  of  the  series  of  cases  but  the  mean  Ll%  of  cyclin  A  labelled  cells  was 
larger  in  the  original  BrdU  series  from  Chapter  2  and  this  difference  was 
significant  (z=2.0203,  p=0.0217).  The  relationship  of  the  labelling  indices 
to  each  other  and  to  the  atypia  scores  is  illustrated  in  Figure  6.4. 
The  results  from  the  series  of  18  cases  studied  in  Chapter  5  are 
shown  in  Table  6.4.  The  mean  Ki67  LI%  as  determined  in  Chapter  5  was 
31.57%  compared  to  the  cyclin  A  Ll%  determined  in  this  study  of  16.50% 
(SID  6.29).  These  indices  correlated  with  each  other  significantly 
(r,  =0.5418,  z=2.2339,  p=0.0132)  and  the  cyclin  A  Ll%  correlated  with  the 
atypia  scores  (r,  =0.4613,  z=1.9020,  p=0.0287).  The  mean  Ll%  for  cyclin  A 
in  this  series  was  in  between  the  two  other  series  described  above. 
6.3.4  Quantitative  results:  1-1/131- 
The  mean  LI/BL  for  the  series  of  15  cases  was  40.931mm  (SD 
11.88)  for  BrdU  and  47.59/mm  (SD  18.28)  for  cyclin  A.  These  indices  were 
158 highly  significantly  correlated  (r,  =0.691  1,  z=2.5858,  p=0.0049)  but  did  not 
correlate  with  the  atypia  scores.  The  mean  GF/BL  for  this  group  was 
11  0.72/mm  (SD  49.30)  and  this  was  significantly  correlated  with  the  atypia 
scores  (r,  =0.9648,  z=3.6101,  p<0.0001). 
From  the  results  in  Chapter  2,  of  the  initial  series  of  20  cases  the 
mean  1-1/131-  for  BrdU  was  46.58/mm  (SD  20.28)  which  correlated  with  the 
atypia  scores.  The  mean  1-1/131-  for  cyclin  A  in  this  series  was  67.98/mm 
(SD  34.21).  These  indices  were  correlated  with  each  other  significantly 
(r,  =0.6992,  z=3.0480,  p=0.0012).  The  mean  GF/BL  for  this  group  was 
141-31/mm  and  this  correlated  with  BrdU  1-1/131-  as  determined  in  Chapter 
2.  The  GF/BL  also  correlated  with  the  cyclin  A  LIM  (r,  =0.8662,  z=3.7755, 
P<0.0001  1). 
As  with  the  Ll%,  the  mean  BrdU  LIM  were  quantitatively  similar 
but  the  mean  cyclin  A  1-1/131-  was  higher  in  the  first  series  of  20  cases.  This 
difference  did  not  reach  statistical  significance  (z=1.3131,  p=0.0951) 
The  series  of  18  cases  studied  in  Chapter  5  gave  a  mean  GF/BL  of 
67.16.  The  mean  cyclin  A  1-1/131-  for  this  group  was  143.03  (SD  53.80) 
which  correlated  with  the  GFIBL  highly  significantly  (r,  =0.8215,  z=3.3870, 
p=0.00005)  and  with  the  atypia  scores  (r,  =0.5232,  z=2.1573,  p=0.0158). 
6.3.5  Ratios  and  distributions 
With  regard  to  the  new  series  of  15  cases  studied,  of  the  total  basal 
cell  population,  an  average  of  19.00%  (SID  8.70)  of  the  cells  were 
identified  by  BrdU  compared  with  an  average  of  21.40%  (SD  9.99)  of  the 
159 cells  identified  by  cyclin  A.  From  a  different  angle,  a  mean  39.29%  (SID 
18.15)  of  all  of  the  BrdU  labelled  cells  were  basal  and  a  mean  38.42%  of 
the  cyclin  A  labelled  cells  were  basal.  Ki67  identified  an  average  of 
39-64%  (SD  26.70%)  of  the  basal  cell  population  equating  to  30.17%  (SD 
16-01)  of  the  total  Ki67  labelled  population. 
The  mean  ratios  of  cyclin  A  to  BrdU  positive  cells  were  1.14  (0-63 
to  1.86)  and  1.16  (0.64  to  2.09)  for  the  percentage  and  per  mm  indices 
respectively  indicating  that  cyclin  A  was  identifying  just  over  15%  more 
cells  than  BrdU.  This  compares  with  the  original  series  where  the  mean 
ratios  were  1.86  (1.13  to  3.71)  for  the  percentage  indices  and  1.47  (0.93 
to  2.88)  for  the  per  mm  indices. 
The  S-phase  to  growth  fraction  ratios  are  listed  in  Tables  6.2  and 
6.3.  If  the  S-phase  represented  by  BrdU  is  SBrdu  and  that  represented  by 
cyclin  A  is  Scyclim  and  the  growth  fraction  identified  by  Ki67  is  GF  the 
means  are  as  follows.  The  meanSBrdU:  GF  was  0.43  (0.22  to  0.62)  and  the 
mean  SYoim:  GF  was  0.48  (0.22  to  0.82)  based  on  the  labelling  index 
percentages.  These  equated  to  a  mean  S,,,  u:  GF  of  0.41  (0.21  to  0.65)  and 
a  mean  S,,,  Oim:  GF  of  0.47  (0.24  to  0.84)  based  upon  the  labelling  indices 
per  mm,  the  latter  being  valid  here  as  the  measurements  were  performed 
on  sequential  sections  and  identical  areas  were  measured.  The  mean 
SB,  du:  GF,  for  the  percentage  labelling  indices,  of  the  original  series  of  20 
cases  was  0.46  (0.11  to  0.94)  as  determined  in  Chapter  2.  The  mean 
S,  Y,  im:  GF  was  0.75  (0.42  to  1.12)  reflecting  the  higher  cyclin  A  Ll%  of  this 
160 group. 
6.3.6  Quantitative  results  by  site 
By  combining  the  results  of  the  two  series  of  cases,  the  mean 
labelling  indices  for  the  two  sites,  tongue  and  floor  of  mouth,  are  listed  in 
Table  6.5,  the  sites  of  origin  of  the  first  group  of  cases  can  be  found  in 
Table  2.1.  There  was  no  significant  difference  between the  two  sites  for 
the  percentage  indices  assessed  by  the  Mann-Whitney  U  test.  There  was, 
however,  a  statistically  significant  difference  between  the  two  sites  with 
regard  to  their  labelling  indices  per  mm  basement  membrane  length  for  all 
three  of  the  markers;  BrdU  (p=0.0375),  Ki67  (p=0.0170)  and  cyclin  A 
(p=0.0322).  The  mean  epithelial  thickness  of  the  two  groups  were 
217.91  pm  (SD  128.07)  for  the  tongue  and  164.39pm  (SD  64.10)  for  the 
floor  of  the  mouth  but  these  were  not  significantly  different  due  to  the  large 
range  of  thickness  at  the  two  sites.  When  the  basement  membrane 
lengths  measured  in  each  of  the  quantified  fields  for  each  of  the  three 
markers  (nine  fields)  for  each  of  the  cases  was  considered  the  following 
was  found.  The  mean  basement  membrane  length  (3  fields)  for  those 
cases  from  the  tongue  was  2260.01pm  (SD  675.37)  and  for  the  floor  of 
mouth  was  1855.81pm  (SD  585.45).  These  were  significantly  different 
(p=0.0239)  and  account  for  the  different  labelling  indices  for  the  two  sites 
when  expressed  per  mrn  basement  membrane  length. 
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6.4.1  Cyclin  A 
There  are  conflicting  reports  regarding  the  cellular  localisation  of 
the  cyclin  A  protein.  Pines  and  Hunter  (1991)  reported  cyclin  A  as  being  a 
predominantly  nuclear  protein  but  indicated  it  was  also  found  dispersed 
throughout  the  cell  following  prophase.  In  the  present  study,  cyclin  A 
im  m  uno  reactivity  was  commonly  observed  in  the  cytoplasm,  but  rarely  in 
the  absence  of  strong  nuclear  staining.  However,  in  the  present  study,  the 
immunohistochernical  detection  of  the  protein  was  in  cells  presumed  to  be 
pre-mitotic  and  would  appear  to  contradict  the  above  report.  Carbonaro- 
Hall  et  al  (1993)  reported  in  immunocytochemical  studies  that  cyclin  A  was 
present  in  the  cytoplasm  but  not  the  nucleus  of  late  G,  cells  and  both  the 
cytoplasm  and  nucleus  of  S-phase  cells.  Cytoplasmic  staining  with  cyclin 
A  antibodies  in  pre-mitotic  cells  has  been  reported  in  tonsillar  epithelium 
(Bodey  et  aL,  1994). 
Jordan  et  al  (1998)  reported  a  mean  Ll  %  for  cyclin  A  of  20.5%  and 
a  mean  Ki67  GF%  of  30.2%  in  a  series  of  36  oral  epithelial  clysplastic 
lesions,  these  figures  being  within  the  range  of  values  derived  from  the 
present  study.  However,  these  authors  reported  no  significant  difference 
between  the  dysplastic  group  and  the  normal  epithelium  except  their 
severely  dysplastic  group.  The  group  of  cases  studied  by  these  authors 
included  more  cases  with  severe  epithelial  dysplasia  than  the  present 
study. 
162 The  mean  cyclin  A  labelling  indices  were  higher  in  the  original 
series  of  20  cases  from  Chapter  2  than  they  were  for  the  series  collected 
for  the  present  study.  This  probably  reflects  the  generally  lower  severity  of 
dysplasia  (atypia  scores  from  3  to  22)  of  the  smaller  series  compared  with 
the  original  series  from  Chapter  2  (atypia  scores  10  to  57).  Additionally, 
the  gene  for  cyclin  A  as  with  other  cyclins  could  be  amplified,  mutated  or 
the  protein  overexpressed,  therefore  acting  as  an  oncogene,  as  part  of  the 
carcinogenic  process. 
Certainly,  apparent  overexpression  of  the  protein  detected 
immunohistochernically  was  evident  in  some  cases  in  this  study, 
particularly  cases  from  the  original  series  which  were  severely  dysplastic 
(Figures  6.3  and  6.4).  Degradation  of  cyclin  A  is  also  required  for  exit  from 
mitosis  (Roy  et  aL,  1991)  and  it  has  proved  difficult  experimentally  to 
produce  constitutive  cyclin  A  overexpression  as  it  may  not  be  compatible 
with  cell  viability  (Rosenberg  et  aL,  1995).  However,  Chao  et  al  (1998) 
recently  reported  overexpression  of  cyclin  A  protein  in  hepatocellular 
carcinoma,  some  of  which  had  amplified  DNA  or  increased  mRNA,  and 
this  was  correlated  with  tumour  recurrence  and  decreased  overall  survival. 
Cyclin  A  for  use  as  an  investigative  tool  for  cell  kinetics  may, 
therefore,  be  of  value  only  in  normal  tissues  because  of  the  possibility  of  it 
being  overexpressed  in  precancerous  or  cancerous  lesions. 
The  curious  observation  of  immunohistochemically  detectable 
cyclin  A  protein  in  the  cytoplasm  often  extending  to  the  basement 
163 membrane  in  cells  that  were  apparently  suprabasal  raises  an  important 
issue  (Figure  6.2).  The  histological  section  is  only  a  two  dimensional 
representation  of  a  three  dimensional  structure  and  although  cells  are 
apparently  suprabasal,  above  or  below  the  plane  of  section  these  cells 
could  be  in  contact  with  the  basement  membrane.  The  thin  cytoplasmic 
processes  observed  with  cyclin  A  not  normally  being  discernible  in 
histological  sections. 
6.4.2  Cyclin  A  and  the  S-phase 
Juan  et  al  (1997)  described  a  series  of  experiments  investigating 
the  relationship  between  BrdU  uptake  and  cyclin  A  expression  assessed 
immunocytochernically  and  by  flow  cytometry  in  MOLT-4  human 
leukaemic  cells.  These  authors  found  a  significant  correlation  between 
BrdU  labelled  cells  and  cyclin  A  labelled  cells.  Moreover,  cyclin  A 
identified  cells  of  the  early  S-phase  that  were  not  yet  labelled  by  BrdU. 
However,  cyclin  A  expression  continues  through  G2  and  the  protein  is 
degraded  at  the  prometaphase  and  theoretically  would  overestimate  the 
number  of  cells  in  the  S-phase.  Assuming  all  the  cells  that  enter  the  S- 
phase  actually  exit  into  G2  it  nevertheless  provides  a  useful  marker  of  cells 
in  this  stage  of  the  cell  cycle.  A  potential  method  for  increasing  the 
specificity  of  cyclin  A  to  the  S-phase  would  be  to  double-stain  sections  for 
both  cyclin  A  and  cyclin  Bl.  The  latter  is  said  to  be  produced  at  the  GýM 
phase  of  the  cell  cycle  (Pines  and  Hunter,  1991)  and  would  indicate  those 
cells  which  have  entered  mitosis. 
164 Cyclin  A  has  been  shown  to  bind  to  both  CDK2  and  p3411  and 
therefore  to  be  important  at  two  points  in  the  cell  cycle  namely  the  S- 
phase  and  the  GJM  phase  (Pagano  et  aL,  1992).  It  could  therefore  be 
expected  that  cyclin  A  labelling  indices  are  greater,  as  found  in  the 
present  study,  than  those  for  BrdU  which  by  its  nature  can  only  be 
expressed  in  the  S-phase. 
However,  the  study  of  BrdU  presented  here  did  not  take  into 
account  the  possibility  of  endogenous  thymidine  synthesis  which  could 
potentially  reduce  the  number  of  BrdU  labelled  cells.  The  protocol  upon 
which  this  was  based  (Thornton  et  aL,  1988)  used  fluordeoxyuridine  to 
block  such  de  novo  synthesis.  However,  these  workers  labelled  their 
endometrial  specimens  for  periods  of  one  to  three  hours,  much  longer 
periods  than  in  the  present  study;  in  such  situations  de  novo  thymidine 
synthesis  may  be  more  significant. 
The  oncogene  B-myb  appears  to  be  closely  related  to  the  S-phase 
and  may  have  a  role  in  the  downstream  activation  of  transcription  factors 
(Saville  and  Watson,  1998).  It  is  activated  by  cyclin  A  and  appears 
essential  for  S-phase  progression.  This  may  be  a  further  avenue  of 
research  with  regard  to  the  S-phase. 
6.4.3  S-phase  and  growth  fraction 
Jordan  et  al  (1998)  reported  a  significant  correlation  between  cyclin 
A  and  Ki67  percentage  labelling  indices  in  normal  and  dysplastic  oral 
epithelium.  The  LI%  for  BrdU  did  not  correlate  with  the  GF%  for  Ki67  in 
165 the  20  cases  of  Chapter  2  nor  did  the  Ll%  for  cyclin  A  determined  in  the 
present  study.  This  probably  reflects  the  variable  proportion  of  the  growth 
fraction  in  the  S-phase  as  evidenced  by  the  S-phase:  growth  fraction 
(Tables  6.2  and  6.3). 
The  variations  of  the  labelling  indices  at  the  two  different  sites  when 
expressed  with  regard  to  the  basement  membrane  length  raised  an 
important  issue  with  regard  to  quantification.  The  morphology  of  the 
epithelium  differs  from  the  floor  or  mouth  and  tongue.  The  latter  has  more 
pronounced  rete  ridges  and  therefore  normally  has  a  longer  basement 
membrane  length  than  that  of  the  floor  of  the  mouth.  Similarly  this  is  often 
observed  in  dysplastic  oral  epithelia.  When  the  indices  based  upon  the 
total  cell  population  were  considered,  the  indices  for  both  sites  were 
quantitatively  similar.  This  indicates  the  need  for  total  nuclear  counts  in 
addition  to  basement  membrane  measurement.  The  latter  is  often 
performed  in  addition  to  labelled  nuclear  counts  to  provide  a  labelling 
index  as  it  is  relatively  quick  to  perform.  This  can  be  flawed  as  it  does  not 
take  into  account  the  thickness  of  the  epithelium  which  can  be  shown  to 
be  variable  as  shown  in  the  present  study.  Total  nuclear  counts  can  take 
considerably  longer  to  achieve,  but  give  more  valid  indices  for  comparison 
of  epithelia  of  differing  thickness  and  basement  membrane  configuration. 
166 6.5  Summary  and  conclusions 
The  studies  presented  in  this  chapter  have  demonstrated  a 
correlation  between  cyclin  A  and  BrdU  labelling  indices.  The  former,  as 
was  to  be  expected,  were  higher  than  the  BrdU  labelling  indices.  There 
was  also  the  possibility  that  the  cyclin  A  protein  was  being  overexpressed 
or  abnormal,  especially  in  more  severely  dysplastic  lesions.  This  may  limit 
the  application  of  this  technique  for  studies  of  the  kinetics  of  tissues  but  in 
normal  or  non  clysplastic  tissues  it  would  appear  that  cyclin  A  is  a  viable 
alternative  to  BrdU  in  the  study  of  the  S-phase. 
Expanding  the  work  of  Chapter  2,  it  was  demonstrated  that  BrdU 
could  be  used  successfully  with  formalin  fixation  and  antigen  retrieval  and 
its  use  could  be  combined  with  other  antibodies  that  recognise  cell  cycle- 
associated  proteins  such  as  Ki67.  From  the  very  limited  follow-up  times  of 
the  new  series  of  BrdU  incubated  cases  it  is  not  yet  possible  to  apply  the 
data  regarding  S:  GF  which  appeared  promising  in  Chapter  2  as  a  possible 
marker  of  prognosis.  The  alternative  use  of  cyclin  A  and  Ki67  was  not 
investigated  on  archival  material  where  long  term  clinical  data  would  be 
available  but  this  is  a  possible  avenue  of  further  study. 
167 Table  6.1  Patient  clinical  details  and  subjective  histological  grading 
Case  Sex  Age  Clinical  lesion  Site  of 
biopsy 
Histology 
1  f  67  leukoplakia  fom*  mild  dysplasia 
2  m  50  erythroplakia  forn  mild/mod  dysplasia 
3  f  39  leukoplakia  ton  hyperplasia 
4  m  31  leukoplakia  forn  mild  dysplasia 
5  M  50  leukoplakia  ton  moderate  dysplasia 
6a  f  34  leukoplakia  forn  moderate  dysplasia 
7  m  58  leukoplakia  forn  keratosis 
8  f  47  leukoplakia  ton  severe  dysplasia 
9  m  63  leukoplakia  ton  mild  dysplasia 
job  M  78  leukoplakia  ton  keratosis 
11  M  52  leukoplakia  forn  mild  dysplasia 
12-  f  31  leukoplakia  forn  mild/mod  clysplasia 
13  f  66  leukoplakia  ton  mild/mod  clysplasia 
14  f  62  leukoplakia  forn  mild  clysplasia 
15  M  50  leukoplakia  ton  keratosis 
*fom=  floor  of  mouth,  ton=  tongue 
"biopsy  from  same  patient  as  case  7  in  original  series  (Chapter2) 
b  biopsy  from  same  patient  as  cases  11  and  15  of  the  original  series 
cbiopsy  from  same  patient  as  case  19  of  the  original  series 
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170 Table  6.4  Summary  of  results  for  series  of  18  cases  from  Chapter  5 
Case  Ki67 
Ll%  LIIBL 
Cyclin  A 
Ll%  LIIBL 
1  32.95  146.74  17.74  74.91 
2  52.28  208.61  26.98  102.12 
3  50.32  166.62  31.23  99.84 
4  22.54  96.32  7.17  22.09 
5  39.58  151.80  16.47  60.19 
6  35.14  109.54  14.92  46.79 
7  21.97  136.07  16.88  73.89 
8  18.15  63.12  11.71  35.41 
9  40.79  292.12  13.85  94.31 
10  28.30  162.24  13.19  74.28 
11  26.18  124.86  18.84  74.79 
12  30.24  181.25  22.01  106.89 
13  30.22  160.26  24.87  112.73 
14  24.27  75.37  10.66  28.94 
is  26.63  134.64  13.92  61.31 
16  29.81  101.99  10.50  33.41 
17  26.90  91.32  11.14  34.80 
18  32.08  171.75  14.85  72.12 
Mean  31.57  143.03  16.50  67.16 
SD  9.22  53.80  6.29  28.80 
Min  18.15  63.12  7.17  22.09 
Max  52.28  292.12  31.23  112.73 
171 Table  6.5  Mean  labelling  indices  by  site 
A.  Tongue  (14  cases) 
Epithelial  BrdU  Ki67  Cyclin  A 
thickness  L1%  LI/BL  Ll%  LIIBL  Ll%  LIIBL 
Mean  217.91  10.82  37.82*  26.25  100.59*  16.02  48.62* 
SD  128.07  3.03  11.96  13.31  65.20  8.60  22.68 
Min  59.51  6.21  17.02  11.17  35.28  8.12  23.46 
Max  437.57  17.34  59.46  60.05  294.99  38.93  106.64 
B.  Floor  of  mouth  (21  cases) 
Epithelial  BrdU  Ki67  Cyclin  A 
-  thickness  Ll%  LIIBL  Ll%  LIIBL  Ll%  LIIWL 
Mean  164.39  11.10  48.39*  29.89  146.60*  17.33  66.20* 
SD  64.10  3.09  19.07  15.22  106.59  8.80  32.61 
Min  79.07  7.04  29.16  14.21  69.74  7.17  26.03 
Max  360.24  20.75  114.28  73.12  553.35  48.56  154.03 
*Significantly  different  groups  (p<0.05) 
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Figure  6.2  Illustrates  the  characteristic  cytoplasmic  staining  obtained 
with  anti  cyclin  A  antibody  (magnification  x478) 
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Figure  6.3  Illustrating  case  number  3  from  the  original  BrdU  series  of 
Chapter  2  with  a  high  cyclin  A  labelling  index  and  lack  of  basal 
staining  (magnification  x236) 
174 to 
e 
to 
0 
J) 
le 
cn 
iz 
CD 
0!  -  1; 
92 
sc 
Co) 
f-) 
fi) 
1  --  . 
1  "b  ga  ee  *a  .  sa 
Q  in«-.  *  ga 
69 
91 
zi 
l 
ag 
OK 
E 
%4- 
U) 
U) 
(0 
OL 
U) 
12 Cl. 
.;, 
8(0 
-0  " 
E 
9c 
«o 
c 
. 
c-  Co  C.  )  ý 
C  C) 
ry 
CL 
x_-  Z 
h-  L) 
175 Chapter  7 
Overall  discussion,  summary  and  conclusions 
176 7.1  Introduction 
The  work  presented  in  the  preceding  five  chapters  has  centred 
around  the  cell  cycle  in  oral  precancerous  lesions.  The  initial  aims  of  the 
work  were  to  investigate  more  objective  assessments  of  dysplastic  lesions 
in  oral  epithelium  with  a  possible  view  to  their  use  as  prognostic  indicators. 
During  the  course  of  the  thesis  the  emphasis  has  changed  a  little  with  the 
kinetic  events  of  the  cell  cycle  being  investigated  but  still  where  possible 
being  related  to  the  dysplasia. 
7.2  Materials  and  methods 
7.2.1  Material 
Three  series  of  cases  of  dysplasia  were  studied  during  the  course 
of  the  thesis.  Two  of  these  were  samples  collected  prospectively  because 
fresh  tissue  was  required  for  incubation  with  BrdU.  The  third  series  was 
obtained  from  archival  tissues  in  an  attempt  to  study  cell  cycle  associated 
markers  without  the  need  to  collect  fresh  tissue.  One  aim  of  this  was  to 
negate  the  requirement  for  prospective  collection  of  samples.  Despite  oral 
cancer  being  prevalent  in  the  West  of  Scotland,  the  prevalence  of 
precancerous  lesions  is  surprisingly  low.  The  archival  series  of  cases  used 
in  Chapters  5  and  6  represented  nearly  all  of  the  dysplastic  lesions  of  the 
tongue  and  floor  of  mouth  for  the  year  of  1996  with  the  exception,  of 
course,  of  those  lesions  for  which  biopsies  were  collected  for  the  BrdU 
study.  These  were  carefully  selected,  however,  to  exclude  those  lesions 
177 that  had  associated  pathology  most  commonly  lichenoid  reactions  and 
fungal  infection.  As  discussed  previously,  the  relative  importance  of 
clysplasia  in  lichenoid  lesions  and  lichen  planus  is  the  subject  of  much 
debate  in  the  literature  and  warrants  a  study  of  this  size  in  its  own  right. 
Similarly,  the  number  of  cases  collected  during  the  course  of  the  study 
was  relatively  few.  However,  with  the  potentially  vast  archives  of  tissue  for 
which  clinical  follow-up  data  would  be  available  the  development  of 
methods  applicable  to  this  form  of  material  would  be  desirable  when  the 
prognostic  implications  of  such  investigations  are  of  prime  importance. 
A  further  potential  source  of  material  for  the  study  of  oral  epithelial 
dysplasia  would  be  that  related  to  existing  carcinomas,  an  approach 
adopted  by  Wright  and  Shear  (1985)  but  not  generally  adopted  by  the 
majority  of  researchers.  Indeed,  for  the  present  studies  this  was 
investigated.  However,  on  observing  the  sections  from  the  files  it  was  felt 
that  in  many  of  the  specimens  the  epithelium  was  poorly  orientated  and 
often  sectioned  obliquely  which  would  not  be  ideal  for  the  kind  of  studies 
performed  here. 
The  study  of  normal  human  oral  mucosa  is  a  potential  problem  as 
by  nature  of  a  pathology  department  biopsies  are  taken  due  to  a 
pathological  lesion  being  present.  Studies  that  do  use  "normal"  tissue 
often  utilise  the  epithelium  overlying  such  lesions  as  reactive  fibrous 
lesions,  mucoceles  or  amalgam  tattoos.  By  the  nature  of  some  of  these 
lesions  the  epithelium  could  be  expected  to  have  an  increased  rate  of 
178 proliferation  and  would  not  be  the  ideal  control  for  studies  of  this  kind. 
Also,  the  tobacco  and  alcohol  consumption  of  patients  from  whom  such 
tissues  are  obtained  are  never  quoted;  it  is  now  widely  accepted  that  such 
habits  affect  the  whole  oral  mucosa  and  could  reasonably  affect  the 
epithelial  cell  proliferation  in  apparently  clinically  normal  mucosa.  The 
ideal  normal  tissue  would  be  obtained  from  healthy  non-smoking 
volunteers.  For  an  invasive  procedure  such  as  a  biopsy,  volunteers  might 
be  difficult  to  obtain.  As  demonstrated  in  the  study  of  Chapter  4,  post- 
mortern  tissue  is  an  attractive  option.  Admittedly,  in  this  study  the  tobacco 
habits  were  unknown  but  could  have  been  obtained.  However,  this  was 
not  relevant  to  the  aim  of  this  study  which  was  to  investigate  the  apparent 
anomaly  of  Ki67  immunoreactivity  observed  in  clysplastic  lesions  in 
histologically  normal  epithelium.  Investigating  the  use  of  post-mortem  )' 
material  for  cell  proliferation  studies  does  not  appear  to  have  been 
performed  previously.  This  potentially  fruitful  source  of  material  may  be 
somewhat  limited  by  the  declining  number  of  post-mortem  examinations 
being  performed  in  the  UK  over  recent  years  (Start  et  aL,  1993)  and  the 
fact  that  most  post-mortems  are  performed  on  individuals  of  an  older  age 
group. 
7.2.2  Methods 
One  of  the  basic  methods  used  extensively  in  this  thesis, 
immunohistochernistry,  is  one  that  is  well  established  and  widely  utilised  in 
studies  of  oral  epithelial  clysplasia.  It  has  the  advantage  over  the  more 
179 recently  developed  molecular  techniques  of  allowing  the  visualisation  of 
the  proteins  in  situ  and  their  relationship  to  the  adjacent  cells  and  tissues. 
The  field  of  immunohistochemistry  has  been  revolutionised  by  the 
development  of  antigen  retrieval  (Shi  et  aL,  1991)  which  has  enabled 
many  antigens  to  be  visualised  in  fixed  and  processed  tissue  which  had 
previously  not  been  possible.  However,  numerous  workers  have  rightly 
highlighted  some  of  the  potential  problems  with  this  procedure.  Most 
notably  is  the  variation  of  staining  intensities  achieved  using  different 
methods  of  antigen  retrieval  with  different  antibodies  and  tissues  as  was 
observed  and  demonstrated  in  the  present  studies.  An  attempt  to  solve 
this  problem  has  been  the  use  of  a  so  called  test  battery  to  be  performed 
with  each  new  antibody  or  tissue.  One  drawback  of  antigen  retrieval 
experienced  in  the  present  study  was  the  occasional  loss  of  tissue  from 
the  slides.  When  this  did  occur  it  was  consistently  with  the  same  cases 
and  may  reflect  some  factor  related  to  the  processing  of  the  tissue. 
Related  to  this  is  the  common  observation  of  increased  artefacts  following 
antigen  retrieval. 
Another  method  developed  during  the  course  of  this  thesis  is  the 
use  of  computer  assisted  technology  for  the  digital  capture,  manipulation 
and  quantification  of  images.  As  demonstrated  in  Chapter  5,  this  enabled 
the  enhancement  of  images  to  render  them  quantifiable  where  this  would 
have  previously  not  been  possible  using  a  conventional  microscope  alone. 
Although  the  software  potentially  allows  automated  counting  of  cells  the 
180 subjective  nature  of  sometimes  interpreting  positively  antibody  labelled 
cells  made  this  approach  undesirable  for  the  present  study.  Also,  the  time 
taken  to  set  the  parameters  for  this  kind  of  automation  is  similar  to  the 
time  taken  to  measure  and  count  the  images  manually.  The  most  time 
consuming  aspect  of  this  procedure  was  actually  locating  the  fields  and 
capturing  the  images. 
7.3  Discussion  of  the  results 
The  studies  presented  in  this  thesis  have  generated  large  amounts 
of  numerical  data  despite  the  relatively  small  numbers  of  cases.  A 
potential  problem  is  the  interpretation  of  this  data  with  respect  to  the  cell 
kinetics  of  the  tissues.  Indeed,  the  kinetic  aspects  of  the  data  have  been 
cautiously  interpreted,  the  data  have  largely  been  used  as  a  comparison 
with  other  cell  cycle  associated  markers,  the  atypia  scores  and  have  been 
related  where  possible  to  the  clinical  outcome. 
There  is  no  easily  adopted  approach  for  the  objective  assessment 
of  oral  epithelial  clysplastic  lesions.  Although  a  number  of  the  markers 
studied  in  this  thesis  have  shown  associations  with  the  atypia  scores  their 
routine  use  in  assessments  seems  unlikely.  The  semi-objective  scoring 
technique  of  Smith  and  Pindborg  (Smith  and  Pindborg,  1969)  used 
throughout  this  thesis  has  not  been  widely  adopted  by  the  majority  of 
researchers.  From  the  author's  experience  of  the  method  this  is  not 
surprising  since  it  is  a  very  time  consuming  procedure  if  performed 
181 correctly.  However,  this  remains  the  only  reliable  method  to  introduce  a 
degree  of  objectivity  into  such  studies. 
The  results  from  Chapter  2  demonstrated  that  BrdU  labelling 
indices  provided  a  possible  objective  assessment  of  oral  epithelial 
dysplasia.  Although  the  finding  that  a  high  S-phase  to  growth  fraction  ratio 
was  in  the  first  series  of  cases  associated  with  malignant  transformation  of 
the  lesions  this  was  interpreted  cautiously.  A  further  longer  term  follow-up 
of  these  patients  is  required  and  due  to  the  often  prolonged  natural  history 
of  such  lesions  this  would  ideally  be  for  as  long  as  possible.  Indeed,  the 
aspect  of  follow-up  of  these  patients  has  highlighted  some  problems  with 
the  current  system  employed  in  the  Glasgow  Dental  Hospital.  It  will  be 
interesting  to  follow  up  the  additional  series  of  patients  from  whom 
biopsies  were  collected  in  Chapter  6  and  to  see  if  cyclin  A  really  has  a  role 
as  an  alternative  to  BrdU  labelling  in  assessment  of  the  S-phase.  The 
development  of  formalin  fixation  for  the  BrdU  processed  tissue  enabled 
sequential  sections  to  be  used  with  other  proliferation  markers  and  should 
have  provided  more  accurate  comparisons  than  the  previous  studies  in 
Chapter  2. 
From  a  practical  point  of  view  with  regard  to  quantification,  BrdU 
was  the  least  subjective  of  all  the  markers  studied,  although  cyclin  A 
immunohistochemical  staining  was  equivalent  in  most  cases,  generally 
producing  definite  nuclear  staining  despite  cytoplasmic  staining  being 
common.  Once  antigen  retrieval  was  Optimised  the  staining  characteristics 
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cyclin  antibodies  was  generally  less  clear-cut  and  required  image 
enhancement  to  enable  quantification  which  despite  this  was  sometimes 
open  to  subjective  interpretation  of  positive  cells. 
From  the  studies  of  Chapters  2  and  4,  it  was  evident  that  Ki67  was 
not  identifying  all  those  cells  which  would  have  been  expected  to  be  in  the 
growth  fraction  and  hence  in  the  active  phases  of  the  cell  cycle  as  it  was 
claimed  to  do  (Gerdes  et  aL,  1983).  The  generally  high  expression  of  the 
G,  cyclins  and  distribution  of  the  D  cyclins  similar  to  that  of  Ki67  meant 
these  were  probably  not  identifying  those  cells  of  the  G,  phase  which  were 
not  being  identified  by  Ki67.  Indeed,  the  studies  of  the  D  cyclins  and  cyclin 
E  probably  created  more  questions  than  answers  in  the  present  study. 
Until  the  precise  role  of  these  proteins  is  'established  in  the  cell  they 
probably  are  of  little  value  in  the  study  of  cell  proliferation. 
The  cross-reactivity  of  the  anti-cyclin  D3  antibody  with  the  smooth 
muscle  of  the  blood  vessels  was  unexpected  and  to  the  authors 
knowledge  has  not  been  reported  previously. 
7.4  Conclusions 
Throughout  this  thesis  numerical  data  has  been  obtained  from 
immunohistochernically  stained  tissue  sections.  The  author  appreciates 
the  limitations  of  making  judgements  based  on  this  due  to  the  inherently 
subjective  nature  of  the  interpretation  Of  positivity.  The  figures  obtained 
are,  at  best,  only  an  estimation  and  in  reality  reflect  a  range  of  values.  It  is 
183 also  appreciated  that  there  are  many  potential  sources  of  error  that  could 
have  been  introduced  at  each  stage.  Firstly  there  is  the  matter  of  sampling 
of  the  lesions  which  may  not  be  truly  representative  of  the  lesion  as  a 
whole.  Secondly  within  the  biopsy  a  limited  number  of  fields  were 
examined  sometimes  only  in  one  tissue  section  which  again  may  not  be 
truly  representative  of  the  lesion  as  a  whole. 
From  the  studies  reported  here  it  was  concluded  that  BrdU  remains 
the  "gold  standard"  for  the  investigation  of  the  S-phase  in  precancerous 
and  cancerous  lesions,  although  cyclin  A  is  promising  for  the  study  of  the 
S-phase  in  minimally  dysplastic  and  normal  tissues.  BrdU  studies  provided 
some  objectivity  with  regard  to  assessment  of  the  degree  of  dysplasia 
within  the  precancerous  lesions  studied  but  this  will  probably  not  be  of 
great  value  in  diagnostic  practice. 
An  ideal  study  would  have  compared  the  results  obtained  in 
Chapter  2  with  normal  mucosa  but  the  problems  of  obtaining  such  tissues 
has  been  discussed  in  Section  7.2.1. 
Once  antigen  retrieval  conditions  were  optimised,  Ki67  was  a  useful 
adjunct  in  the  study  of  cell  proliferation  states  in  oral  precancerous  lesions 
-  despite  its  now  known  drawback  of  not  identifying  all  of  the  cycling  cells. 
Although  an  attractive  idea,  the  ratio  of  the  S-phase  to  the  growth  fraction 
requires  more  study  before  its  usefulness  as  a  prognostic  indicator  can  be 
proven. 
The  G,  cyclins,  Dl,  D3  and  E,  did  not  contribute  at  this  stage 
184 specifically  to  the  study  of  oral  epithelial  dysplasia,  but  have  contributed  to 
the  growing  body  of  data  on  cyclins  and  various  disease  states.  The 
specificity  of  the  antibodies  used  in  this  study  requires  further 
investigation. 
7.5  Suggestions  for  future  research 
From  the  preceding  chapters  and  the  review  of  the  literature  it  is 
clear  that  long  term  follow  up  of  oral  precancerous  lesions  will  be  essential 
to  determine  the  possible  prognostic  value  of  the  parameters  studied  in 
this  thesis.  One  possible  approach  to  this  is  to  study  groups  of  archival 
cases  where  the  outcome  of  the  lesions  is  known.  Retrospective  studies 
often  have  the  disadvantage  of  incomplete  data  recording  and  properly 
constructed  prospective  studies  are  much  more  likely  to  be  helpful. 
If  sufficient  lesions  of  idiopathic  leukoplakia  could  be  identified, 
studies  of  these  lesions  either  with  cell  cycle-associated  markers  or  other 
markers  are  advocated  to  investigate  their  differing  pathogenesis  and 
apparently  greater  potential  for  malignant  transformation. 
In  the  field  of  cell  cycle  research,  a  number  of  areas  highlighted  in 
this  thesis  require  further  study.  First  there  is  the  expression  of  the  Ki67 
protein  and  its  precise  function  within  cells.  Once  this  has  been 
established  it  may  be  of  more  value  particularly  in  cell  kinetic  studies. 
Further  studies  of  the  HsMCM/BM28  antigen  (Todorov  et  aL,  1998)  as 
discussed  in  Section  1.5.10  are  advocated  to  see  if  this  truly  represents  all 
185 cycling  cells  unlike  Ki67. 
With  regard  to  the  cyclins,  the  expression  of  the  D  cyclins  in  oral 
epithelial  dysplastic  lesions  could  be  studied  by  other  techniques.  In  the 
first  instance,  looking  at  the  D  cyclin  mRNA  levels  within  the  cells  would 
give  a  good  initial  indication  whether  or  not  the  protein  was  being 
overexpressed.  Reverse  transcriptase  PCR  or  in  situ  hybridisation  would 
be  appropriate  techniques  for  this  kind  of  study. 
Other  antibodies  have  become  available  for  studying  proteins 
related  to  the  cyclins,  such  as  the  CDKs  or  the  CDKIs.  Investigation  of 
these  may  enhance  the  understanding  of  their  related  cyclins. 
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216 Appendix  1.  Features  of  dysplasia 
1.  drop-shaped  rete  ridges 
2.  irregular  epithelial  stratification 
3.  keratinisation  below  the  keratinised  layer  and  individual  cell 
keratinisation 
4.  basal  cell  hyperplasia 
5.  loss  of  intercellular  adherence 
6.  loss  of  polarity  of  the  basal  cell  layer 
7.  hyperchromatic  nuclei 
8.  increased  nuclear:  cytoplasmic  ratio 
9.  anisonucleosis  and  anisocytosis 
10.  pleornorphic  nuclei  and  cells 
11.  increased  numbers  of  mitoses 
12.  mitoses  present  above  the  basal  layers 
13.  bizarre  or  abnormal  mitoses 
The  above  features  are  those  cited  by  Smith  and  Pindborg  (1969)  forming 
the  basis  for  their  scoring  system.  The  current  WHO  guidelines  include  the 
above  features  and  add  the  presence  of  prominent  nucleoli  (Pindborg  et 
aL,  1997). 
217 Appendix  2.  Working  solutions 
Carnoy's  fixative  (Pearse,  1980) 
Ethyl  alcohol  60  ml 
Chloroform  30  ml 
Glacial  acetic  acid  10  ml 
10%  buffered  formalin 
Made  from  neutral  buffered  formaldehyde  concentrate  (Genta  Medical, 
York,  UK)  diluted  1  in  5  with  distilled  water.  Constituents  when 
reconstituted  (pH  7.0): 
formaldehyde  solution  10%  V/V 
sodium  phoshphate  0.65%  w/v 
sodium  acid  phosphate  0.35%  w/v 
Bromodeoxyuridine  (M,  307.1) 
used  in  a  solution  of  4x1 
0-4M  (=0.0004M) 
15ml  of  solution  used  per  incubation 
measure  out  1.84mg  BrdU  into  glass  universal  containers,  store  at  - 
20'C 
add  15ml  minimum  essential  medium  (MEM)  to  container  prior  to  use 
TBS  (Tris-buffered  Saline) 
Comprises  0.05M  Tris/HCI 
0.15M  NaCl 
at  pH  7.6 
11  51  101 
Trizma  HCI  tj.  Ubg  30.3g  60.6g 
(Sigma) 
Trizma  Base  1.39g  6.95g  13.9g 
(Sigma) 
NaCl  8.76g  43.8g  87.6g 
218 Antigen  retrieval  buffers 
Citrate,  buffer  pH  6.0 
Dissolve  2.1  gm  citric  acid  monohyd  rate  in  11  of  water. 
Adjust  pH  with  sodium  hydroxide  to  pH  6.0 
I  rnM  EDTA  pH  8.0 
"  Mw  EDTA  disodium  salt  372.24 
"  to  make  51,  dissolve  1.96g  in  51  dH20 
"  adjust  to  pH  8.0  with  sodium  hydroxide 
0.01M  acetate  pH  2.0 
1M  sodium  acetate  solution  prepared  by  dissolving  82.04  g  anhydrous 
(1  36.09g  crystals)  in  distilled  water  and  making  up  to  11. 
to  make  pH  2  solution,  100  ml  of  sodium  acetate  and  105  ml  of  IM  HCI 
and  make  up  to  500  ml  with  distilled  water 
219 Appendix  3.  Histological  methods  (Bancroft  and  Stevens,  1990) 
Haernatoxylin  and  Eosin 
Mayers  haernatoxylin  solution 
haematoxylin  2.5g 
water  2500ml 
potassium  alum  125g 
sodium  iodate  0.5g 
citric  acid  2.5g 
chloral  hydrate  125g 
1%  acid  alcohol  solution 
hydrochloric  acid  25ml 
alcohol  2475ml 
Scott's  tap  water  substitute 
magnesium  sulphate,  50g 
sodium  bicarbonate  8.75g 
water  2500ml 
thymol  1  crystal 
1%  eosin 
calcium  chloride  12.5g 
water  2500ml 
eosin  25g 
Method 
1.  dewax  sections  in  xylene  and  rehydrate  through  graded  alcohols  to 
water 
2.  stain  nuclei  with  haernatoxylin  for  10  minutes 
3.  rinse  in  water 
4.  differentiate  in  1%  acid  alcohol  for  5  sec 
5.  rinse  in  water 
6.  blue  in  Scott's  tap  water  substitute 
7.  wash  in  water 
8.  counterstain  in  eosin  for  10  seconds 
9.  dehydrate,  clear  and  mount 
220 Periodic  acid  Schiff  (PAS) 
1.  sections  to  water 
2.  oxidise  in  1%  periodic  acid  for  10  minutes 
3.  wash  well  with  water 
4.  wash  in  water 
5.  immerse  in  Schiff  reagent  (Sigma)  for  30  minutes 
6.  wash  well  with  water 
7.  counterstain  with  haernatoxylin 
8.  wash  with  water 
9.  differentiate  with  1%  acid  alcohol 
10.  wash  with  water 
11.  blue  in  Scoffs  tap  water  solution 
12.  rinse  in  water 
13.  dehydrate,  clear  and  mount 
221 Appendix  4  Smith  and  Pindborg  atypia  scoring  technique 
Feature  Objective 
magnification 
Score 
1.  "drop-shaped"  rete  ridges  X10  0/2/4 
2.  irregular  epithelial  stratification  X10  0/215 
3.  keratinisation  below  the  keratinised  layer  X10  0/1/3 
4.  basal  cell  hyperplasia  X10  0/1/4 
5.  loss  of  intercellular  adherence  X10  01115 
6.  loss  of  polarity  X10  0/216 
7.  hyperchromatic  nuclei  X10  012/5 
8.  increased  nuclear-cytoplasmic  ratio  x40  0/2/6 
9.  anisocytosis  and  anisonudeosis  x40  0/216 
10.  pleomorphic  cells  and  nuclei  x40  0/2/6 
11.  mitotic  activity  x40  0/1/5 
12.  level  of  mitotic  activity  x40  013110 
13.  bizarre  mitoses  x40  016/10 
14.  hyperplasia/  atrophy 
15.  surface  characteristics 
Total  score 
For  each  of  the  individual  features  sections  are  examined,  compared  with 
photographic  standards  and  assigned  a  grade;  0  if  the  feature  is  not 
present,  the  middle  score  if  the  feature  is  slight  and  the  highest  score  if 
the  feature  is  marked.  The  sum  of  the  individual  scores  produces  the 
atypia  score.  Features  14  and  15  are  not  given  numerical  scores. 
222 Appendix  S.  Reagents 
feagent  Full  Name  Company  Code 
Anti-BrdU  Monoclonal  mouse  Anti-  Dako  M0744 
bromodeoxyuridine  clone  Bu20a 
Anti-Cyclin  A  Monoclonal  mouse  anti-cyclin  A  antibody  Novocastra  NCL-CYCLIN  A 
Anti-Cyclin  DII  Monoclonal  mouse  anti-cyclin  DI  Novocastra  NCL-CYCLIN 
antibody  D1-GM 
Anti-Cyclin  D3  Monoclonal  mouse  anti-cyclin  D3  Novocastra  NCL-CYCLIN  D3 
antibody 
Anti-Cyclin  E  Monoclonal  mouse  anti-cyclin  E  antibody  Novocastra  NCL-CYCLIN  E 
Anti-KI67  Monoclonal  mouse  anti-human  Ki67  Dako  M0722 
antigen  cJone  Ki67 
Anti-NCL  Ki67  MMI  Mouse  monoclonal  antibody  NCL-Ki67-  Novacastra  NCL-Ki67-MM1 
MMI  clone  MMI 
BrdU  5!  -bromo-2-deoxyuddine  Sigma  B5002 
Citric  Acid  Citric  Acid  monohydrate  BDH 
DAB  3,3'diaminobenzidine  tetrahydrcholoride  Sigma  D5905 
DAB  Substrate  Kit  DAB  Substrate  Kit  for  peroxidase  Vector  SK4100 
EDTA  Ethylenediamininetetraacetic  acid  BDH  44388-2G 
disodium  salt 
HCI  IM  HCI  CONVOL  Concentrate  BDH  18036/513 
Hydrogen  Peroxide 
MEM 
NaCl 
NAP-5-Columns 
Polysine 
SG  Substrate  Kit 
Superfrost  Plus 
Tlzma HCI 
Trizma  base 
Trypsin 
Vectastain  Elite  ABC 
Kit 
VIP  Substrate  Kit 
BDH 
Minimum  essential  medium  (Eagles)  with  GIBCO 
glutamax-I  with  Earles  salts 
Sodium  Chloride  BDH 
NAP-5-column  Sephadex  G25  Pharmacia 
Silane  coated  slides  BDH 
SG  Substrate  Kit  for  peroxidase  Vector 
Microscope  slides  BDH 
Tris[hydroxymethyq  amino-methane  Sigma 
hydrochloride 
Tds[hydroxymethyq  amino  methane  Sigma 
Mouse  IgG 
VIP  Substrate  Kit  for  peroxiclase 
Dako 
Vector 
Vector 
10128N 
41090-028 
30123-50 
17-0853-01 
406/0178/00 
SK4700 
406/0179/00 
T3253 
T1503 
S2012 
PK6102 
SK4600 
223 Appendix  6.  KS300  macro  for  the  quantification  of  cyclins  (Chapter  6) 
1.  ################################ 
2.  ##Cyclin  Study################## 
3.  ##Oral  Epithelial  dysplasia##### 
4.  ################################ 
5.  ##Richard  Oliver################ 
6.  ##Glasgow  Dental  Hospital####### 
7.  ##February  1997################# 
8.  ################################ 
9.  #  start 
10.  tvframe  6,28,512,512 
ll.  ################################ 
12.  ##First-delete  all  images  in  gallery 
13.  imgdelete 
14.  Gclear  0 
15.  ################################ 
16.  ##Open  display  windows 
17.  ################################ 
18.  showwindow  "Display",  l 
19.  showwindow  "Messages",  l 
20.  showwindow  "Gallery",  l 
21.  ################################## 
22.  ##Capture  image 
23.  case  -  "962 
24.  tvlive 
25.!  tvwbalance  1 
26.  tvinput  1 
27.  imgdisplay  1 
28.  ################################## 
29.  path  =  "c:  /ks300/conf/images/cyclinDl'I 
30.  imgsetpath  path 
31.  read  case,  "Enter  case  number" 
32.  write 
33.  write 
34.  write 
35.  write  "  Case  number:  ",  case 
36.  write  "  Cyclin  Dl" 
37.  imgsave  l,  case+".  bmpff 
38.  ################################## 
39.  ##enhance  contrast 
40.  ################################ 
41.  normalize  1,2,9 
42.  ##Now  measurements  for  cyclinD1 
43.  ################################ 
44.  MSload  "x20" 
45.  MSload  "basalx20" 
46.  MSmeaspoint  2,  "lbmx20",  1,13,  l,  2,2,2 
47.  Gmerge  2,255 
48.  MSload  "s  basal" 
49.  MSmeaspoiRt  2,  'Isuprax20II,  l,  l0,  l,  2,2,2 
50.  Gmerge  2,255 
51.  MSload  "basnill 
52.  MSmeaspoint  2,  "basnl",  1,12,  l,  2,2,  l 
53.  Gmerge  2,255 
54.  MSload  "totalx2011 
55.  MSmeaspoint  2,  "totalff,  l,  1,  l,  2,2,  l 
56.  Gclear  0 
57.  ################################ 
58.  write  "  Case  number:  ",  case 
59.  write  "  Cyclin  D3" 
60.  ################################ 
61.  tvlive 
224 62.!  tvwbalance  3 
63.  tvinput  3 
64.  imgdisplay  3 
65.  ################################## 
66.  path  -  "c:  /ks300/conf/images/cyclinD3'I 
67.  imgsetpath  path 
68.  imgsave  3,  case+".  bmp" 
69.  ################################ 
70.  normalize  3,4,4 
71.  ################################ 
72.  ##Now  measurements  for  cyclinD3 
73.  ################################ 
74.  MSload  "x20" 
75.  MSload  "basalx20" 
76.  MSmeaspoint  4,  "lbmx2O",  1,13,1,2,2,2 
77.  Gmerge  4,255 
78.  MSload  "s  basal" 
79.  MSmeaspoint  4,  "suprax2O",  1,14,1,2,2,2 
80.  Gmerge  4,255 
81.  MSload  "basnl" 
82.  MSmeaspoint  4,  "basnl",  1,9,1,2,2,1 
83.  Gmerge  4,255 
84.  MSload  "totalx20" 
85.  MSmeaspoint  4,  "total",  1,1,1,2,2,1 
86.  ################################ 
87.  Gclear  0 
88.  ################################ 
89.  tvlive 
90.!  tvwbalance  5 
91.  tvinput  5 
92.  imgdisplay  5 
93.  ################################### 
94.  path  -  "c:  /ks300/conf/images/Ki6711 
95.  imgsetpath  path 
96.  imgsave  5,  case+".  bmp" 
97.  ################################ 
98.  write  Case  number:  ",  case 
99.  write  Ki67" 
100.  ################################ 
101.  normalize  5,6,9 
102.  ##Now  measurements  for  Ki67 
103.  ################################ 
104.  MSload  "x20" 
105.  MSload  "basalx20" 
106.  MSmeaspoint  6,  "lbmx2O",  1,13,1,2,2,2 
107.  Gmerge  6,255 
108.  MSIoad  "s-basal" 
109.  MSmeaspoint  6,  "suprax2011,  l,  l4,1,2,2,2 
11O.  Gmerge  6,255 
iii.  MSload  "basnlvt 
112.  MSmeaspoint  6,  "basnl",  1,9,1,2,2,  l 
113.  Gmerge  6,255 
114.  MSIoad  "totalx20" 
115.  MSmeaspoint  6,  "total",  1,1,1,2,2,  l 
116.  ################################ 
117.  Gclear  0 
118.  ################################ 
119.  write  "  Cyclin  E" 
120.  ################################ 
121.  tvlive 
122.!  tvwbalance  7 
123.  tvinput  7 
124.  imgdisplay  7 
225 125.  ################################# 
126.  path  =  'Ic:  /ks3OO/conf/images/cyclinE" 
127.  imgsetpath  path 
128.  imgsave  7,  case+".  bmp" 
129.  ################################# 
130.  ################################ 
13l.  normalize  7,8,9 
132.  ##Now  measurements  for  cyclinE 
133.  ################################ 
134.  MSload  "x20" 
135.  MSload  "basalx20" 
136.  MSmeaspoint  8,  "lbmx2O",  l,  l3,1,2,2,2 
137.  Gmerge  8,255 
138.  MSload  "s  basal" 
139.  MSmeaspoint  B,  Ilsuprax2O",  l,  l4,1,2,2,2 
140.  Gmerge  8,255 
141.  MSload  "basnl" 
142.  MSmeaspoint  8,  "basnlI',  l,  9,1,2,2,  l 
143.  Gmerge  8,255 
144.  MSload  "totalx20" 
145.  MSmeaspoint  8,  "total",  1,1,1,2,2,1 
146.  ################################ 
147.  Gclear  0 
148.  ##close  down  windows 
149.  ################################ 
150.  showwindow  "Display",  O 
151.  showwindow  "Gallery",  O 
152.  showwindow  "Messages",  O 
153.  ################################ 
154.  stop 
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